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Ultraviolet radiation (UVR) results in a transient suppression of selected immune
responses to antigens encountered following exposure. Urocanic acid (UCA), found
in the stratum corneum of the epidermis as the rrans-isomer, absorbs UV light
whereupon it changes to the cis-isomer. Cis-UCA mimics many of the suppressive
effects ofUVR on immune responses.
Previously cA-UCA has been shown to produce a dose dependent, antigen specific
suppression of the delayed hypersensitivity (DH) response to herpes simplex virus
(HSV) in a murine model of infection, in an identical manner to UVB-irradiation. A
time course of DH revealed an initial response 1 hour after antigen challenge,
followed by a second response at 24 hours, both of which were suppressed if the
mouse had been UV irradiated or treated with cis-UCA prior to infection. Skin
painting murine ears with cA-UCA resulted in a reduction in the number of ATPase
positive cells (Langerhans cells) in epidermal sheets prepared 24 hours later, while
trans-UCA had no effect. In an attempt to elucidate the mechanism of action of cis-
UCA two histamine receptor antagonists were employed; cimetidine (H2) and
terfenadine (HI). When cis-VCA was applied together with either of the antagonists
no significant reduction in the number of ATPase positive cells was observed.
Similarly if cis-UCA was applied together with either antagonist the suppression of
the DH response to HSV was blocked. Thus cis-UCA may act through a histamine-
like receptor. A number of structural analogues of UCA were tested for their ability
to suppress the DH response to HSV to further elucidate the structures required to
induce immunosuppression. Tumour necrosis factor-a (TNF-a) has been implicated
to be ofmajor importance in the induction ofUV-induced immunosuppression.
Mice pretreated with neutralizing antibodies to TNF-a were found to be resistant to
the immunosuppressive effects of UV, but there was little effect on cis-UCA induced
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suppression of the DH response to HSV. These results extend the mechanism by
which cis-UCA modulates suppression of immune responses.
UVB and UVA plus psoralens (PUVA) are successfully employed in the
management of psoriasis but their use is largely empirical and little is known of their
effects on immunity. A number of parameters of immunity were measured in
patients with psoriasis undergoing UVB or PUVA therapy. These were compared
with patients receiving coal tar treatment and with normal subjects undergoing UVB
irradiation. Serum immunoglobulin (Ig) isotypes, complement components and
percentages of subsets of peripheral blood mononuclear cells (PBMC) were within
normal ranges in most of the psoriasis patients. These, and lymphoproliferative
response to HSV and to the mitogen, concanavalin A (Con A), remained unchanged
throughout therapy. Epidermal cells and blood adherent cells were used to present
HSV to PBMC enriched T cells, in a lymphoproliferative assay. The functional
antigen presenting ability of adherent cells remained unchanged throughout therapy
while that of epidermal cells was suppressed and recovered, in most instances, after
UVB therapy had been completed. The epidermis of patients with psoriasis
contained about three times the quantity ofUCA of normal subjects but no difference
was observed in suction blister fluid. During UVB irradiation, the percentage of cis-
UCA rose in both the epidermis and suction blister fluid of all subjects and it
remained elevated in the blister fluid after therapy had finished. TNF-a was
measured in suction blister fluid and its concentration did not alter consistently as a
result of therapy. Natural killer (NK) cell activity was measured in subjects
receiving broad band UVB, PUVA or TLOl narrow band (311-313 nm) therapy.
Four weeks of PUVA and TLOl therapy resulted in a significant suppression in NK
cell activity which took greater than four weeks after the last treatment to recover to
normal. Cis- but not trans-UCA resulted in a dose dependent suppression in NK cell
activity in vitro. Whether any immune modulation measured in psoriasis patients





1.1 THE SKIN IMMUNE SYSTEM
1.1.1 The Evolution Of The Concept Of The Skin Immune
System
The skin is the largest organ of the body and it carries out a number of physiological
functions including the maintenance of body temperature, production of endocrine
mediators in addition to containing peripheral neural receptors and nerve endings. It
prevents undesirable water loss and acts as a barrier to the penetration of exogenous
compounds. In addition it acts as a physical barrier to mechanical trauma,
potentially pathogenic microorganisms and the photons of sunlight.
The skin is more than a passive protective covering as it is an active component of the
immune system. This fact was potentially recognized as far back as 460 BC by
Hippocrates; Plato and Galen also believed that the skin was not merely a physical
barrier but acted like a fisherman's net, linking elements of the body which were
otherwise isolated. There is a strong historical link between early immunology and
skin physiopathology, exemplified by the experiments of Jenner, in which
observations of immune induction after vaccination with cowpox through the skin
were made. Classical subtypes of DH have been characterised in the skin, and skin
tests to evaluate DH remain one of the most reliable indicators of cell mediated
immunity.
The concept of the skin-associated lymphoid tissue (SALT) was introduced by
Streilein in 1978. This included the major antigen presenting cell of the epidermis
known as the Langerhans cell (LC), epidermotropic recirculating subpopulations of
T cells, the cytokine producing keratinocytes (KC) and also the skin-draining
peripheral lymph nodes. A number of other immunologically active cells and
mediators have since been included with SALT, for example mast cells, tissue
macrophages, neutrophilic granulocytes, indeterminate cells, veiled cells, vascular
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endothelial cells and also the afferent lymphatic endothelium (starting in the dermis).
Taken in combination with the SALT, this system was nominated the skin immune
system (SIS) by Bos and Kapsenberg (1986).
The following section is a concise summary of the immunological functions of a
number of populations of skin cells, and briefly discusses the pathways by which
they may operate in generating immune responses to antigens which are encountered
in the skin. An excellent account and full literature citation is given in "The Skin
Immune System" Bos (1990).
1.1.2 Langerhans Cells
LC were first described in 1868 by Paul Langerhans and were originally thought to be
of neural origin and function. They are now known to be the primary antigen
presenting cells (APC) of the skin, and are pivotal in generating immune responses
to antigens encountered in the skin including contact sensitizers, haptens and protein
antigens (reviewed in "Epidermal Langerhans Cells" Ed Schuler (1991); Kapsenberg
et al., 1990). The LC is the main DC of the epidermis, located below the upper
stratum granulosum, but rarely in the basal layer, and it constitutes approximately
3-4 % of the total number of epidermal cells. The dendritic processes almost connect
to form a complete network covering the epidermis as illustrated in Chapter 3 (Fig
3.2 (a) and (b)). Similar to other DC, LC are bone marrow derived (Katz et al.,
1979), have a low buoyant density (Teunissen, et al., 1988) and low phagocytic
capacity. LC are capable of inducing allogeneic T cell responses, antigen specific T
cell responses and cytotoxic T cell activation (see below).
LC exhibit unique trilaminar cytoplasmic organelles known as Birbeck granules,
which allows their identification by electron microscopy. Resident, as well as
freshly isolated LC share a number of phenotypic characteristics in common with
mononuclear phagocytic cells. A range of cell markers identified on LC are outlined
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in Table 1.1 (adapted from Romani et al., 1991). Histochemically they exhibit
nonspecific esterase and ATPase activity. Immunophenotypically they bear Fc-IgG
II and complement receptors as well as MHC class II antigens. The phenotype of LC
is not stable. In culture LC undergo profound morphological changes. They acquire
a pronounced DC morphology and the expression of some markers continuously
decreases (eg Fc-IgG II receptors, ATPase activity, Birbeck granules) whereas
others greatly increase (eg MHC II, RFD 1, CD25, CD40, CD54, CD58).
Table 1.1
LC markers
Marker Resident Freshly Isolated Cultured
LC LC LC
CD1 + +
CD4 ±/~ ? 9•
FcR IgG + +
C3R + +
HLA-DR + + ++
HLA-DP + + ++
HLA-DQ + + ++
RFD-1 + ++
ICAM-1 9• + +
LFA-3 ? ± +/++
LFA-1
ATPase + + +/-
Non-specific Esterase +
Birbeck Granules + + —
Human LC express CD4 in low quantities but murine LC do not (Schmidt et al.,
1984). Murine LC express IL-2 receptor (Steiner et al., 1986).
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These phenotypic changes are thought to be induced by granulocyte/macrophage
colony stimulation factor (GM-CSF) and interleukin (IL) -1 (Heufler et al., 1988).
Tumour necrosis factor alpha (TNF-a) does not appear to affect the morphology of
LC but does maintain their viability (Koch etal., 1990). TNF-a may also be
involved in LC migration from the epidermis to the draining lymph node (DLN)
(Cumberbatch and Kimber , 1992). As discussed below LC may migrate from the
skin to the DLN, and are thought to undergo maturation during this process.
Essentially cultured LC are indistinguishable from certain DC of the lymphoid tissue,
and have been proposed to represent the difference between LC in the epidermis and
DLN.
In vivo, LC are thought to initiate the induction of immune responses against
antigens encountered in the skin by providing the primary sensitizing signal to T
cells. A substantial amount of experimental evidence indicates that LC pick up
antigen in the epidermis, mature functionally and phenotypically as they move from
the epidermis through the afferent lymphatics (possibly as veiled cells) into the DLN
where they reside as mature DC or interdigitating cells and present antigen to T cells,
resulting in proliferation of antigen responsive T cells (Barker and Billingham, 1968;
Bergstresser et al., 1980; Botham etal., 1987; Kinnaird et al., 1989; Knight etal.,
1985a; Knight etal., 1985b; Macatonia etal., 1986; Siberberg-Sinakin etal.,
1976). Following sensitization T cells may recirculate and preferentially home to the
skin. The most compelling evidence in support of this hypothesis derives from a
report by Kripke et al (1990). In this study skin from C3H mice was grafted onto
BALB/c recipient mice. Sensitization of the mice through the grafted tissue with
FITC (fluorescein isothiocyanate) resulted in the accumulation of antigen bearing DC
in the DLN which were found to be of graft donor origin. A number of the DC in the
draining LN were found to contain Birbeck granules.
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Epidermal cell preparations containing LC induce primary and secondary T cell
responses to alloantigens, haptens and also soluble protein antigens (reviewed by
Stingl and Shevach, 1991) including herpes simplex virus (HSV) proteins (Williams
et al., 1991). An area of controversy is the effect of culturing LC on their antigen
presenting function. A number of groups have reported that cultured LC have a
greatly enhanced antigen presenting capacity (Shimada et al., 1987; Teunissen et al.,
1990). This finding has been disputed by the work of Cohen and Katz (1992) and
Romani et al (1989) who found no enhancement after culturing. The contradiction
may arise from differences in the antigens employed, differences in the activation
state of the responder cells or may result from differences in the extent or method of
LC enrichment.
KC are a rich source of cytokines (see section 1.1.4.) but little is known of the
secretory capacities of LC. Sauder et al (1982) demonstrated that epidermal cell
suspensions which were greatly enriched for LC (84-97%) constitutively produced
significant JL-1 activity. This finding must still be treated with a degree of caution
as it is possible that contamination by KC may affect this finding. More recently
P D Cruz has demonstrated the production of IL-1 and IL-6 by LC (personal
communication).
1.1.3 Dermal Dendrocytes
A population of DC has been identified which reside in the dermis (Cerio et al.,
1989; Sontheimer et al., 1989). Dermal dendrocytes (DD) have a folded nucleus
and a very ruffled irregular surface. The cytoplasm contains organelles which are
required for active metabolism, but does not contain Birbeck granules.
Phenotypically DD express ATPase and non-specific esterase activity as well as
CD45, CDllb, CDllc and MHC class II antigens. They do not express CD 1,
CD 14 or CD 15 and are therefore distinct from endothelial cells, but share certain
6
features with LC. Phenotypically they share features with other APC. Evidence in
the mouse indicates that they may in fact be capable of initiating cell-mediated
contact hypersensitivity (CH) in vivo (Tse and Cooper, 1990).
1.1.4 Keratinocytes
For many years keratinocytes (KC) were thought to function merely as building
blocks in the epidermis but it has become apparent that they are very efficient
producers of a number of cytokines (outlined in Table 1.2), which have profound
effects in the skin. The first of these factors to be identified, and the most well
characterized is ETAF (epidermal cell thymocyte activating factor) (Luger et al.,
1981; Sauder et al., 1982) which is now known to be identical to monocyte derived
IL-1 (Kupper etai, 1986; Luger etal., 1983 (a); Luger et al., 1983 (b)). It is
produced constitutively whereas the other cytokines tend to be produced following
stimulation by trauma, chemicals, UVR (Nickoloff et al., 1990) or by other
cytokines which may be KC derived themselves (Ansel et al., 1990).
Table 1.2
Keratinocyte Produced Cytokines
Interleukin Colony-Stimulating Factors Others
(IL) (CSF)
IL-1 a GM-CSF IFN-a (Interferon-a)
IL-1 p G-CSF (Granulocyte-CSF) IFN-P (Interferon-P)






FGF (Fibroblast growth factor)
PGE-2 (Prostaglandin E-2)
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KC are capable of phagocytosis and endocytosis (Luger et al., 1983 (b)). In vitro
the T cell cytokine IFN-y (but not a or p) induces HLA-DR expression on human and
murine KC (Basham et al., 1985; Czernielewski and Bagot, 1986). MHC class II
expression on KC in human graft versus host disease has also been reported (Lampert
et al., 1981). Furthermore, examination of a number of other dermatoses revealed
HLA-DR expression on KC only when there was a lymphoid infiltration into the skin
eg mycosis fungoides, eczema, discoid lupus erythematosus and lichen planus
(Lampert 1984), which may indicate that IFN-y is also of importance in vivo. IFN-y
induced the expression of OKM5 on KC (Simon and Hunyadi, 1987). OKM5 is
found on a number of cell types including endothelial cells, monocytes, platelets and
C32 melanoma cell line. ICAM-1 may be absent from KC or expressed at very low
levels, but its synthesis may be enhanced by treatment with IFN-y or TNF-a (Dustin
et al., 1988). The expression of adhesion molecules on KC by IFN-ymay play an
important role in the trafficking of T cells through the epidermis, particularly in
inflammatory dermatoses.
Despite the fact that KC constitutively produce IL-1 and may be induced to express
MHC Class II antigens and ICAM-1, both necessary for antigen presentation, it has
not been possible to demonstrate antigen presentation by these cells (Breathnach et
al., 1986; Chu et al., 1990). This may be due to inadequate antigen processing,
despite their being capable of phagocytosis and endocytosis, or perhaps the low
expression of Class II.
1.1.5 Lymphocyte Populations of the Skin
The overwhelming majority of lymphocytes in the skin are T cells. Early attempts to
locate lymphocytes in normal human skin gave very inconsistent results. However
reinvestigation more recently by Bos et al (1987) revealed that 90% of T cells in the
skin were located in the dermis. Here they were clustered and localised around post¬
capillary venules and adjacent to cutaneous appendages. In contrast to circulating T
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lymphocytes the majority of dermal T cells were activated, ie expressed HLA-DR
and IL-2 receptors. In addition there was an approximately even distribution of
CD4+CDw29+(4B4+) (helper/ memory) and CD8 (suppressor/cytotoxic) T cell
subsets; CD4+CD45+(2H4+) naive T cells were found to be relatively rare in the
skin (less than five percent), despite forming 50% of peripheral blood CD4+ T cells
(Bos etal., 1987; Bos etal., 1989). It is unclear whether these memory cells have
immigrated into the skin in an activated state or whether they have been locally
activated, or reactivated. It has been demonstrated that CD4+CDw29+ T cell subsets
show enhanced endothelial cell binding, compared with that of CD4+CD45+subsets
which may indicate that CD4+CDw29+ cells preferentially immigrate into the skin
(Pitzalis et al., 1988). Intraepidermal T cells were randomly distributed and were
found to be predominantly CD8+, but they account for only 10% of the total skin
lymphocytes.
Two types of T cell receptors (TCR) have been identified. The most common is a
disulfide-linked heterodimer comprising an a and a (3 transmembranous polypeptide,
with variable regions at the periphery. The TCR is noncovalently associated with the
CD3 complex, forming the CD3-TCR complex, in which the CD3 complex is
thought to transduce the activation signal upon recognition of the appropriate antigen
by the TCR. The second TCR is present on a small percentage of thymocytes (0.1-1
%) and peripheral T cells (1-9%). It consists of a heterodimer with transmembranous
polypqtide^designated the y and 5 subunit. This receptor is also linked to the CD3
complex, but the antigen specificity remains unknown.
T cells with the y/5-TCR are extremely rare in the human skin (Bos et al., 1988;
Foster et al., 1988). In contrast, murine skin contains a population ofDC which are
CD45+ Thyl+ CD5" CD4" CD8" MHC IF and were originally known as Thy-1+
dendritic epidermal cells (Bergstresser et al., 1983; Tschachler et al., 1983). These
cells are now known to be T cells which uniformly express the y/8-TCR on their
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surface (Koning et al., 1987; Kuziel et al., 1987; Stingier al., 1987) and have
more recently been renamed dendritic epidermal T cells (DETC) (Steiner et al.,
1988). The functional role of DETC remains unknown, and despite attempts by
several groups, no human equivalent has been identified.
Murine CD4+ cells can be further subdivided into T helper 1 (Thl) and T helper 2
(Th2) cells on the basis of their cytokine production profile. Thl cells produce
predominantly IL-2, IFN-y and TNF-(3 whereas Th2 produce IL-4 but not IL-2. Thl
appear to be more important in mediating DH responses, whereas Th2 cells appear to
preferentially support antibody production by B cells. The situation is probably
more complicated in man.
One other population of Thy-1+ cells found in the skin is necessary for the elicitation
of contact hypersensitivity (CH) responses (reviewed by Askenase et al., 1991). CH
responses in mice are biphasic, with an early response at around two hours followed
by the classical reponse 24-48 h following antigen challenge (Van Loveren etal.,
1983; Lavaud et al., 1991). Elicitation of the response is due to the sequential
action of two different antigen specific Thy-1+cells. The early acting, or initiating
cell, was revealed to be an unusual phenotype, for an antigen specific cell; Thy-1+,
CD5+, CD4", CD8", CD3", slg", CD45RA+ (not found on mature T cells),
Macl+, IL-2R" and I1-3R+ (present on pre-B and pre-T cells) (Herzog et al., 1989).
This cell type produces antigen-specific non-IgE factors which sensitize mast cells for
the release of the vasoactive amine serotonin (5-hydroxytryptamine; 5HT) at the
local site of antigen challenge. 5HT initiates CH by acting on endothelial cells
which allows the recruitment of effector cells. The effector cells in contrast to the
initiator population were Thyl+, CD5+, CD4+, CD8" and CD3+ (Herzog et al.,
1989). The 24 h swelling is therefore dependent on the initial response at two hours.
It has also been found that monoclonal IgE is capable of initiating CH (Ptak et al.,
1991). When a low dose (1-10 |ig per mouse) of IgE was injected a one hour peak
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and subsequent CH responses were observed, but when a higher dose was given
(10-100 M-g Per mouse) there was a large immediate hypersensitivity reaction but no
CH response. It was thought that the higher dose of IgE may have been sufficient to
induce histamine release from mast cells. Histamine has previously been shown to
suppress DH reactions (Norval et al., 1989b). Treatment of the mice with
cimetidine (histamine class 2 receptor (H2) antagonist) permitted the higher dose of
IgE to initiate the DH response (Ptak et al., 1991). Histologically there is evidence
that an early initiating event occurs in human DH responses. One hour after antigen
challenge mast cell degranulation occurs, followed by the induction of ELAM-1 on
post capillary venules at two hours, peaking at 24 h (Waldorf et al., 1991).
Cellular infiltrates in inflammatory dermatosis consist predominantly of T cells.
This has been demonstrated in a number of diseases varying from very common
disorders such as eczema and psoriasis, to uncommon malignancies such as
cutaneous T cell lymphomas.
1.1.6 Mast Cells
Mast cells constitute a heterogeneous population, as demonstrated histochemically,
morphologically, biochemically and functionally. They occur in large numbers in
the skin (7000 mm-3 mast cells in human skin) and are located predominantly in the
perivascular region of the papillary dermis, less frequently in the deeper dermis and
very rarely in normal epidermis. Activation by immunological or non
immunological stimuli results in the release ofmediators which are stored in
cytoplasmic granules, or are synthesised very rapidly. Mast cell mediators are very
diverse and have complex functions. They include vasoactive substances (such as
serotonin and histamine), chemotactic factors, active enzymes and structural
proteoglycans. Serotonin is a necessary requirement for the elicitation of DH
responses (Askenase et al., 1991). Mast cells are a principal source of histamine.
Histamine is capable of inducing a variety of cellular functions through its
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heterogenous receptors (Hill 1990; Mitsuhashi and Payan, 1992). Histamine also
has specific effects on immune responses (reviewed by Falus and Meretey 1992;
Melmon and Kahn 1987).
Mast cells express and release a number of cytokines including IL-1, 3, 4, 5, 6, 8,
TNF-a, GM-CSF and IFN-y. In addition they are capable of phagocytosis and on
stimulation with IFN-y they express MHC-II antigens (reviewed by Moller et al.,
1991). Therefore mast cells may play an impotant role in regulating immune
responses, in addition to being of major importance in initiating immune responses.
1.1.7 Endothelial Cells
The vascular endothelium consists of a monolayer of cells lining the circulatory
system, and forms a mechanical barrier between the blood and extravascular tissues.
The dermal endothelium therefore plays a vital role in emigration of cells from the
blood into the skin. The majority of lymphocytes found in the skin are memory T
cells (Bos et al., 1989) indicating that the selection of circulating cells is not a
random process.
Large families of adhesion molecules have been identified on the surface of cells and
multiple ligand receptor interactions are thought to play an important role in
trafficking of cells (Albelda and Buck 1990; Shimizu et al., 1992). A number of
adhesion molecules have been identified on endothelial cells, and their
corresponding ligands on T cells (Nickoloff, 1991b). The expression of several
adhesion molecules is greatly enhanced during inflammatory reactions as a result of
the release of cytokines such as IL-1 IFN-y and TNF eg IL-1 and TNF-a both induce
the expression of ICAM-1 and ELAM.
MEL-14 in the mouse (Gallatin et al., 1983) and Hermes 1 in humans (Jalkanen et
al., 1986) are found on the surface of lymphocytes and are thought to be involved in
lymphocyte homing to peripheral lymph nodes (LN). In vitro, antibodies to these
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molecules block the binding of these cells to high endothelial venules, and in vivo
they also block the homing of lymphocytes to the peripheral LN. To date the
molecules involved in "cell homing into the skin" remain to be identified.
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1.2 HERPES SIMPLEX VIRUS
1.2.1 Herpes Simplex Virus Infection
There are six members of the family Herpesviridae which are known to infect man,
herpes simplex virus types 1 and 2 (HSV-1 and HSV-2), varicella zoster virus,
cytomegalovirus, Epstein Barr virus and human herpes virus 6. HSV-1 is an
enveloped virus possessing an icosahedral capsid, approximately 100 nm in
diameter, which encases linear double stranded DNA of approximately 152 000 base
pairs with the potential to code for approximately 70 polypeptides.
HSV-1 has a predilection for the oral mucosa where it is commonly responsible for
mucocutaneous infections, more commonly known as "cold sores" (Fig 1.1).
Typically lesions in most individuals progress from erythema through stages of
papules, vesicles, erosions or ulcers before healing. Following a primary infection
with HSV-1 the virus is thought to travel up the sensory nerves serving the site of
infection and become latent in the sensory neurons. In certain individuals
reactivation of the virus may occur, resulting in a recrudescent perioral lesion. UVR
is a common triggering factor. In a previous study of healthy subjects suffering from
recrudescent HSV infection who were recruited in Edinburgh, at least 30% noted UV
to be a triggering factor for their recrudescent HSV (Vestey et al., 1989).
1.2.2 Immune Responses to HSV
Most information pertaining to immune responses to HSV have been gained from
animal models (Wildy and Gell, 1985). The immune response to HSV is complex
and involves most arms of the immune response. Cell mediated immune responses
appear crucial in the clearance and recovery from HSV infection, while antibody
responses are relatively unimportant.
During HSV infection the virus is virtually exclusively confined to the epidermis.
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Figure 1.1
HSVInfection, (a) A typical human recrudescent orofacial lesion, (b) Epidermal
infection with HSVin the murine model of infection used in this study
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Sprecher and Becker reported that the pathogenicity of HSV-1 in mice was dependent
on epidermal LC density (Sprecher and Becker, 1987; Sprecher and Becker, 1989).
LC are thought to take up the viral antigens and travel to the DLN where presentation
to T cells takes place. Following sensitization activated T cells recirculate to the
skin. The infiltrating T cells secrete IFN-ywhich results in the expression of MHC
class II antigens and ICAM-1 on KC, and the release of IL-1 from LC and KC.
Expression of adhesion molecules on KC may enhance T cell/KC interactions and
migration of CD8+ lymphocytes into the epidermis as is found late in HSV lesions.
IL-1 release may attract cells to the site and amplify immune responses. Both
cytotoxic and DH resposes are required for the efficient clearance of HSV from the
skin (Martin and Rouse 1987; Wildy and Gell 1985). Macrophages, which are
resistant to HSV replication, are important in the the control of infection (Morahan et
al., 1985). NK/K cells are found adjacent to KC which exhibit the greatest
cytopathic effect (Heng et al., 1989).
Most subjects develop high antibody titres to the virus during a primary infection
which remain elevated throughout the life of the subject, and vary little even with
recrudescences (Vestey et al., 1989). High antibody titres do not appear to prevent
recrudescences but there is some evidence that antibody dependent cell-mediated
cytotoxicity may play a role early in HSV infections (Kohl, 1991). Cell-mediated
immune responses to HSV in man have been monitored in peripheral blood
predominantly. Patients develop Th responses (T helper cell), as determined by in
vitro lymphoproliferative responses to HSV antigens, during primary infections.
Lyrnphoproliferative responses are usually similar for HSV-1 and -2 antigens,
reflecting the multiplicity of type-common antigens (Vestey et al., 1989). The
degree of lymphoproliferation varies between individuals but is not related to the
severity or the likli hood of subsequent recrudesences. In addition to Th HSV-
specific cytotoxic T cell reponses are found and DH responses to intraepidermal HSV
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challenge is also detectable. Both of these persist indicating immunological
memory. Analysis of NK cell activity, HSV-specific lymphoproliferation and IFN
production suggests that a temporary depression in immune responses may occur just
before or during a recrudescence (Vestey et al., 1989). Thus recrudescent lesions
may occur if there is a delay in, or suppression of, the normal cell mediated
immunity to HSV. It is possible that triggering factors for recrudescent HSV




Ultraviolet radiation (UVR) consists of electromagnetic radiation of wavelengths
ranging from 200-400 nm. This has been broken into defined wavebands as shown
in Fig 1.2. Unfiltered sunlight contains the complete UV spectrum, but the amount
reaching the earth's surface is directly dependent on its wavelength. Nitrous oxide in
the thin upper atmosphere blocks the germicidal short UVC wavelengths. At lower
altitudes of the stratosphere (15-30 km ) molecular oxygen and ozone absorb the
lower UV wavelengths. The relative irradiance from the sun is shown in Fig 1.2,
but the UV spectrum of incident radiation from the sun on the earth's surface at a
given time is dependent upon the latitude, time of day and year, weather, air
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In 1985 it was reported that a "hole" in the ozone layer had developed over Antarctica
each Spring since 1979 (Farman et al„ 1985). Between 1969 and 1986 the average
concentration of ozone in the stratosphere had decreased by approximately two
percent per year, much faster than models had predicted (NASA, 1988). Ozone
depletion leads to a greater amount ofUV penetrating the atmosphere. Increased
environmental exposure to UV may have important effects on crop yields, plankton
and fish populations, which may have important implications to the food chain
(Cullen et al., 1992) as well as human health.
As world travel becomes more accessible, many people now expose themselves to
intense sunlight for a few weeks in a year. Some also expose themselves to artificial
UV sources for cosmetic purposes in solaria or as phototherapy in the treatment of a
number of common dermatoses such as psoriasis and eczema. Other possible
sources of exposure include halogen desk lamps, fluorescent light bulbs and welders
lamps.
1.3.2 The Biological Effects Of UV
The biological effects of UV are determined by the interactions at the body surface
particularly in skin and eyes. One important role of UVR is in the synthesis of
Vitamin D in the skin which is necessary for bone formation. Many people find that
exposure to UVR is linked to a general feeling of well being. Cosmetically, some
Caucasians believe tanning to be beneficial. The formation ofmelanin, the pigment
which produces the tan, does protect other cells from UVR damage. UV exposure is
highly effective in the treatment of a large number of skin diseases. However these
positive effects are possibly outweighed by some negative effects of UV exposure.
UVR, particularly in the UVB range induces erythema, more commonly known as
"sunburn". This is a local effect caused by the dilation of blood vessels and
increased blood flow to the skin. If the UV dose has been particularly high this may
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be followed by blistering and peeling of the skin. Susceptibility to erythema
corresponds to the skin type of the subject.
Frequent and prolonged exposure to UVR over a substantial period results in
permanent damage to the skin shown as dryness and wrinkling (Kligman, 1989).
This process is known as photoageing and can be distinguished histologically from
the natural ageing process by elastosis and the formation of mature collagen
(Kligman, 1979).
Non-melanoma skin cancers (NMSC) are the most common of all tumours in the
Caucasian population, with a low mortality rate of one percent or less (Pollock Shea,
1988). Two main forms exist; basal cell carcinoma (BCC) and squamous cell
carcinoma (SCC), both of epidermal origin. NMSC are directly related to UVR.
They usually occur on areas of the body which have been most exposed to UV and
have a higher prevalence close to the equator. Mice chronically exposed to UVR
develop NMSC (Blum 1959). The action spectrum for skin tumour production is
similar to that for erythema, that is UVB wavelengths are more efficient than UVA
(De Gruijl and van der Leun, 1991). Malignant melanoma (MM) is much rarer than
NMSC, but is increasing at an alarming rate, particularly in Northern countries
(MacKie et al., 1992). The mortality rate from MM is much greater than NMSC.
The correlation between UV exposure and MM is not as clear cut as that of NMSC,
although it does occur more frequently in fair-skinned individuals with a history of
blistering sunburn in their childhood. It is not restricted to UV-exposed areas of the
body, and is not found in people such as outdoor workers with a very high UV
exposure.
UVR also affects the eye. Absorption of UVR by the eye can give rise to
inflammation of the cornea (keratitis) and conjunctiva (conjunctivitis; "snow
blindness"). UV light may be an important factor in senile cataract formation (Pitts
et al., 1986; Taylor et al., 1988).
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1.3.3 The Effect of UVR on Immune Responses
Cutaneous irradiation with UVB results in a transient systemic suppression of
selected immune responses to antigens encountered thereafter (reviewed by
Baadsgaard et al., 1991; Gallo etal., 1990; Morisson et al., 1989a). This was first
shown in 1977 for the transfer ofUV-induced tumours, which are highly
immunogenic, to sygeneic receipient mice. The tumours were rejected unless the
mouse had previously been UV-irradiated (Fisher and Kripke, 1977). This
suppression was transferrable by lymphocytes (Daynes and Spellman, 1977). In
these experiments high doses ofUV were administered, but subsequent experiments
revealed suppressed induction of CH responses and reduction of ATPase"1" cells in
mice following much lower, sub-erythemal doses ofUVB (100-300 J m~2) (Toews et
al., 1980). Studies of the effects ofUV on immune responses have focussed on the
induction of CH responses to a range of allergens in mice (reviewed by Gallo et al.,
1990) and recently similar experiments have been performed in man (Cooper et al.,
1992; Yoshikawaetal., 1990).
Some reports have indicated differences between high dose and low dose models of
UV-induced immunosuppression, showing that two different mechanisms of
suppression may occur depending on dose, and wavelength of UV (reviewed by Cruz
and Bergstresser, 1992; Kripke, 1991), as outlined in table 1.3 (taken from Cruz
and Bergstresser, 1992).
However Noonan and De Fabo (1990) reported that the dose-response curves for
local and systemic immunosuppression were identical, although the time course of
generation of local and systemic suppression were different. Thus the effects of high
dose and low dose may be very similar with the local effects of low dose irradiation
requiring more time to become apparent systemically.
To confuse the issue further, experiments have also been conducted in mice to
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determine whether low-dose UVB treatment has a similar suppressive effect on the
expression of immunity. When the skin of hapten immune mice were exposed to a
low dose of UVB and then challenged with the hapten the expression of the CH
response was actually enhanced, compared with non-irradiated controls (Polla et al.,
1986; Yoshikawa et al., 1992).
Table 1.3
Comparison ofLow- and High-dose Models ofUV-induced Immunosuppression.
LOW-DOSE UVB HIGH-DOSE UVB
Irradiance < 5 x 10^ J m~2 > 105 J nr2
Location of Only in irradiated skin Both irradiated skin and
unresponsiveness to distant unirradiated sites
hapten
Action spectrum for peak < 300 nm 320 nm
unresponsiveness
Generation of hapten- Present Present
specific Ts cells
Demonstrated impairment Epidermal LC Splenic macrophage
in antigen-presenting cells
Implicated sources or Irradiated LC cis-UCA
mediators of Thy-1+ EC Prostaglandins
immunosuppression I-J, Ia+EC IL-1
T6"DR+ cells KC derived mediator(s)
Ts: suppressor T lymphocytes
Few reports have examined the effect of UV exposure on the outcome of microbial
infection, but what information is available indicates that suppressed immunity is
induced to a range of organisms including protozoa, yeast, bacteria and viruses as
outlined below.
Leishmania is a parasitic protozon. Ulcerating nodular skin lesions may occur and in
mucocutaneous leishmaniasis there maybe severe and mutilating. In humans these
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lesions appear more commonly on UV-exposed regions of the body. Using a murine
model, Giannini found that UV irradiation resulted in impaired immunity to the
protozoa (Giannini, 1986). The severity of the lesion induced by Leishmania was
significantly reduced in mice exposed to UVB, but there was no effect on
dissemination of the organism to other organs of the body. There was a significant
suppression in the DH response to the organism in irradiated mice, and no protection
was induced against a second inoculation at a distant site.
Candida albicans is a commensal yeast of the oral cavity, gut, skin and vagina
which can cause opportunistic infections at these sites. In a murine model of
infection UV irradiation markedly suppressed the DH response (Denkins et al.,
1989).
Mycobacteria cause diseases such as leprosy and tuberculosis. BALB/c and C3H
mice exposed to UVB either before or during infection with Mycobacterium bovis
had significantly reduced DH responses to antigen challenge (with BCG) when the
mice had been infected at a site distant from the UV exposure compared with
unirradiated controls (Jeevan and Kripke 1989). The total number of bacteria
isolated from the spleen and LN was significantly higher in the UV-irradiated
animals, which demonstrated systemic suppression. In addition supernatants from
KC which had been UV irradiated in vitro suppressed the DH response to BCG when
injected intravenously into mice prior to infection (Jeevan et al., 1992b).
Further studies by this group examined the effect of low dose UVB prior to infection
at the site of irradiation with Candida albicans, BCG or Schistosoma mansoni in
mice. The induction of DH responses to C. albicans and BCG were unaffected by
UVR, but the number of viable organisms recovered from the lymphoid organs of
UVR mice infected with BCG was significantly enhanced relative to unirradiated
controls. UVR had no effect in mice infected with 5. mansoni (Jeevan et al.,
1992a).
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It was suggested that the involvement of the epidermal LC as the primary APC in the
induction of immunity may be critical in determining whether the immune response
will be affected by local UVR. Preliminary experiments by Chung et al., (1988)
showed that UV-irradiated mice injected intravenously with Staphylococcus aureus,
Escherichia coli and Candida albicans had a suppressed ability to clear the organisms
in comparison with unirradiated controls.
UVR also has important implications for the outcome of viral infections. Thus it has
been proposed that UVB may enhance immunosuppression in individuals with human
immunodeficiency virus (HIV). It has also been shown that UVB can activate HIV
viral replication (Zamudzka and Beer, 1990), and also that HIV infects epidermal
LC (Zambruno et al., 1991). Therefore HIV infected patients may be at
considerable risk from the deleterious effects ofUVR (Flegg, 1990). This theory
has recently been substantiated in a murine model of infection with murine leukemia
virus, which induces an immunodeficiency syndrome (MAIDS) which resembles the
early stages of human AIDS. In vivo irradiation of mice infected with the virus
resulted in more pronounced changes in immune responses due to MAIDS infection,
including IgM levels, mitogenic responses to PHA (phytohaemagglutinin,) Con A
and LPS (lypopolysacharide), mixed lymphocyte reactions (MLR), antigenic
responses to sheep red blood cells and histopathologic changes in the spleen (Brozek
et al., 1992).
UV exposure is a common triggering factor for the reactivation of latent HSV-1,
resulting clinically in a "cold sore" (Perna et al., 1987; Spruance 1985; Vestey et
al., 1989). Previously in this laboratory a murine model of HSV infection had been
employed to study the effects of UVB on primary immune responses to the virus.
Mice were shaved dorsally and irradiated with a single low dose (96 mJ cm-2) of
UVB prior to infection with the virus, either epidermally (see Fig 1.1) or
subcutaneously. Eight to ten days later the mice were challenged with inactivated
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HSV intradermally and the DH responses measured. The UVB irradiated group
displayed a 60-90% suppression ofDH which was antigen specific (Howie et al.,
1986 (a)) if the mice were infected between two and fourteen days after irradiation.
Spleen cells from UV-irradiated mice which had been infected with HSV shortly after
irradiation, were transferred to syngeneic mice which were already infected with
HSV. This resulted in an antigen specific suppression of the DH response when the
recipients were challenged with HSV antigen. The cells transferring the suppression
were T lymphocytes of two phenotypes, Lyl+2" (CD4+) and Lyl~2+ (CD8+)
(Howie et al., 1986a). The suppression could also be transferred by UV-irradiated
epidermal cells, but these had to be injected at the same time and location as the
virus, suggesting that a local interaction between the two had to take place for
suppression to be induced. In this instance T-cells were generated which mediated
the suppression, but these were of one phenotype only; Lyl+2~ L3T4+ Thyl+
(Howie et al., 1987). Epidermal cells derived from mice which had been irradiated
three days previously had an impaired capacity to present HSV antigen (Howie et al.,
1986b).
Although UV-induced immunosuppression of CH and DH responses appear to be
very similar the dose responses are different (Kim et al., 1990). Much higher doses
of UV are required to suppress CH responses, which also has a different wavelength
dependency from DH (discussed in section below) suggesting that the mechanism
may be different.
1.3.4. The Mechanism(s) of UV-induced Immunosuppression
The Effect of IJVR on LC and Antigen Presentation
Low doses ofUVB were shown to reduce the number and alter the morphology of
epidermal LC (Elmets et al., 1983; Towes et al., 1980). This may be due to an
altered expression of MHCII or enzyme ATPase activity, destruction of the LC or
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migration of LC from the epidermis. This is a controversial issue as some authors
have reported a reduction in the expression of MHC II (Aberer et al., 1981) while
others have reported no alteration, or possibly enhanced expression (Czernielewski et
al., 1984; Norlund et al., 1981). A recent report (Spencer et al., in press)
examined the number of LC and the expression ofMHC class II in ultra-thin sections
through MHC II+ epidermal cells by electron microscopy before and after a standard
course ofUVB phototherapy. This revealed a reduction in the number ofMHC II+
cells but those which remained exhibited a significantly increased expression of
MHC class II. No MHC class II negative LC were found following UVR. This
observation ties in well with the findings of Ashworth et al. (1989) who reported that
PUVA therapy depleted the number of LC in the epidermis. The residual class II
positive cells retained normal HLA-DR and CDla expression, and on a per cell basis
in vitro alloantigen expression was unaltered. Following UVB irradiation ofmice an
increased number of DC are found in the DLN, suggesting that UVB induced DC
migration from the epidermis (Moodycliffe et al., 1992).
In 1980 Toews demonstrated that C57BL mice exposed to low doses of UVB (< 200
J nr2 a day for four days) failed to mount a CH response to DNFB
(dinitrofluorobezene) when it was applied to the site of irradiation. This was
accompanied by a reduction of epidermal ATPase+ cells and loss of dendritic
morphology in those which remained. Further experiments revealed that antigen
specific suppressor inducer cells were present in the spleen of the irradiated mice
(Elmets et al., 1983), suggesting that altered APC function was responsible for
activating specific suppressor pathways. Following application of FITC (fluorescien
isothiocyanate) to murine skin, FITC-bearing epidermal LC leave the epidermis and
collect in the DLN, where they interact with T cells to initiate the CH response
(Kripke et al., 1990). Normally, the DLN cells induce CH responses when injected
into the footpad of a syngeneic mouse (Kripke et al., 1990) but following UV-
irradiation they failed to induce CH, despite FITC-bearing cells being present.
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Instead, suppresssor T lymphocytes were induced in the recipients (Okamoto and
Kripke, 1987). FACS (fluorescence activated cell sorter) purified, hapten
derivatised LC irradiated in vitro with a single dose ofUVB (200 J m"2) failed to
induce contact allergic responses when injected intravenously into syngeneic mice.
In addition these mice failed to mount a CH response when sensitized at a later time
with the same hapten (Cruz et al., 1989). This indicated that UVB did not prevent
antigen presentation but induced tolerance. Further experiments (reviewed by Simon
et al., 1992) demonstrated that UVB irradiation of purified hapten derivatised LC
reversed the normal capacity of these cells to preferentially activate Thl rather than
Th2 cell clones in vitro. The Thl cells in these experiments were tolerant to
subsequent stimulation with unirradiated hapten derivatised LC. They retained the
capacity to proliferate in response to exogenous IL-2, indicating that they were not
physically deleted, but were functionally anergic.
Simon et al., (1991) had prevously reported that mouse Thl, butnotTh2, clones
required an ICAM-1-mediated activation signal from LC for optimal proliferation.
UVB depresses the expression of ICAM-1 on human (Krutmann et al., 1990) and
murine (Tang and Udey, 1991) LC, and therefore it is possible that ICAM-1 serves
as a UVB-sensitive accessory factor for Thl cells alone.
On in vitro UV irradiation human or murine epidermal cell populations containing LC,
lose their ability to act as APC to T cells in a lymphoproliferation assay using a range
of antigens (Austad and Braathan, 1985; Czernielewski et al., 1984; Stingier al.,
1981). Irradiated epidermal cells exhibit suppressed alloactivation properties
(Cooper et al., 1985). There is also evidence in humans that following irradiation
the epidermis is re-populated with T6" Dr+ (OKM5+) cells which preferentially
activate suppressor inducer T cells (Baadsgaard et al., 1990b).
Altered APC capacity may not account for all the effects ofUVR on the immune
system, particularly in the case of systemic suppression when UV irradiation and
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antigen sensitization are undertaken at different sites.
The Effect of UVR on Keratinocvtes
KC are the major cytokine producing cells of the epidermis, and therefore UVB
induced changes of these cells may play an important role in alteration of cutaneous
immune responses. UVB irradiation of human KC both in vitro and in vivo increases
the synthesis of IL-1 (Kupper et al., 1987; Murphy et al., 1989; respectively)
which can suppress CH responses in mice (Robertson et al., 1987). Murine KC
irradiated in vitro also produce a factor which blocks the activity of IL-1 (contra-IL-1;
Schwarz et al., 1987) and this factor is also found in the serum of mice following in
vivo irradiation (Schwarz et al., 1988). Other soluble factors are released by KC
following UVR which are capable of suppressing DH responses (Kim et al., 1990;
Schwarz, 1986b). UVA irradiation of KC released factors which were capable of
suppressing CH responses but not DH responses, but UVB induced factors were
capable of suppressing DH but not CH responses (Kim et al., 1990), indicating that
CH and DH responses may be different. UV-irradiation of epidermal cells resulted
in increased TNF-a production in vitro (Kock et al., 1990) and in vivo (Oxenholm et
al., 1987). Following UVB, but not UVA irradiation, local production of IL-6 is
increased (Kirnbauer et al., 1991), and correspondingly increased IL-6 has been
detected in serum from UVB irradiated individuals (Urbanski et al., 1990), which
may play an important role in the systemic sunburn reaction.
The Effect of UVR on Circulation of Lymphocytes
In mice, UV irradiation on six consecutive days induced an alteration in lymphocyte
distribution in the regional LN (Spangrude et al., 1983). The number of radio-
labelled lymphocytes that migrate to the peripheral LN in UV exposed mice was
increased compared with unirradiated controls, and this effect persisted for two
months. The prolonged retention of lymphocytes in the LN is possibly due to PG,
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which are released on UV irradiation, as PG can induce efferent lymphatic blockage
(Chung et al., 1986). Another possibilty for the prolonged retention of lymphocytes
could be that UVB alters the morphology of high endothelial venule structures,
which play a pivotal role in lymphocyte homing. UVB irradiation may also alter the
expression of adhesion molecules such as ICAM-1, which may upset the balance of
cell recirculation (Norris et al., 1990; Tang and Udey, 1991).
The effect of UVR on circulating cells of the blood in man is a controversial issue
and it is possible that any detected changes are transient. Thus, some authors
reported a temporary decrease in circulating T cells after UVB irradiation or PUVA
therapy (Cormane et al., 1977; Hafteketal., 1979; Morison et al., 1979a; Rivers
et al., 1989), but others found no modulation following a variety of UV regimens
(Harper et al., 1979; Hersey et al., 1988; Morison et al., 1979b; Mutzas etal.,
1991). Differences in the source, wavelengths, duration or dose ofUV, as well as
the time of sampling may explain these apparently conflicting data.
The Effect of IJVR on Mast Cells
Low dose UVB has been shown to result in suppression of mast cell degranulation
(Dannoefa/., 1986). In contrast, high dose UVB irradiation induces mast cell
degranulation (Danno et al., 1986). Mast cells are located in the dermis of normal
skin and UVB is thought to penetrate the skin poorly. It is therefore likely that the
effects ofUVB are mediated through the release of soluble factors in the epidermis,
such as IL-1, PG and EL-3. Recently the effect of UV-irradiation on LC in mast cell
deficient mice was studied (Ikai and Kanauchi, 1991). Mast cell deficient mice had
a reduced number of LC compared with normal mice but on UV-irradiation they
exhibited the same reduction in LC (ATPase+ cells) as normal controls, although no
measurement of immunity was made.
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The Role of Photo-receptors in IJV-Induced Immunosuppression
UVB penetrates the skin poorly and therefore it mediates at least part of its action on
the immune system through specific photo-receptors in the skin. A number of
constituents of the epidermis absorb UV-light and have been proposed as candidates
including DNA, membrane associated compounds such as arachidonic acid (Kaleta
et al., 1988), tryptophan and UCA (urocanic acid). TNF-a is also thought to play
an important role in determining UV-induced immunosuppression.
UV irradiation results in dimer formation between adjacent pyrimidine base pairs
which may play an important role in erythema. The role of of dimer formation in
UV-induced immunosuppression was tested by using enzymes which repair
pyrimidine dimer damage to DNA, such as T4 endonuclease, which were
incorporated into liposomes. They were found to increase the repair of UV-induced
pyrimidine dimers in murine skin (Kripke et al., 1991). Application of T4
endonuclease liposomes immediately following UV exposure restored a 70%
suppression of the DH response to almost normal values by this group.
A further possibility is a membrane asociated molecule which may be activated
following UV to release cytokines or other immunomodulatory compounds. An
example may be the release of arachidonic acid from membrane phospholipids
(Kaleta et al., 1991) which is a precursor for prostaglandins, which are important
inflammatory mediators.
Inbred strains of mice display varying genetic susceptibility to the
immunomodulatory effects UV-irradiation (Streilein and Bergstresser, 1988), and it
is possible that genetically determined UV-susceptibility may occur in humans also
(Yoshikawa et al., 1990). In mice the trait appears to be restricted to polmorphisms
at the LPS and TNF-a loci (Yoshikawa and Streilein, 1990). Thus TNF-a is
increased on UV-irradiation in UV-sensitive strains. Intradermal injection of TNF-a
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at the site of hapten application mimics the effects of UVB irradiation by impairing
the induction of CH responses and altering the numbers and morphology of MHCII
positive cells (Vreemer and Streilein, 1990; Yoshikawa and Streilein, 1990). As
UVB irradiation enhances DC migration to the DLN (Modycliffe et al., 1992), and
TNF-a increases the migration of epidermal LC to the DLN (Cumberbatch and
Kimber, 1992) it is possible that increased TNF-a on UV-irradiation induces DC
migration to the DLN, which may result in altered antigen presentation.
A particularly interesting candidate as an important photo-receptor of UV-induced
immunosuppression is UCA, and this is considered in detail in the following section.
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1.4 UROCANIC ACID
1.4.1 Location and Biochemistry
UCA (deaminated histidine, 4-imidazoleacrylic acid) was discovered in 1874 in the
urine of dogs (Jaffe). It is a major component of the epidermis, consisting of
approximately 0.6% of the total dry weight (Tabachnick, 1957). It is formed from
histidine in a one step deamination by the enzyme histidase (histidine-ammonia
lyase) during the process of keratinization, when histidine rich proteins are released
from the keratohyalin granule (Baden and Pathak, 1967). Histidase is synthesised in
the stratum spinosum and granulosum but is only active in the stratum corneum, but
the mechanism of enzyme activation is unknown (Scott, 1981). The plasma
membrane of keratinized cells is highly impermeable, and urocanase is not found in
the epidermis, therefore UCA accumulates in the superficial layers of the stratum
corneum (Baden and Pathak, 1967; Zannoni and La Du, 1963). Six to twelve times
as much histidine is synthesized into UCA in the epidermis compared with protein
(Baden and Pathak, 1967; Reavan and Cox, 1965). Histidase activity is also found
in the liver but in that organ UCA is further metabolised by the enzyme urocanase to
imadazoalone proprionic acid and finally to glutamic acid which is excreted in the
urine. It is of interest that urocanase only metabolises the trans-isomer but not the
ris-isomer. The metabolism of histidine is outline in Fig 1.3 (taken from Norval et
al., 1989c).
Serial tape stripping of normal human epidermis down to the stratum granulosum,
followed by alkali extraction and analysis for UCA by HPLC (high pressure liquid
chromatography) revealed that the greatest amounts of UCA were situated between
the third and seventh strip, out of a total of 14 consecutive strips, the median value
being 4 (ig cm"2 (Schwartz et al., 1986a). Similar results were obtained by Norval
et al., 1989a) UCA is soluble and it is possible that the UCA of the extreme
superficial layers is lost in sweat.
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Figure 1.3
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1.4.2 The Photobiology of UCA
UCA is a major absorber ofUV light in the epidermis. On UVR the naturally
occurring trans-isomer undergoes a UV-dependent isomerization to form the cis-
isomer (illustrated in fig 1.3). While the absorption maximum is 264 nm in vitro the
quantum efficiency of isomerization is maximal at 313 nm (Morrison et al., 1984).
UVA irradiation in vivo results in isomerization of UCA (Schwarz et al., 1987;
Riicker et al., 1991), but Shwartz et al also reported that the same dose of UVA in
vitro did not. They proposed that a unknown photosensitizing agents produced in
vivo may have been responsible for the isomerization, a theory also recently
proposed by De Fabo et al. (1991). However it has been demonstrated that in vitro
PUVA treatment of a solution of trans-UCA resulted in isomerization (Gruner et al.,
1992), although the possibility exists that the psoralen acts as a photosensitizing
agent. Others have found that in vitro UVA irradiation of trans-UCA in the presence
of psoralens had little or a slightly protective effect on the isomerization (H. Morrison
personal communication; our unpublished observation). More recently, using
monochromatic light it has been demonstrated that isomerization of UCA in vitro
takes place up to 320 nm (Gibbs et al., submitted for publication). This was also
true when mice were irradiated in vivo (Gibbs et al., submitted for publication).
UVB irradiation of human forearm followed immediately by sequential tape stripping
revealed that the highest percentage of cw-UCA was found in strips 1-8 (Norval et
al., 1989a). The relative percentage of m-UCA produced was dependent on the
dose of UVB employed in the study eg 6 mj cm*2, 12 mJ cm"2 or 24 mJ cm"2
resulted in production of 20-39 %, 35-50 % and 35-60 % cis-UCA respectively. A
number of reports indicate that cfs-UCA may not be confined to the epidermis.
Radiolabeled trans-UCA was applied to mouse epidermis. Two hours after
irradiation 14C was detected in the serum and spleen, but at six days it was no longer
detectable in the serum with reduced quantities remaining in the spleen (Reeve et al.,
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1991). A monoclonal antibody which recognises cis-UCA but not trans-UCA was
employed in a competitive inhibition ELISA to detect cis-UCA in the serum of mice
following UVB (A. Moodycliffe, personal comunication). In addition cis-UCA has
been detected in human urine following whole body UVB (Prof. J D Bos, personal
communication) and also in suction blister fluid, which is thought to be mainly
derived from the dermis (Pasanen et al., 1990).
UCA was proposed to be a natural sun screen because of it's UV-absorbing properties
(reviewed by Morrison, 1985). Topical application of UCA in three subjects did
afford modest protection against sunburn (Baden and Pathak, 1967). A number of
commercially available sunscreens containing UCA were recently shown to form cis-
UCA on UVR in vitro (Reeve and Mitchell, 1991). When the irradiated lotion or
the lotion plus a normally sub-immunosuppressive dose of UVB were given to
hairless mice a 68% and 56% suppression in the CH response (respectively) was
measured. This demonstrates the potentially hazardous nature of UCA as a
constituent of a sun screen lotion. The absorption spectrum of UCA overlaps the
photomutagenesis action spectrum considerably which suggests that it may be a more
efficient photoprotecting agent against the UV damage to DNA than that of erythema
(Morrison 1985).
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1.4.3 UCA and Immunosuppression
In 1983 De Fabo and Noonan published an action spectrum of UV-induced
immunosuppression of CH response in BALB/c mice using 10 different wavelengths
of narrow band UV-light of 5-15 nm intervals. This spectrum resembled the UV-
absorption spectrum of trans-UCA very closely, which led to the proposal that trans -
UCA was the photoreceptor involved in UV-induced immunosuppression (De Fabo
and Noonan, 1983a). Following this report experiments in histidenaemic mice,
which had a mutant histidase gene, and formed less than 10% of the normal quantity
ofUCA, revealed that these mice were resistant to UV-induced immunosuppression
(De Fabo et al., 1983b). Conversely mice fed on a histidine rich diet, and therefore
with an enhanced epidermal UCA content were more sensitive to the suppressive
affects ofUV on CH responses (Reilly and De Fabo, 1991). There is now a large
body of experimental evidence which indicates that cis-UCA alone is capable of
mimicking many of the effects of UV-induced immunosuppression (reviewed
Noonan and De Fabo, 1992; Norval et al., 1989a).
Previously the immunosuppressive effects of low dose UV on the DH response in a
murine model of HSV infection had been characterized (Howie et al., 1986 a;
Howie etal., 1986b; Howie etal., 1987; discussed in section 1.3.3). Subsequently
the effects of applying UV-irradiated UCA were found to mimic the effects ofUVR
exactly. Application of a mixture of UCA isomers to the epidermis or
injected subcutaneously, followed by infection with HSV five hours or three days
later resulted in a dose dependent suppression of DH response when the mice were
challenged with inactivated HSV antigen eight to ten days later (Ross et al., 1986).
Using purified cis-UCA a significant suppression of the DH response to the virus
resulted at doses as low as 1 (ig of cis-UCA per mouse. The suppression was
mediated by the induction of antigen specific T cells of two phenotypes,
L3T4+ Ly2" and L3T4~ Ly2+ (Ross et al., 1987). Mice were treated epidermally
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with a mixture of UCA isomers and 24 h later epidermal cells from the treated site
were transferred to naive syngeneic mice at the same time and place as infection with
HSV. A suppressed DH response resulted on challenge with the virus, which was
again found to be antigen specific but was due to the induction of T cells of only one
phenotype, L3T4+ Ly2" (Ross et al., 1987/88). This suggested that two signals are
possibly generated by cis-UCA, one locally inducing the L3T4+ Ly2" phenotype and
one systemically inducing the L3T4" Ly2+ alone or inducing the L3T4+ Ly2" also,
(as found with UVR; section 1.3.3). A series of UCA analogues were synthesised
and their potential to suppress DH carried out (Norval et al., 1989b).
A number of other groups have reported that cw-UCA suppresses CH responses in
mice (Harriott-Smith and Halliday, 1988; Reeve et al., 1989). In a similar manner
to UVR, cis-UCA has been reported to produce soluble suppressive factors in the
serum of mice (Harriot-Smith and Halliday., 1988). Treatment of chronically UV-
irradiated mice with UCA enhanced UV-induced tumour yield per mouse, and a
greater number were aggressive squamous tumours (Reeve et al., 1989). UCA
forms photoadducts with DNA in vitro (reviewed Morrison, 1985) which may play a
role in this process, but it is more likely that UCA suppresses immune responses to
tumour antigens generated in the skin following UVR. Further experiments by
Reeve et al revealed that mice treated with cimetidine, a H2 receptor antagonist, had
a reduced number of UV-induced tumours suggesting that a histamine receptor may
be involved in the process (Matheson and Reeve, 1991).
It has previously been shown that UVB or PUVA treatment of a recipient prolonged
the graft survival (Pamphilon et al., 1991). Cis-UCA prolonged the survival of
allogeneic MHC disparate skin grafts in mice in a dose dependent manner (Gruner et
al., 1992). In 30 % of cases treatment with ris-UCA, but not trans-, prevented the
onset of acute lethal graft-versus-host disease and delayed it in others (Gruner et al.,
1992). Likewise permanent acceptance of heart allografts in rats (Oesterwitz et al.,
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1990), enhanced survival of rabbit corneal transplants (Williams et al., 1990) and
prolonged survival of heterotopic fetal mouse skin or pancreas were obtained in
animals which were treated systemically with cis-UCA for seven days after
transplantation (Guymer et al., 1990).
Antigen presentation is a pivotal event in the induction of CH, or DH to viruses or
tumour antigens. Cis-UCA, but not trans-\JCA, has been shown to affect the
morphology, phenotype and function of APC in murine models. Culturing
epidermal sheets in the presence of cis-UCA for three days resulted in a reduction in
Ia+ cells but had no effect on the number of ATPase+ (Noonan et al., 1985).
Treatment with cis-UCA, but not trans- in vivo resulted in the reduction of Ia+ cells
at the site of application but no effect on the number of I-J+ cells was observed (Ross
et al., 1987/88). The morphology of the cells which remained was exactly the same
as that after UVR i.e. the dendrites had retracted and the network of cells was no
longer apparent (Kurimoto and Streilein, 1992). Human epidermal cells from
suction blister roofs were also found to have reduced expression of HLA-DR
following a three day incubation in vitro with cA-UCA (Rasanen et al., 1987).
Functionally, human epidermal cells and peripheral blood monocytes were also
found to have a reduced ability to produce IL-1 in addition to a reduction in HLA-DR
expression following incubation with cis-UCA (Rasanen et al., 1987; Rasanen et al.,
1989). UVR is associated with a reduced antigen presenting function by splenic DC
(Noonan et al., 1988), similarly c/s-UCA injected intravenously resulted in an
impaired ability of purified sple^nic dendritic cells to present antigen in an in vitro
lymphoproliferation assay seven days after injection (Noonan et al., 1988).
However simply adding cis-UCA to proliferation assays had no effect on the uptake
of 3H-thymidine (Noonan etal., 1988; Higaki et al., 1986). The mechanism of the
APC defect remains to be elucidated.
Histamine and trans-UCA induce the production of cAMP (adenosine3', 5'-cyclic
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monophosphate) by dermal fibroblasts in vitro which ci's-UCA down regulates in a
dose dependent manner (Palaszynski et al., 1992). This may indicate a role for the
dermal fibrobast in UV-induced immunosuppression, but more importantly it
indicates that cis-VCA may be capable of modulating second messenger systems
which play a pivotal role in cell signaling.
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1.5 Aims of Thesis
Previously in this laboratory pre-treatment with cis-UCA had been shown to result in
suppression ofDH responses to HSV in a murine model of infection (Ross et al.,
1986; Ross et al., 1987) in a very similar manner to UVB irradiation. Histamine,
which is linked metabolically, and is structurally very similar to UCA (Fig 1.3) was
also found to result in suppression of the DH to HSV (Norval et al., 1989b).
Therefore, cis-UCA may have induced suppression of the response through
histamine-like receptors, which are found on cells of the immune system (reviewed
Falus and Meretey, 1992; Hill, 1990). A primary aim of the present study was to
confirm this hypothesis by investigating the effect of known histamine receptor
antagonists on cis-UCA induced modulation of immune responses. The results are
outlined in Chapter 3. In addition, CH responses had previously been shown to be
biphasic, with an early response two hours following antigen challenge in immune
mice, which was subsequently followed by the classical CH response 24-48 h later
(reviewed by Askenase et al., 1991). It was aimed in the present study to determine
whether the elicitation phase of DH to HSV in mice followed similar kinetics. If so,
it was aimed to establish what effect pre-treatment with UV or UCA isomers had on
phases of the elicitation of the response. The results from this study may be found in
Chapter 4.
As discussed in the Introduction UVB results in profound changes in epidermal LC
and altered antigen presentation. It was therefore of interest to establish what effect
in vivo or in vitro treatment with UCA isomers had on the ability of murine APC to
present HSV antigen or Con A to T cells in an in vitro lymphoproliferation assay.
These experiments are outlined in Chapter 5.
Phototherapy is commonly employed in the management of a number of dermatoses.
Its use is largely empirical, and little is known of its mechanism of action. It is
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possible that it may act, at least in part, by modulation of immune responses. Most
previous investigations of the immunological effects ofUV irradiation have been
conducted either in experimental animals or in humans using regimens bearing little
resemblance to those used therapeutically. It was aimed in the present study to
examine the effects of standard courses of UVB and PUVA therapy on various
parameters of systemic and cutaneous immunity in patients with psoriasis. The
results were compared with two control groups: the first consisted of normal subjects
who were given a standard course ofUVB phototherapy and, the second, patients
with psoriasis who received topical coal tar paste treatment instead ofUV irradiation.
Assays included several humoral components, phenotypic profiles and counts of
peripheral blood mononuclear cells (PBMC), UCA isomers and TNF-a analyses,
and in vitro lymphoproliferative responses (LPR) to Con A and HSV. The results
are given in Chapter 6, and in Chapter 7 studies on the modulation of natural killer





2.1 GENERAL MATERIALS AND METHODS COMMON
TO MURINE AND HUMAN STUDIES
2.1.1 HSV Culture
The virus used to infect mice and also as an inactivated antigen, used in
lymphoproliferation and enzyme-linked immunosorbent assays (ELISA), was an
isolate ofHSV-1 from a clinical case, which was plaque-purified in Vero cells.
Vero cells were cultured in Eagle's minimal essential medium pH 7.4 (Northumbria
Biologicals Limited, UK) supplemented with 5% new born calf serum, 2 mM L-
glutamine, 100 IU ml"1 penicillin and 200 pig ml-1 streptomycin. Plaque assays for
infectious virus were performed using monolayers of Vero cells in microtitre plates
with 0.25% Seaplaque agarose (FMC Corporation, USA) in the overlay. After 2-3
days incubation at 37°C the cells were fixed in formol saline, stained with Giemsa,
and the plaques counted under the low power of a light microscope. The virus was
stored at -70°C in small aliquots for upto one year, after which the viability of the
virus diminished. Three different batches of HSV were used through out the study
which varied from 4 x 107 to 10** plaque forming units (pfu) ml"1.
2.1.2 Preparation of HSV Antigens
UV-inactivated HSV-1 was prepared from stock HSV-1 by irradiation of a thin film
of sonicated virus with 300 mJ cm-2 UVB under 2 Philips TL 20W/12 lamps. UV-
inactivated antigen was used in proliferation assays and DH experiments. The same
batch of HSV antigen was used for all assays for a particular individual in Chapter 6.
Mock infected sonicated Vero cells were used as the control antigen.
The antigen used for the HSV ELISA were glycine extracted antigens. Monolayers
of Vero cells in Roux flasks were infected with HSV at a multiplicity of 2-3 pfu per
cell and incubated at 37°C in 4% CO2 in a humidified incubator. The cells were
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harvested 24 h post infection with gentle agitation with glass beads. Glycine extracts
of the infected cells were prepared using the method of Booth et al., (1979).
Briefly, cells were suspended in buffer prepared from five parts 0.1 M aqueous
solution of glycine and three parts 0.1 M aqueous sodium hydroxide. The cells were
disrupted by three freeze/thaw cycles and ultrasonicated for one minute and
vigorously agitated between each cycle. Uninfected Vero cells were treated in
exactly the same manner and used as control antigens. The protein concentration of
the extracts were determined by the Lowry method (Lowery et al., 1951). The
extracts were stored at -70°C in small aliquots.
2.1.3 UCA and Histamine Receptor Antagonists and Agonists
Trans-UCA was purchased from Sigma UK and contained no detectable cis-UCA as
measured by HPLC (employing the method outline by Norval et al., 1988). Purified
cfr-UCA was prepared by thin layer chromatography, by J. Crosby (Bristol
University) as previously described (Norval et al., 1989). In some initial
experiments, both UCA isomers were dissolved in dimethyl sulfoxide (DMSO) at
10 mg ml-1 and subsequently diluted in ethanol for skin painting (topical application)
or 0.01M phosphate buffered saline pH 7.2 (PBS) for use in all other experiments.
In more recent experiments cis-UCA was dissolved at 10"1 M and trans-UCk at
10"2 M in PBS respectively.
Cimetidine (H2 receptor antagonist) and terfenadine (HI receptor antagonist) were
obtained from Sigma UK Ltd. They were dissolved at 10 mg ml"1 in DMSO. Each
was diluted just before use in ethanol for skin painting. Cimetidine was dissolved in
PBS for subcutaneous injections or tissue culture. DMSO was used as the diluent for
terfenadine when it was injected subcutaneously alone or together with UCA. 4-
methylhistamine, a known H2 agonist, was a kind gift from Dr T. G. Payne, Sandoz
Pharma Ltd, Basel, Switzerland. This was dissolved at 20 mg ml"1 in DMSO and
further diluted in PBS. Thioperamide (H3 receptor antagonist) and (R)-a-
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methylhistamine (H3 agonist) were gifts from Dr M. Clark, Schering Plough
Corporation, New Jersey, USA. Both substances were soluble in PBS at
10 mg ml-1.
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2.2 MURINE MATERIALS AND METHODS
2.2.1 Mice
C3Hf Bu/Kam female mice, aged 8-12 weeks, were used throughout. They were
bred and maintained in the Department of Medical Microbiology animal house.
2.2.2 UV Irradiation
Mice had their backs shaved and were placed in a perspex box with narrow chambers
to prevent it turning around or climbing up towards the UV-source. They were
irradiated under a bank of two Philips TL20W/12 UV lamps with a output range of
270-320 nm (the relative output spectrum was very similar to that of the Philips UV 6
lamp illustrated in Fig 2.1). The irradiance was 80 pW cm"2, 10 cm from the source,
measured inside the perspex box using an Industrial Research Radiometer (Dr J D
Simpson, Radiation Protection Services, Edinburgh). In all experiments the mice
were irradiated with a single suberythemal dose of 96 mJ cm-2. The UVA source
employed was a single VL-6L lamp (Viber Lourmat, Marne La Vallee, France)
which emits over the range 310-400nm (similar to the UVA source illustrated in
Figure 2.1). The output of the lamp, measured using the same meter used to
measure the output of the PUVA lamps (2.3.2>), was 1 mW cm-2 at a distance of 9 cm
from the source (approximate distance of the back of the mouse from the source).
The mice were irradiated with a single dose of 200 mJ cm-2 ofUVA.
2.2.3 ATPase Staining of Epidermal Sheets
For enumeration of LC in murine epidermis, 20 pi volumes containing 20 pg cis- or
20 pg trans-UCA alone or 20 pg cis-UCA with 20 pg of the histamine receptor
antagonists were painted on each ear surface of the mice after tape-stripping twice.
Control mice received the vehicle alone after tape stripping twice. A further control
group was not tape stripped before being painted with the vehicle. The mice were
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killed 24 h later, the ears removed, ear surfaces split and epidermal sheets prepared
by floating ear surfaces dosal side down in 0.76% tetrasodium ethylenediamine tetra-
acetic acid (EDTA) (pH 7.2) at 37°C for two hours (Juhlin and Shelley, 1977). The
epidermal sheets were fixed in 1.3% sodium cacodylate/formaldehyde buffer and
stained for ATPase using ADP as a substrate (Chaker et al., 1984). One group of
mice was irradiated for 20 min under 2 Philips TL20W/12 lamps giving a dose of 96
mJ cm-2 ofUV in the range 270-350 nm. Epidermal sheets from the dorsal surface
only of the ears were prepared 3 days later. The specimens were coded at this stage
and examined "blind" microscopically. The number of ATPase4" cells was counted in
at least 40 fields of view of 0.14 mm*2 (using a graticule) chosen randomly for each
sheet. The significance of the counts was determined by Student's t-test.
2.2.4 HSV Infection of Mice
Two methods ofHSV infection were employed; (a) epidermal or (b) subcutaneous.
(a) The dorsal side of mice were shaved and the shaved area was tape stripped six
times, followed by 4 x 104 pfu ofHSV in 10 |il being rubbed into the tape stripped
site. Approximately two thirds of the mice developed lesions between day four and
eight following infection (Fig l.lb). Mice were selected on the basis of a visible
clinical lesion, and those which did not develop lesions were discarded. In a few
instances mice developed zosteriform lesions which result in hind leg paralysis and
these mice were killed.
(b) Mice were infected subcutaneously with 5 x 105 pfu of HSV in 100 |il of PBS.
2.2.5 Lymph Node and Spleen Cell Preparations
After killing the mice with ether inhalation, LN and spleens were removed
aseptically and collected into RPMI 1640 (Gibco Ltd., Paisley, UK) supplemented
with 5 mM 2-mercaptoethanol, 2 mM L-glutamine, 100 IU ml-1 penicillin,
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200 p.g ml"1 streptomycin, 100 pg ml"1 gentamicin and 10 pg ml"1 fungizone (tissue
culture medium, TCM) plus 10% FCS (foetal calf serum) (Gibco Ltd, Paisley, UK).
They were disaggregated by grinding them through a fine wire mesh and the cells
were washed twice in TCM plus 10% FCS. The cells were finally resuspended at a
concentration of 1 x 106 ml"1 in TCM plus 10% FCS and viable cell counts
determined by trypan blue exclusion; usually > 90%. T enriched cells (TEC) were
prepared by passage over nylon wool columns (see section 23.9).
2.2.6 Preparation of Antigen Presenting Cells and T Enriched
Cells
a
Peritoneal macrophages (PM) were derived by lavage of the peritoneum with 10 mis
of PBS per mouse. Viability was determined by trypan blue exclusion and
was > 95%.
Epidermal sheets were prepared from mouse ears. The mouse was killed, the ears
removed and split into two surfaces. These were floated dermis down in 1% trypsin
(Sigma UK Ltd, Poole) in PBS for 45 min at 37°C. The ear surface was then placed
in a dish containing TCM supplement with 10% FCS to stop further action of the
trypsin. Using fine forceps the epidermal sheet was pulled off allowing the
epidermal cells to float into the medium. The dermis was discarded and the
epidermis pulled apart in the medium followed by filtration through fine wire mesh.
The single cell suspension was washed twice in TCM and resuspended at 1 x 106
cells ml"1.
T enriched cells (TEC) were prepared from spleen cell suspensions in an identical
manner to that employed for human peripheral blood mononuclear cells (see section
2.3.8). Nylon wool columns only were used to enrich T cells from LN cell
suspensions only (as outlined in 2.3.8)
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2.2.7 Lymphoproliferation Assay
The mice were given a primary infection with HSV epidermally. At least two weeks
later the mice were inoculated with HSV subcutaneously (section 2.2.4). Eight to ten
days following the secondary infection spleens and LN were collected and single cell
suspensions prepared (section 2.2.5). Two hundred |il of the cell suspensions or
TEC were placed into each well of a 96 well plate of varying dimensions (Falcon,
Oxnard, USA). To quintuplicate wells 0, 0.3%, 3% or 10% of either PM or
epidermal cells (EC) were added. The plates were either incubated without any
further additions, 5 |ig ml"1 Con A, 1 pfu cell"1 of HSV antigen or an equivalent
number ofmock infected Vero cells (102 ml"1). The cells were incubated for five
days at 37°C in 5% CO2 in a humidified incubator, and pulsed with 0.75 |lCi 3H-
thymidine (Amersham, Little Chalfont, UK) per well over the final 24 h of culture.
The cells were then harvested onto glass fibre paper and the uptake of 3H-thymidine
measured using a Packard liquid scintillation counter and the results calculated as in
section 2.3.12.
2.2.8. The Effect of UCA on DH to HSV.
This protocol has been described previously (Howie et al., 1986) and is illustrated in
Fig 3.3. Briefly, 100 p.1 volumes containing the appropriate concentrations of cis-
UCA alone, or with the histamine receptor antagonists, were either painted on the
shaved backs of the mice after tape-stripping twice or injected subcutaneously into
the flank 5 h before subcutaneous infection of the mice with 5 x 105 pfu HSV. To
act as control groups, mice were injected subcutaneously with the vehicle alone
before being infected with HSV or being sensitized with an equivalent number (103)
of sonicated, uninfected Vero cells. There were normally 8 mice in each group.
Ten days later, the thickness of each ear was measured; then the mice were
challenged by injecting 10 jn.1 (4-10 x 105 pfu) inactivated HSV into each ear pinna
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using a 31 gauge needle. Succesful intradermal injections were characterized by the
formation of a "blip" which was visible by eye. The ears were re-measured 24 h
later and DH calculated as an average ear increase per mouse.
rr^n ^ 100 x net increase experimental mice \Percentage suppression ot DH - 100 ( „et increas^oS-ol Sice >
Concentrations ofm-UCA used lay within a physiological range (Noonan et al.,
1988). The significance of the suppression was calculated by Student's t test.
2.2.9 TNF-a Specific Antibodies
The protocol followed was based on that of Vermeer and Streilein (1991).
Polyclonal rabbit anti-mouse serum from hyperimmune New Zealand rabbits
immunized with recombinant TNF-a was purchased (NBS Biologicals, Hatfield,
Herts, UK). The neutralizing activity was 1 x 106 units ml"1. The serum was
preservative free and had been sterilized using a 0.22 pm filter. Mice received 2 x
104 units of anti-TNF in 100 pi intraperitoneally two hours before treatment with cis-
UCA or a single dose of UVB (96 mJ cm*2). Control mice received 100 pi of PBS
intraperitoneally.
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2.3 HUMAN MATERIALS AND METHODS
2.3.1 Patients
A total of 44 patients with chronic plaque psoriasis and six with guttate psoriasis were
studied. Healthy individuals acted as controls. The subjects were recruited in two
cohorts; one for the studies outlined in Chapter 6 and the other for the studies in
Chapter 7. Patient details are outlined in Table 6.1 and 7.1 at the begining of these
chapters. All subjects were attending the Department of Dermatology, Royal
Infirmary of Edinburgh with the exception of group C and D in Chapter 7, who were
attending the Photobiology Unit, Ninewells Hospital, Dundee. Normal healthy
voluteers were recruited from hospital or university staff in Edinburgh. All subjects
were in good general health, taking no other immunosuppressive medication, and
were of skin types II or III. Liquid paraffin/white soft parafin (50/50) or emulsifying
ointment were used as non-UV absorbing emollients before and during therapy by all
psoriatic patients, including those receiving topical coal tar.
The aim of the study described in Chapter 6 was to examine the effect of UVB
phototherapy or PUVA therapy on immune function in patients with psoriasis, and
the possible role of UCA in any immune modulation. Chapter 7 aimed to examine
the effect of various UV-based treatments on NK cell function. Details of the
samples taken and the time course of sampling are outlined in Chapter 6 and 7. The
UV-treatment regimens employed are outlined below. In both studies psoriatic
subjects who were treated with increasing concentrations of coal tar paste (1-4%)
under stockinette dressings acted as one control. In addition, where possible





Subjects received the UVB regimen normally employed for psoriasis in Edinburgh.
They were irradiated with incremental doses ofUVB starting with 37 mJ cm-2 in an
uprightWaldmann 1000 UVB cabinet (Fig 6.2 illustrates a Waldmann upright cabinet
used for phototherapy) containing 26 Sylvania tubes, emitting 42% in the UVA
waveband, 57.6% in the UVB and approximately 0.3% in the UVC. The relative
output spectrum from the lamps is illustrated in Fig 2.1. Irradiance was determined
using a filtered photodiode meter (Jagger, 1967) which was calibrated against
measurements made with a UV-visible spectroradiometer (model 742, Optronic Lab
Inc, UK), and the total output (250-400 nm) was 1.4 mW cm-2. They were treated
three times a week until clear (4-6 weeks).
2.3.3 PUVA Therapy (Edinburgh)
Patients in Edinburgh who received PUVA therapy (Chapter 6) were irradiated twice
weekly in a Waldmann 6001 PUVA cabinet containing UVA lamps emitting
10.5 mW cm-2 UVA and 0.3 mW cm'2 UVB. Irradiance was monitored using a
Waldmann PUVA meter calibrated at the regional Medical Physics Department,
Durham. The relative output of the lamps is illustrated in Fig 2.1. Patients received
0.8 mg kg"1 body weight of 8-methoxypsoralen orally 2 h before each irradiation.
The minimal phototoxic dose for each patient was determined and, at the first
treatment they received 70% of that dose followed by doses increased by 20% at each
subsequent treatment, up to a total of 20 treatments. The relative output spectrum of
these lamps is illustrated in Fig 2.1.
2.3.4 PUVA Therapy (Dundee)
Patients studied in Chapter 7 received PUVA therapy in Dundee. A Waldmann 6000
cabinet incorporating 62 Sylvania FR74T12 fluorescent lamps (UVB = 0.4 mW cm-2,
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UVA = 9.8 mW cm-2) was used, and irradiance assessed using the same meter as
outlined above. All patients had their minimal phototoxic dose determined, and the
first irradiation dose was 70% of this. Treatment was then given twice weekly with
40% incremental doses (less if erythema occurred) at each visit until minimal residual
activity was achieved (15-20 treatments). The relative output spectrum of these
lamps is very similar to that of the PUVA lamps used in Edinburgh (Fig 2.1).
2.3.5 Narrow Band UVB (TLOl) Therapy
Patients had their minimal erythema dose (MED) determined and an initial dose of
70% ofMED was given. They were treated three times weekly and at each visit the
dose was increased by 40%; the increment was reduced or omitted depending on the
occurrence and severity of erythema. Treatment was stopped when psoriatic plaques
had resolved to the point of impalpability over all affected areas, excepting minimal
residual activity on knees or elbows (15-20 treatments). The irradiation, determined
as for the UV6 lamps, was given in an upright cubicle incorporating 50 Philips 100W
fluorescent lamps and was 4.1 mW cm-2. The relative output of the TLOl lamp is
illustrated in Fig 2.1.
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Figure 2.1


































Oropharyngeal swabs were collected into 5 mis of Eagle's minimal essential medium
plus 5% new born calf serum (supplemented as in section 2.1.1). The samples were
stored at -70°C until being assayed for plaque forming units on monolayers of Vero
cells.
2.3.7 Preparation of Peripheral Blood Mononuclear Cells
Venous blood was collected into preservative-free heparin (10 U ml"1 final
concentration) and PBMC isolated by centrifugation (1500g for 25 min) on
lymphopaque (Nyegaard Ltd., Birmingham, UK). The cells were washed three
times in PBS containing 5 U ml"1 of heparin and two percent autologous plasma,
and resuspended in RPMI 1640 (Gibco Ltd., Paisley, UK) supplemented with 5 mM
2-mercaptoethanol, 2 mM L-glutamine, 100IU ml"1 penicillin, 200pgml"1
streptomycin, 100 pg ml"1 gentamicin and 10 pg mH fungizone (TCM) plus 15%
autologous plasma. In the case ofNK cell activity assays 10% FCS (Gibco Ltd.,
Paisley, UK) was added instead of autologous plasma. Viability was determined by
trypan blue exclusion, and was found to be greater than 95%.
2.3.8 Preparation of Adherent Cells and T Enriched Cells
The PBMC were incubated in 50 ml tissue culture flasks (Falcon, Oxnard, USA) for
lh at 37°C (5 ml of cells containing up to 3 x 107 cells). Non-adherent cells were
washed off and the adherent cells (AC) scraped off using a cell scraper (Costar
Corporation, Cambridge, USA). AC were resuspended in TCM at 5 x 105 mH.
The non-AC were then enriched for T cells by passage over a nylon wool column
(Julius et al., 1973). Briefly 2g of teased nylon wool was placed in the barrel of a
10 ml syringe. The column was equilibrated with TCM plus 15% autologous plasma
at 37°C for at least 1 h before adding 2 mis of non-AC to the column (the number of
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cells added to the column never exceeded 6 x 107) for 90 mins at 37°C. The cells
were eluted from the column with TCM plus 15% autologous plasma (warmed to
37°C), washed and finally resuspended in TCM plus 15% autologous plasma at 5 x
105 cells ml"1 (TEC). The viability of all cell populations was greater than 95%,
determined by trypan blue exclusion.
2.3.9 Preparation of Epidermal Cell Suspensions
The method employed was that of Vestey et al., (1990). In brief, suction blister
roofs were raised under negative pressure from uninvolved areas of the forearm
(illustrated in Fig 2.2), the blister fluid was collected and stored at -70°C and the
roofs placed into 0.5% trypsin (T2021) (Sigma UK Ltd, Poole). They were
incubated at 37°C for lh with gentle agitation to prepare a single cell suspension.
Fifteen percent autologous plasma was added, the cells were then washed twice and
resuspended at 5 x 105 cells ml"1 in TCM.
2.3.10 HSV-Specific ELISA
The ELISA method employed that of Vestey et al., (1988) (based on that of Booth et
al., (1979)). Briefly, HSV or control glycine extacted antigen (described in section
2.1.2) was used to coat Immunoplates (Nunc, Gibco Ltd, Paisley, UK) at 10 (ig
protein ml"1 in sodium carbonate/bicarbonate buffer (pH 9.6) overnight at 4°C. After
washing with PBS containing 0.1 % bovine serum albumin (BSA; Sigma UK Ltd,
Poole) and 0.05% Tween 20 (wash buffer), 100 p.1 of doubling dilutions of test
serum, in PBS plus 1% BSA, were added to the wells and incubated at room
temperature for 2-3 h. The plates were then washed with wash buffer and incubated
for 2-3 h at room temperature with a 1:500 dilution of goat anti-human IgG antibody
conjugated to alkaline phosphatase (Sigma UK Ltd, Poole). The plates were washed
again and 100 (il of diethanolamine buffer (pH 9.8) containing p-nitrophenyl
phosphate substrate (Sigma UK Ltd, Poole) added for for approximately 20 min,
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until a strong colour change had developed in the wells containing a pooled HSV
positive control serum. The reaction was then stopped by the addition of 50 |il of
3M aqueous sodium hydroxide. The plates were then read on a spectrophotometer at
405 nm. The antibody titre was estimated as the dilution of serum which gave an
absorbence greater than the mean plus three standard deviations of eight wells of
pooled negative serum at 1:100 dilution.
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Figure 2.2
Suction BlisterRoofs. Suction blister cups were held in place by means ofan
elasticised bandage and a negative pressure of -150 mm Hg applied using a hand
operatedpump. Suction blisters were raised in 45-60min. The blister roofs were
removed under sterile conditions using scissors and thefluid collected. Epidermal
cell suspensions were prepared as outlined in 2.3.5.
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2.3.11 Fluorescent Flow Cytometry
The method employed was that used by Vestey et al., (1988). Briefly 5 x 105
PBMC were stained with the murine monoclonal antibodies outlined in Table 2.1
over night at 4°C. An irrelevant antibody was used to determine the background
nonspecific binding (approximately 1.1% of the total histogram). The cells were
then washed in PBS with 1% BSA (Sigma UK Ltd, Poole) and incubated with sheep
anti-mouse IgG F(ab')2 fraction conjugated to FITC (Sigma UK Ltd, Poole) at a 1:40
dilution at 4°C for 45 mins (with the exception of those cells stained with anti-CD16
which was directly labelled with phycoerythrin). The cells were then washed in PBS
plus 1% BSA, resuspended in 1ml of cold PBS plus 1% BSA and fixed by the
addition of 1% formaldehyde solution. Approximately 104 cells were analysed on a
Coulter EPICS 'C' flow cytometer (output 150 mW at 488 nm, flow rate 400-500
cells s"1). The percentage of cells exhibiting fluorescent levels higher than the
background was recorded. All flow cytometric analysis was carried out byW Neill.
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Table 2.1
Monoclonal Antibodies Employed in this Study
Cell Surface Target cell Monoclonal Source
Marker antibody
CD3 T cells DAKO-T3 Dakopatts





















CD56 NK cells Leu 19 Beckton
Dickinson
*: large granular lymphocytes
A: natural killer cells
killer cells
¥: Gift from Dr K Guy
Dakopatts, High Wycombe, UK
Beckton-Dickison, California, USA
2.3.12 Lymphoproliferation Assay
Two hundred pi of human PBMC or TEC were plated into each well of a 96 well
round bottom plate (Falcon, Oxnard, USA). To quintuplicate wells 0, 0.3%, 3% or
10% of either AC or EC were added. The cells were either incubated without any
further additions, 5|ig ml*1 Con A, 1 pfu cell"1 of HSV antigen or an equivalent
number of mock infected Vero cells (102 ml"1). The cells were incubated for six
days at 37°C in 5% CO2 in a humidified incubator, and pulsed with 0.75 pCi 3H-
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thymidine (Amersham, Little Chalfont, UK) per well over the final 24 h of culture.
The cells were then harvested onto glass fibre paper and the uptake of 3H-thymidine
measured using a Packard liquid scintillation counter. The stimulation index (SI) for
each culture was calculated as:
_ mean counts min -1 (cpm) test
mean counts min -1 (cpm) control
Arithmetic mean cpm had previously been employed in this laboratory for several
studies involving HSV responses and for the sake of direct comparison with previous
work, arithmetic means were used in preference to geometric means in the present
study.
2.3.13 Determination of Natural Killer Cell Activity
K562 erythroleukaemic cells, which are sensitive to lysis by NK cells (Lozzio and
Lozzio, 1975) were employed as target cells in all experiments. They were cultured
in TCM plus 10% FCS. 106 cells were labelled with 100 pCi of sodium chromate
(51Cr; Amersham, Little Chalfont, UK) for 4h at 37°C. The cells were washed
three times with PBS and resuspended in TCM plus 10% FCS at 105 cells ml"1. One
hundred |il of 51Cr-labeled cells were placed in each well of a round bottomed 96
well plate (Falcon, Oxnard, USA).
PBMC suspensions at 4 x 106 cells ml"1 were doubly diluted in TCM and 100 pi of
each dilution was added to quadruplicate wells containing the labelled target cells,
thus resulting in effector (E) to target cell ratios (E:T) of 40:1 through to 1.25:1.
Spontaneous 51Cr release was determined by adding 100 pi of TCM to quadruplicate
wells and maximum release by adding 100 pi of 2% acetic acid to quadruplicate
wells. The cells were incubated for 18h at 37°C in 5% CO2 in a humidified
incubator. The plates were then spun at 500 g for five minutes before removing
120 pi of the supernatant for determination of radioactivity (mean cpm) using a
Packard liquid scintillation counter. The standard errors at each E:T cell ratio were
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always less than 10% of the mean value. The % specific 51Cr release was
determined by:
% Snecific 5lry Release - ( Test cpm - Spontaneous cpm \A Specific Cr Release - V Maximum Cpm-Spontaneous cpm / xlUU
2.3.14 The Effect of in vitro Irradiation of PBMC on NK Cell
Activity
PBMC were washed and resuspended in indicator free PBS at 2 x 107 cell ml"1.
Fifty pi of the suspension was placed in single wells of a 96 well flat-bottomed plate
(Falcon, Oxnard, USA). Adjacent wells remained empty to remove the possibility
that cells in these wells may be irradiated with reflected UV-from the neighbouring
well. The plate was spun at 500 g for 5 min (before irradiation) to form a monolayer
of cells in each well.
(i) Irradiation of cells with TLOl (311-313 nm).
A single TLOl lamp (Philips) was used to irradiate the cells. The output of the lamp
was measured using the meter employed in 2.3.2. The plate containing the cells was
placed on the bench at a distance of 20 cm from the lamp. Two glass sheets (UV
opaque) were placed over the plate and pulled back at known time intervals to expose
cells to shorter time intervals.
(ii) Irradiation of cells with monochromatic light.
A single grating monochromator (Rank Hilger D330, UK) with a 450W xenon arc
source was used. Wavelength and band width (2.6nm) calibrations had been
performed using a medium pressure mercury lamp and an Instaspec photodiode array
spectograph (Oriel Corporation, UK) respectively, by N Gibbs. A 5 mm diameter
liquid light guide (Oriel Corporation, UK) was employed to direct the light onto
single wells of cells chosen randomly. The cells were irradiated with incremental
wavelengths and the irradiance was measured using a Fliger-Watts FT17 thermopile
calibrated by the National Physical Laboratory, UK.
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Following irradiation the cells were resuspended in 1 ml of TCM plus 10% FCS.
The viability of the cells was determined by trypan blue exclusion before serially
doubly diluting the cells and determining the NK cell activity of the irradiated cells.
The 40:1 E:T cell ratio was attained by incubating 100 pi of PBMC at 2 x 106 with
100 p.1 of 51Cr-labelled target cells at 5 x 104.
2.3.15 The Effect of UCA Isomers on NK Cell Activity in vitro
Serial tenfold dilutions of cis - (10_1M to 10~8 M) or trans - (10"2 to 10"8) UCA were
carried out in PBS. Ten pi of the appropriate concentration of UCA were added to
0.5 ml of E cells. The cells were then added to wells of 96 well round bottomed
plate (Falcon) and approximately 15 min later labelled target cells were added at an
E:T cell ratio of 40:1. This resulted in a final concentration when the target cells had
been added of 10"3 M to 10~10 M cis- or 10"4 M to 10"10 M trans -UCA. One
hundred pi of 10'1 M cis- or 10"2 M trans-UCA were added to 0.4 ml of cells,
containing the same number of cells as 0.5 ml above, resulting in the final
concentrations of 10"2 and 10"3 M respectively. NK cell activity was determined
following an 18 h incubation as usual.
2.3.16 TNF-a Quantification
The amount of TNF-a present in the suction blister fluid was determined using an
ELISA kit (purchased from NBS Biologicals, Hatfiel Herts, UK). One hundred pi
of each sample or standard was added to each well.
2.3.17 Urocanic Acid Analysis
Epidermal UCA was initially quantified from 4 successive tape strips taken from the
buttock (Norval et al., 1988). The UCA was extracted from each strip with 0.1 M
KOH and analysed for UCA. The values for the four strips were then pooled. More
recently, six filter paper discs soaked in 0.1 M KOH which were held in place with
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Finn Chambers for 30 min were applied to the inner-forejirm (Jansen et a\ 1991).
The filter discs were placed in 0.1 M KOH and stored in the dark at room temperature
for 24 h, to extract the UCA, before storage. Twenty |il of suction blister fluid was
also analysed.
All samples were taken from uninvolved sites. They were stored in the dark at -70°C
until analysis. Total UCA and relative amount of each isomer were determined by




THE ROLE OF HISTAMINE-LIKE RECEPTORS IN
IMMUNOSUPPRESSION INDUCED BY C/S-UCA
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3.1. INTRODUCTION
LC are pivotal in presentation of HSV antigen to T lymphocytes and thus in the
generation of DH responses to the virus. UVR reduces the surface marker expression
by LC in the epidermis and also their ability to present antigen (discussed in section
1.3). In the absence of a monoclonal antibody specific for murine LC, membrane
ATPase staining was employed to study the effect of UCA isomers on their numbers
and morphology.
Previously in the laboratory a single sub-erythemal dose of UVB prior to infection of
mice with HSV resulted in an antigen-specific suppression in the DH response to the
virus on subsequent challenge (see section 1.3.3). Cis-UCA was found to mimic the
effects of UVB in this system (outlined in section 1.4.2). A number of structural
analogues of UCA were synthesised and the ability of these compounds to induce
immunosuppression of DH to HSV tested (Norval et al., 1989 b). The structures of
these compounds are outlined in Fig 3.1. It was of interest to find that histamine,
which like UCA is formed from histidine in a one step process, was suppressive.
These results indicated that a histamine-like receptor may be involved in ra-UCA
induced immunosuppression of DH to HSV. Therefore the effect of histamine
receptor type 1 (HI) and 2 antagonists on epidermal LC and DH responses in mice
treated with cw-UCA was examined. Subsequent experiments employed a H2
receptor and an H3 receptor agonist on the DH response to HSV. A number of
additional UCA analogues were tested for their ability to suppress the DH response to
HSV to extend previous studies and in order to deduce the molecular structure
required by UCA to induce suppression.
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Figure 3.1
Urocanic AcidAnalogues Previously Testedfor Immunosuppression of the DH
Response to HSV. Cis- and trans-isomers of2-furanacrylic acid, 2-pyrroleacrylic
acid and 2-thiopheneacrylic acid effectively suppressed the DH response to HSV at
levels of 1 pg per mouse, the cis-form being more effective generally than the trans-
isomer, and 2-pyrroleacrylic acid was particularly potent. Both isomers of 3-
thiopheneacrylic acid were only marginally immunosuppressive. Neither isomer of
2-methlyurocanic acid had any suppressive activity. Dihydrourocanic acid and























3.2 1 The Effect of UCA Isomers on Epidermal ATPase+ Cells
Following two light tape strips of both ear surfaces, mice were painted on both ear
surfaces with cis- or trans-UCA, or with cis- or trans-UCA together with cimetidine
or terfenadine or the histamine receptor antagonists alone, and epidermal sheets
prepared 24 h later. In addition, some mice had received a suberythemal dose of
UVB (96 mJ cm"2) three days before preparing the epidermal sheets from the dorsal
ear surfaces. The sheets were stained for ATPase activity and the number of
ATPase+ cells determined by light microscopy.
In the control epidermal sheets, tape stripped twice and painted with the vehicle, the
LC formed a complete network (Fig 3.2 (a)) and had a very characteristic dendritic
morphology (Fig 3.2 (b)). Following painting with cis-UCA the picture was very
similar to that following UVR. The number of cells had decreased significantly,
thus the complete network had been disrupted (Fig 3.2 (c)) and the cells which
remained did not have the dendritic morphology (Fig 3.2 (d)). In some areas, there
were none of these cells left, but rounded cells with some scattered granular ATPase
staining were present (Fig 3.2 (e)).
The number of ATPase+ cells in the control mice which had been tape stripped prior
to painting with the vehicle was 1136 mm-2 (sem ± 25) and this compared to 1068
mm-2 (sem ± 19) in mice which had not been tape stripped; this was not statistically
significant by Student's t-test. The number of ATPase4" cells declined following
UVB irradiation and cis-UCA application compared with the control group painted
with the vehicle, but there was only a slight decrease in the cell numbers following
treatment with trans-UCA or the histamine receptor antagonists alone (table 3.1). If
cis-UCA was applied together with cimetidine and terfenadine, a decrese in the
number of cells occurred. The number of ATPase4" cells after either cis-UCA plus
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cimetidine or ra-UCA plus terfenadine alone was considerably greater than ris-UCA
alone.
Table 3.1
Number ofATPase+ Cells in Epidermal Sheets from Murine Ears
Treatment No. Fields Mean No. % Reduction
Counted ATPase+
Cells (mm 2)
in A I Pase+
Cells *
Vehicle 240 1068±19 —
20 jig cw-UCA 80 408 ±31 62
20 pg trans-CCA 80 933 ± 36 13
20 jig cimetidine 80 1095 ±27 -3
20 jug terfenadine
20 pg ris-UCA +
20 pg cimetidine















ATPase Staining ofEpidermal Sheetsfrom Murine Ears 24 h After Tape Stripping
andPainting with (a) vehicle (x 10),(b) vehicle (x 40), (c) 20 pg ( x 10),
(d) 20 pg cis-UCA (x 40), (e) 20 pg cis-UCA (x 40). Arrows show ATPase+ cells




3.2.2 DH Response to HSV
The DH protocol is outlined in Fig 3.3. Mice were pretreated with a single dose of
UVB (96 mJ cm-2) three days before, or a single dose of UCA five hours before
being infected subcutaneously with HSV. Application of UCA epidermally or
subcutaneously had a similar effect on DH. Ten days later each mouse was
individually marked and the thickness of each ear measured before challenging with
inactivated HSV antigen. Twenty four hours after challenge the thickness of each ear
was measured again and the increase in thickness taken as a measure of DH to the
virus. The average increase per mouse was calculated and the mean value for each
group (consisting of six to eight mice) calculated. Table 3.2 shows the effect of
UVB or UCA isomers alone on the DH response to HSV.
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Figure 3.3
The Protocol Employed to Assess the DH Response to HSV. Mice were pre-treated
with UVB or cis-UCA (three days or five hours) before infection with HSV. Ten days
later the ears of each mouse were measured before challenging with inactivated HSV
antigen. 24 h later the increase in ear thickness was assessed and taken as a
measure of the DH response.
Urocanic acid
I 3 days UVB5 hours UCA
HSV S/C
V2—c ^ 10 days
Measure e;
thickness







































































































































































































































































C/s-UCA was applied together with either cimetidine or terfenadine (Fig 3.4
illustrates the structures of these compounds), or with each of the antagonists alone
five hours before infection with HSV. Cis-UCA caused a significant suppression in
the DH response when given alone, but when it was given together with the HI or
H2 receptor antagonists, there was only a small depression of the DH response.
Cimetidine or terfenadine alone had a similar effect, or no effect at all. Therefore,
the antagonists appeared to negate the effects of cis-UCA on DH responses. Trans-
UCA had been shown to induce only a small suppression of the DH response to HSV
(Ross et al., 1986). Cimetidine or terfenadine had little effect on this (data not
shown).
At a later date thioperamide, a highly specific H3 receptor antagonist (Arrang et al.,
1987) became available, the molecular structure of which is illustrated in Fig 3.4.
The ability of this compound to inhibit the suppression of the DH response to HSV
induced by cis-UCA was tested in the same manner as the HI and H2 antagonists.
The results, outlined in Fig 3.5, revealed that thioperamide alone did cause a
suppression in the DH response, but this did not reach statistical significance. No
significant difference between mice which were treated with cis-UCA alone or with
cis-UCA plus thioperamide was measured (p > 0.05 by Students t-test).
These results indicated that a histamine-like receptor may indeed be involved in
immunosuppression induced by cis-UCA. Therefore, known histamine receptor
agonists should induce suppression of the DH response to HSV. The hypothesis was
tested using 4-methylhistamine, a known H2 agonist, and (R)-a-methylhistamine, a
known H3 receptor agonist (Arrang et al., 1987). The structures of these
compounds are illustrated in Fig 3.4. The mice were pre treated with 100 pg of the
H-receptor agonist in 100 pi of PBS subcutaneously five hours before infection with
HSV. The results illustrated in Fig 3.6 show that pretreatment with the H2 agonist
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Figure 3.4
The Chemical Structure ofHistamine Receptor Antagonists and Agonists Employed in
this Study















4 - Methylhistamine dihydrochloride (H - 2 receptor agonist)
.NH-
hnn^-n me
(R) - a - Methylhistamine (H - 3 receptor agonist)
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resulted in a significant suppression of the DH response, but the H3 agonist had no
effect at all. This result mirrors those obtained with the histamine receptor
antagonists; the H2 antagonist blocked the effects of cis-UCA whereas the H3 had no
effect on cis-UCA.
Fig 3.5
The Effect ofa Selective H3 Receptor Antagonist (thioperamide) on the
Immunosuppression ofthe DH Response to HSV induced by cis-UCA. (*: p < 0.05
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The Effect ofHistamine Receptor Agonists on DH to HSV. Mice were pretreated 4-
methylhistamine dihydrocloride (H2 agonist), Fig(a), or (R)-a-methylhistamine (H3
agonist), Fig (b), subcutaneouslyprior to infection with HSV andDH measurement.
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3.2.3 The Effect of UCA Analogues on DH to HSV
Four new UCA analogues became available for testing in addition to the ones already
studied (Fig 3.1). Their immunosuppressive potential was tested by DH
following the same protocol as used with UCA isomers. The first two analogues (A
and B) were prepared by Dr Perti (University of Turku, Finland). In these
compounds the position of the acrylic acid side chain had been moved on the
imidazol ring. The structures are illustrated in Fig 3.7. They were dissolved at 20
mg ml"1 in DMSO and then diluted 1:20 before injecting 100 pi subcutaneously five
hours before infection with HSV. Neither compound had any significant effect on
the DH response as shown in Table 3.3.
Table 3.3
The Effect of UCA Analogues on the DH Response to HSV.
Pre-treated Sensitize Increase in p* %
With (5 h later) Ear Thickness Compared Suppression




Vehicle Vero 1.4 ±0.9 — —
Vehicle HSV 10.9 ± 0.9 — —
100 p.g trans-UCA HSV 10.0+1.2 p > 0.5 9.4
100 p.g cis-UCA HSV 5.1 ±0.9 p < 0.001 61.1
100 p.g trans- A HSV 9.9 ±1.3 p > 0.5 10.5
100 p.g cis- A HSV 11.3 ±0.9 p > 0.5 -4.2
100 (ig trans- B HSV 10.2 ± 2.2 p > 0.5 7.4
100 p.g cis- B HSV 9.2 ±2.2 p > 0.5 17.9
* Student's t-test
The third and fourth analogues (C and D) were prepared by Dr Bardshiri (University
of Bristol) and consisted of six membered rings unlike the five membered ring of
UCA. The structure of these compounds is shown in Fig 3.7. These compounds
were dissolved in DMSO at 10 mg ml"1 and then diluted to 1 mg ml"1 in PBS prior to
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injecting the mice with 100 pi subcutaneously five hours before infecting the mice
with HSV. The experiment was carried out on two separate occasions and the results
are shown in table 3.4. The c/s-isomer of compound three induced a consistent
suppression of the DH response whereas compound 4 appeared to be relatively
ineffective at inducing suppression. The trans-isomer of neither compound had a
significant effect.
Table 3.4
The Effect of UCA Analogues with a Six MemberedRing
EXPERIMENT 1
Pre-treated Sensitize Increase in P %
With (5 h later) Ear Thickness Compared Suppression
Subcutaneously (mm x 10"2) With
± sem Control
Vehicle Vero 1.5 ±0.3 — —
Vehicle HSV 11.7 ± 1.2 — —
100 pg trans-UCA HSV 11.1 ± 1.3 NS 5.9
100 pg c/s-UCA HSV 6.4 ±1.1 <0.01 52.0
100 pg trans- C HSV 13.1 ±1.5 NS -13.7
100 pg cis-3- C HSV 7.9 ±0.8 <0.02 37.7
100 pg trans- D HSV 10.4 ± 0.7 NS 12.7
100 fig cis- D HSV 10.3 ± 1.2 NS 13.7
EXPERIMENT 2
Vehicle Vero 4.4 ±0.5 — —
Vehicle HSV 14.4 ± 0.5 — —
100 pg c/s-UCA HSV 8.1 ±0.5 p< 0.001 62.6
100 pg cis- C HSV 10.5 ± 0.5 p< 0.001 39.0
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3.3 DISCUSSION
There is increasing evidence that m-UCA may be a mediator of at least some of the
effects of UVB irradiation in inducing immunosuppression (reviewed in section 1.4).
In this chapter the effect of skin painting murine ears with cis-UCA on ATPase+ cells
in epidermal sheets has been described. The number of ATPase+ cells declined
markedly to a level approximately the same as that found after a low dose of UVB
irradiation. In some areas ATPase+ cells remained but they had lost most of their
dendritic morphology, no longer forming a network across the epidermal sheet; in
other areas, granular staining was noted associated with round cells which were not
characterised further. Trans-UCA had no significant effect on LC morphology or
numbers. Iacobelli et al. (1985) reported that exposure of guinea pig skin to low
doses ofUVB altered the linear distribution of LC membrane ATPase resulting in
aggregation of the marker. In contrast higher doses caused actual cytomembrane
damage. Therefore, the effect of cA-UCA is remarkably like that described
following UVB irradiation, where it is possible that membrane surface markers of
LC are susceptible to UVR and also suffer some morphological damage (Aberer et
al., 1981; Koulu et al., 1985; Toews et al., 1980). Alternatively loss of LC from
the epidermis may occur (Ashworth etal., 1989; Moodycliffe et al., 1992; Spencer
et al., in press). There is the possibility that cis-UCA may affect the ATPase
enzyme activity which is extremely sensitive to the effects of UVB (Aberer et al.,
1981; Lynch etal., 1981). A recent report by Moodycliffe et al., (1992) suggested
that UVB irradiation resulted in accumulation of DC in the DLN but cis-UCA did not.
However cis-UCA, but not trans-UCA, has been shown in a number of experimental
systems to affect the morphology, phenotype and function of antigen presenting
cells, as discussed in section 1.4.2 (Kurimoto and Streilein, 1992; Noonan et al.,
1985; Rasanen et al., 1987; Ross etal., 1987/88). Cis-UCA administered
intradermally (Kurimoto and Streilein, 1992) resulted in a significant reduction of
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Ia+ epidermal cells as well as altered dendritic morphology, and in this study the ears
were lightly tape stripped to allow better absorption of UCA. No such measures
were taken by Moodycliffe et al., (1991) and it is therefore possible that m-UCA
needs to percolate through to the dermis where it exerts its effects on cells such as the
DD by inducing, for example, the production of TNF-a (Kurimoto and Streilein
1992). TNF-a also reduces the number of Ia+ cells in murine epidermal sheets and
induces the DC of the epidermis to migrate to the DLN (Cumberbatch and Kimber,
1992).
A preliminary experiment suggested that c/s-UCA painted for example, onto the left
ear of a mouse significantly reduced the number of ATPase4" cells in epidermal sheets
prepared from the right ear (909 ± 29.9 ATPase+ cells mm"2 from left ear compared
with 1068 ±31 mm"2 from an untreated ear surface; mean of 20 fields of view ±
sem). Subcutaneous or intradermal injection of physiological doses of cis-UCA also
reduced the number of ATPase+ cells in epidermal sheets prepared from murine ear
surfaces 24 h following injection (709 ± 30.5 or 500 ± 24.4 from mice treated
subcutaneously or intradermally respectively; mean of 20 fields of view ± sem).
This study needs to be repeated but may indicate that cis-UCA itself leaves the
epidermis, or induces another mediator in the epidermis, such as TNF-a, which may
have an effect at a distant site. In contrast to the results presented in this chapter,
Noonan et al (1985) reported that culturing epidermal sheets in the presence of cis-
UCA for three days resulted in a reduction in Ia+ cells but had no effect on the
number of ATPase cells.
Previously it had been shown that suppression of DH to HSV resulted if mice were
skin painted with m-UCA before being infected with virus (Ross et al., 1986). This
effect was dose dependent, as little as 1 pg cis- UCA per mouse inducing
reproducible suppression. To obtain information on the structural features necessary
to generate suppression, a series of structural analogues of UCA isomers were
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prepared and tested (Norval et al., 1989). An unsubstituted 5-membered ring was
required for suppressor activity while the acrylic acid side chain could be modified
considerably or even replaced, as occurs in histamine, while still maintaining
suppressor activity. Moving the position of the acrylic acid side chain abrogated the
suppressive activity (Table 3.3), while the six membered rings were capable of
inducing suppression (Table 3.4).
It is also of interest that histamine and UCA are closely linked metabolically, each
being formed in a single step from histidine. It seemed possible, therefore, that
UCA may occupy receptor sites similar to histamine. To begin testing this
hypothesis, two histamine receptor antagonists (an HI and an H2 antagonist) were
used to find out whether they might alter the effects of cis-UCA on ATPase4" cells in
the epidermis or on the suppression ofDH responses. Clearly both antagonists
substantially reduce the effects of cis-UCA. The highly specific H3 receptor
antagonist thioperamide had no effect on cis-UCA induced suppression of the DH
response. Thus cfr-UCA may act through histamine receptors on the surface of
particular cells in the epidermis and elsewhere. This theory was substantiated by
employing an H2 and an H3 agonist. No highly selective HI receptor agonist exists
(Hill 1990). As predicted, 4-methylhistamine, an H2 agonist, induced suppression
of the DH response but (R)-a-methylhistamine, an H3 agonist, had no effect at all
(Fig 3.6). Thus the effects of cis-UCA on immunity appear to be mediated through a
histamine-like receptor, but it does not appear to bear any resemblence to the H3
receptor.
Previously, Reeve et al. (1989) reported that mice which were treated epidermally
with UCA plus chronic UVR produced a greater number and more invasive UV-
induced tumors than those chronically irradiated without UCA application.
Furthey(vork by this group showed that mice treated with cimetidine which were
chronically UV-irradiated suffered from fewer UV-induced tumours than unirradiated
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control mice (Matheson and Reeve, 1991). These results also suggests that a
histamine receptor may play an important role in UV-induced immunosuppression
and that cis-UCA may interact with the receptor. It would be interesting to examine
the effects ofH receptor antagonists on UV-induced suppression of the DH response
to HSV and reduction in epidermal ATPase cells.
Most preformed histamine is stored in the cytoplasm ofmast cells and basophils. It
is also produced de novo by histidine decarboxylase in adherent peritoneal cells and T
cells. For many years histamine was mainly regarded as a vasoactive mediator which
initiated inflammatory reactions, but it has become evident more recently that
histamine is capable of regulating a variety of immune effector cells especially T cells
and monocytes /macrophages by interacting with cell receptors or by recruiting them
to particular local sites. Most effects are suppressive, resulting for example, in
decreased antigen and mitogen induced lymphoproliferation, cytotoxic T cell activity
and inhibition of IL-1, IL-2, IFN and TNF-a production (reviewed Falus and
Meretey, 1992; Beer and Rocklin, 1987; Melmon and Khan 1987). The effect is
likely to be dependent on the type of receptors and cells as well as on the local
concentration of histamine in given circumstances.
In addition to the suppression of the DH response to HSV in the model presented in
this chapter, histamine has been implicated in the suppression ofDH responses in
other circumstances. Serum histamine is increased in patients with active dermatitis
(Ring 1989) and several investigators have reported that a suppression of CH
responses in subjects with active atopic dermatitis (Jones et al., 1973; Masami and
Takayuk, 1989).
Some studies with cimetidine indicate its immunomodulatory properties. In addition
to its inhibitory effect on gastric acid secretion, cimetidine increased DH responses in
patients with duodenal ulcers, perhaps by preventing the normal inhibitory role of
histamine acting via H2 receptors on T lymphocytes (Avella et al., 1978). T
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suppressor cells have been reported to produce a suppressor factor in response to
histamine (Avella et al., 1978) and cimetidine may block H2 receptors on such
suppressor cells, thus augmenting DH responses (Jorizzo et al., 1980). Recently,
after oral administration to healthy volunteers, cimetidine has been shown to increase
mitogen-induced proliferation of lymphocytes, possibly due to an increase of CD4
subset numbers and an increase in the functional ability of macrophages (Brockmeyer
et al., 1989). Furthermore, Belsito et al. have found that cimetidine enhanced the
allergic contact hypersensitivity response in mice, if given at the time of sensitization
(Belisto et al., 1990). The increase was not due to effects on mast cells or epidermal
antigen presenting cells (Langerhans cells or Thyl+ dendritic epidermal cells), but to
an inhibition of the induction of T suppressor cells at sensitization.
It was of interest in the present study that both an HI and H2 receptor antagonist were
able to block the activity of cis-UCA. This may be an indication that cis-UCA acts
in more than one way, through more than one type of receptor. Indeed, there is
already some indication of this possibility as m-UCA applied epidermally before
HSV infection induced two subclasses of T cells (L3T4+ Ly2~ and L3T4 Ly2+)
which suppressed the DH response to the virus, while transfer of epidermal cells from
mice skin-painted with cA-UCA to naive mice at the time of HSV infection induced
only one subclass of T suppressor cell (L3T4+ Ly2") (Ross et al., 1986, Ross et al.,
1987/88). One interaction could be directly through H2 receptors on T suppressor
cells, as in the study of Belsito et al. (1990), which may be blocked by cimetidine.
The second is likely to be local, through the epidermal antigen presenting cells,
altering perhaps trafficking of cells, expression of surface markers or release of
cytokines. Alternatively, a receptor is only as specific as the antagonists employed
to characterise it, and it is conceivable that a distinct UCA receptor exists towards
which the cimetidine and terfenadine have some degree of specificity.
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In order to test this hypothesis, in vitro ligand binding assays need to be performed.
Binding studies would require a population of cells which are known to express
histamine and/or UCA receptors, preferably from the skin. Preliminary experiments
indicate thatm-UCA treatment of purified murine LC abrogates their ability to
present antigen to Thl cells (Dr P D Cruz, personal communication). Little is
known about the distribution of histamine receptors in the skin, particularly whether
they are present on LC or not. It may be possible to select epidermal cells according
to their receptor expression by for example, passing them through histamine-
sepharose or UCA-sepharose colums. Alternatively, UCA isomers or histamine
could be covalently linked to magnetic beads. It would be interesting to see if
histamine and UCA columns or beads selected the same population of cells. In
addition the relative potencies of the ligands used in the binding studies could be
compared with their biological activity in an in vitro model of immunomodulation by
cis-UCA. However, the mechanism of action of UCA appears to be complex and it
is difficult to produce an in vitro model of suppression using m-UCA. A sensitive
reproducible system of in vitro modulation by cw-UCA would permit competition
studies to be carried out.
A range of concentrations of antagonists, agonists and ris-UCA may have been
employed in the experiments described in this chapter to further evaluate the role of a
histamine receptor in m-UCA induced immunomodulation.
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CHAPTER 4
FURTHER STUDIES OF THE MECHANISM OF UVR OR CIS-




Inbred strains of mice display varying susceptibilities to the immunosuppressive
effects ofUVR. Thus UVB-susceptible strains, such as C57 BL, display impaired
CH responses when exposed to UVR prior to sensitization whereas other strains,
such as BALB/c, when treated in exactly the same way, develop normal CH
responses (Streilein and Bergstresser, 1988). There may also be a variation in
genetic susceptibility to the immunosuppressive effects ofUVR in humans
(Yoshikawa et al„ 1990). In the mouse, susceptibility is restricted to
polymorphisms at the Tnfa and Lps loci (Yoshikawa and Streilein 1990), although
there may be at least one other locus involved. On UV-irradiation it is thought that
UV susceptible strains produce TNF-a whereas resistant strains do not.
TNF-a, injected intradermally in mice, reduces the number of Ia+ cells at the site of
injection (Vermeer and Streilein 1990). In addition when TNF-a is injected
intradermally at the site of hapten application, the effect of low dose UVB
irradiation is again mimicked and a reduced CH response is subsequently produced
on antigen challenge (Yoshikawa and Streilein, 1990). This phenomenon is strictly
local and could be reversed by administering neutralizing TNF-a antibodies, as
could the effect of UVB (Yoshikawa and Streilein 1990). It was therefore of interest
in the present study to examine the role of TNF-a in UVB and c/s-UCA induced
suppression of the DH response to HSV.
As discussed in section 1.1.5, the elicitation phase of a CH response is biphasic with
a substantial ear swelling occurring only two hours after antigen challenge, followed
by the classical CH swelling 24-48 h later. In the following chapter the time course
of the DH response to HSV was studied. Further experiments were conducted to




4.2.1 The Role of TNF-a in the Suppression of the DH Response
to HSV Induced by UVB or cis-UCA
TNF-a has been implicated as a mediator of major importance in UV-induced
modulation of immunity. The experiments in this section were designed to
determine whether TNF-a played a role in UV-induced suppression of the DH
response to HSV, and similarly whether it was important in the modulation induced
by cis-UCA. Mice were pre-treated intraperitoneally with neutralizing anti-TNF-a
antibodies two hours before either a single dose of UVB (96 mJ cm-2) or
subcutaneous injection of 100 (ig cis-CCA (dissolved in PBS). Control mice
received PBS intraperitoneally prior to cis-CCA or UVB. The mice were then
infected subcutaneously with HSV three days after UVB or five hours after cis-UCA
treatment and the DH response measured in the usual way (Fig 3.3). The mean data
per group is outlined in Table 4.1 below. Pre-treatment with neutralizing TNF-a
antibodies had no effect on the suppression ofDH to HSV induced by cis-UCA but
significantly reduced that induced by UVB.
Cis-UCA was injected subcutaneously in these experiments and as it is possible that
the local concentration of cis-UCA within the epidermis is of importance. The effect
of pre-treatment with anti-TNF-a on cA-UCA applied epidermally was tested in the
DH model. The results are outlined in Table 4.2. It may be seen that UV-induced
suppression of the initiation of the DH response was again abrogated if neutralising
TNF-a was given prior to irradiation. Once more there was no effect on cis-UCA













































































































































































































































The Effect ofNeutralising Anti-TNF-aAntibodies on cis-UCA Induced Suppression of
the DH response to HSV. Following treatment with anti-TNF-a, mice were UV-
irradiated, injected with 100 fig or skin painted with 100 pg ofcis-UCA (in 100 pi of
ethanol on a shaved back). The results represent the mean increase in ear thickness
per group
Neutra¬ Two hours later: Sensitized Increase in P %
lising Treated with with ear thickness Suppre
TNF-a (mm x 10"2) -ssion
Abs ± sem
— PBS Vero 1.5 ±0.4 — —
— PBS HSV 7.4 ±0.8 — —
— 96 mJ cm-2 UVB HSV 3.3 ±0.6 <0.02 69.5
— 100 jig ds-UCA (s/c) HSV 3.8 ±0.6 <0.01 61.0
— 100 |ig ds-UCA (epid') HSV 3.1 ±0.6 <0.001 72.9
+ PBS HSV 6.8 ± 2.4 NS 11.0
+ 96 mJ cm"2 UVB HSV 6.4 ±0.9 NS * 16.9
+ 100 |ig ds-UCA (s/c) HSV 2.9 ± 1.0 <0.01A 76.3
+ 100 |lg cis-CCA (epid') HSV 1.4 ±0.8 <0.001A 100
s/c: injected subcutaneously. epid': applied to epidermis
* Significantly different from UVB alone (p < 0.05; paired t-test).
A Not significantly different from ds-UCA alone (p > 0.05; paired t-test)
Abs: antibodies
Cis-CCA had previously been shown to produce a dose dependent suppression of the
DH response to HSV, even at a dose as low as 1-10 |ig per mouse. It was therefore
possible that the dose of ds-UCA employed in the experiments above was too high
for the anti-TNF-a to be effective. The following experiment was designed to
confirm that anti-TNF-a had no effect on high or low doses of d.v-UCA, applied
subcutaneously or epidermally. High doses of UCA (100 [ig per mouse) or low
doses (10 p.g per mouse) were applied subcutaneously or epidermally following
treatment with a vehicle or TNF-a antibodies prior to infection. The results in Table
4.3 reveal that all groups were significantly suppressed relative to the positive control
group, and in addition, prior treatment with TNF-a antibodies had no effect on cis-
UCA induced suppression of the DH response.
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Table 4.3
The Effect ofNeutralising Anti-TNF-a Antibodies on Suppression of the DH Response
to HSV Induced by Various Doses of cis-UCA
Neutra Two hours later: Sensitize Increase in P %
-Using Treated With ear thickness Compared suppre¬
TNF-cx (mm x 10"2) with +ve ssion
Abs ± sem
— PBS Vero 0.4 ±0.2 — —
— PBS HSV 8.3 ±0.9 — —
— 10 |ig cA-UCA (epid') HSV 5.2 ±0.9 <0.05 39.2
— 10 pg cA-UCA (s/c) HSV 3.8 ±1.0 <0.01 57.0
— 100 |!g cA-UCA (epid') HSV 3.2 ± 0.4 <0.001 64.6
— 100 |ig cis-UCA (s/c) HSV 2.6 ±0.4 <0.001 72.2
+ PBS HSV 8.9 ±0.8 NS -7.6
+ 10 [ig cA-UCA (epid') HSV 3.8 ±1.0 <0.01A 57.0
+ 10 |ig cA-UCA (s/c) HSV 1.1 ±0.2 <0.001A 91.1
+ 100 fig cA-UCA (epid') HSV 4.1 ±1.1 < 0.02A 53.1
+ 100 |ig cA-UCA (s/c) HSV 1.0 ±0.4 <0.001A 92.4
s/c: injected subcutaneously. epid' applied to epidermis
A not significantly different from cA-UCA alone
4.2.2 The Time Course of the DH Response to HSV in Mice
The CH response in mice has been reported to be biphasic, with an early initial ear
swelling response two hours after antigen challenge (Van Loveren et al., 1983;
Lavaud et al., 1991). It is possible that a CH response to a sensitizing chemical and
a DH response to a replicating virus are different and therefore the time course of a
DH response to HSV was examined, taking ear measurements every hour following
antigen challenge. The time course was carried out on three occasions and produced




Time Course of the DH Response to HSV. Non-immune (sensitized with uninfected
Vero cells) and HSV infectedmice were challenged with inactivated HSV antigen 10
days after sensitization. Earmeasurements were recordedfor each mouse every
hourfor 4 h and also 24 h after challenge. The mean increase in ear thickness (±
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A primary ear swelling response occurred one hour following antigen challenge
during the DH response to HSV in mice. It was therefore of interest to determine
whether UVR or cw-UCA treatment before infection with the virus suppressed this
response in addition to the classical DH response noted previously. Mice were
irradiated with 96 mJ cm-2 ofUVB, 200 mJ cm-2 UVA or injected subcutaneously
with 100 pg of ci's-UCA prior to infection with HSV. Ten days later the ears were
challenged with HSV antigen and ear measurements taken at 1, 2, 3.5 and 24 h after
challenge. The full time course was determined on two occasions with UVA, twice
with UVB and three times with cis-UCA. The results were similar on each occasion.
The results from one such experiment are shown in Fig 4.2.
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Figure 4.2
The Effect ofUVR or cis-UCA on the Primary Ear Swelling in the DH Response to
HSV. The graph represents the mean net ear swelling (test group minus the negative




















Time After Antigen Challenge (h)
During subsequent DH experiments the ear measurements were determined lh and
24 h following antigen challenge. The mean data from these experiments are
illustrated in Table 4.4.
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Table 4.4
The Effect ofUVB or cis-UCA on the DH Response to HSV. The data illustrated in
the table represent the mean net increase in ear thickness (test groupminus back
ground swelling in non-immune mice). The significance ofdifferencesfrom the
positive group were tested by Student's t-test. In the case ofthe UVB group the UVB
values were compared with the corresponding 5 positive controls within the same
experiment.



















7.7 ± 2.4 ND
8.6 ±0.7 —
3.6 ± 0.7 0.002
3.5 ±0.6 < 0.0001
3.8 ±3.1 ND
The results clearly indicate that both cis-UCA and UVB significantly suppress the
one hour as well as 24 h ear swelling response to HSV.
Having established that UV and cis-UCA suppressed the one hour swelling response
it would have been of interest to determine what cell populations were present at the
site of antigen challenge in each of the groups at each stage of the DH response.
Time did not permit detailed studies to be undertaken. One preliminary experiment
was carried out using only two mice from one experiment to determine the number of
ATPase+ cells one hour and 24 h following antigen challenge. Having measured the
thickness of the ear the mouse was killed, the ears removed, epidermal sheets were
prepared and stained for ATPase activity. The samples were coded and 40 fields,
chosen at random, were counted per mouse. The results are shown in Table 4.5.
Following antigen challenge there was a drop in the number of ATPase+ cells in the
epidermis at one hour which was more pronounced at 24 h. A greater number of
ATPase+ cells were found in the epidermis of mice which exhibited a suppressed DH
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response i.e. those mice which have received UVA, UVB or ris-UCA prior to
infection. These results merit further investigation.
Table 4.5
The number ofATPase+ Cells Present in the Epidermis During a DH Response.
Mice were pre-treated with 96 mJ cm'2 ofUVB, 200mJ cm'2 UVA or 100 pg ofcis-
UCA subcutaneously before infection with HSV. Ten days later the ears were
challenged with HSV antigen. The mouse was killed, the ears removed and
epidermal sheets stainedfor ATPase activity.
Pre- Sensitize ATPase+ Cells % ATPase+ Cells %
treated (5h later) (mm-2) ± sem Redu¬ (mm*2) ± sem Redu¬
with lh After Challenge ction 24h After Challenge ction
PBS Vero 926 ±48.0 672 ± 26.4 —
PBS HSV 731 ±29.7 21.1 433 ± 34.0 35.5
UVA HSV 696 ±41.1 24.8 553 ± 36.5 17.7
UVB HSV 804 ±42.6 13.1 527 ± 37.2 21.6
cis-UCA HSV 804 ± 40.8 13.1 587 ±35.8 12.6
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4.3 DISCUSSION
4.3.1 The Role of TNF-a in UVB and c/s-UCA-Induced
Suppression of the DH Response to HSV
The results outlined in Tables 4.1-4.3 demonstrate that neutralising anti-TNF-a
antibodies administered to mice prior to UVR abrogate the suppression ofDH to
HSV induced by UVR. It was therefore surprising that the same treatment had no
effect on cis-UCA induced suppression, which had been shown previously to be
remarkably similar to UV-induced suppression of the DH response to the HSV (Ross
etal., 1986; Ross etal., 1987; Ross etal., 1987/88).
It is possible that the dose, the timing or route of application of cis-UCA relative to
that of the anti-TNF-a administration in these experiments did not exactly
correspond to the induction of cis-UCA produced following UVR in vivo. Two
different doses of cis-UCA were administered via two different routes, epidermally
and subcutaneously, but this had no effect on the outcome of the DH response.
It is also possible that UCA is not the only mediator of UV-induced
immunosuppression, and may not act via a TNF-a dependent mechanism. Genetic
susceptibility to UVR in inbred strains of mice is restricted to polymorphisms in the
Lps and Tnfa loci (Yoshikawa and Streilein, 1990), therefore if cis-UCA was solely
responsible for the immunomodulatory effects of UVR one might expect cis-UCA to
have no effect on the induction of CH responses in UV-resistant strains of mice.
However it was recently reported that intradermal injection ofUV-irradiated UCA
(containing approximately 50% of the cis-isomer) resulted in suppressed CH
responses to dinitroflurobenzene (DNFB) in both UV-susceptible (C57BL and
C3H/HeN) and UV-resistant strains (BALB/c and C3H/HeJ). Cis-UCA was more
effective at producing suppression of the response in the UV-susceptible strains but
did cause significant suppression in the UV-resistant mice at concentrations of 10 |ig
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of cis-UCA per mouse (Kurimoto and Streilein, 1992). Comparing the total UCA
content of the ears of different strains ofmice, housed in the departmental animal
house, it was found that C3H (UY-susceptible strain), BALB/c and C57B1 contained
371, 396 and 182 ng mg*1 weight weight of UCA respectively. Therefore the UV
resistant strain (BALB/c) did not have less UCA than the susceptible strains (M.
Norval personal communication). It would be of interest to know if the rate of
isomerization of UCA in UV-resistant and UV-susceptible strains of mice is the same
following UVR.
It was also recently reported that UVB induced DC migration from the epidermis to
the DLN but UCA did not (Moodycliffe et al., 1992). Injection of recombinant
TNF-a has also been shown to induce DC migration (Cumberbatch and Kimber,
1992) and pre-treatment with neutralising anti-TNF-a antibodies suppressed UV-
induced migration of DC from the epidermis (A Moodycliffe personal
communication). Thus it seems reasonable to suggest that UVR induces TNF-a
production (Kock et al., 1990; Oxenholm et al., 1988) which induces DC migration
and this in turn leads to altered antigen presentation and induction of suppressed
immune responses to antigens encountered in the skin shortly thereafter. CA-UCA,
however may act through histamine-like receptors, as demonstrated in Chapter 3,
which also results in suppressed immunity. This mechanism may be dependent on
the dose or wavelength of UVR.
Kurimoto and Streilein (1992) recently reported that pre-treatment of C57BL/6 mice
with neutralising anti-TNF-a antibodies partially reduced the suppression of CH
responses to DNFB by cis-UCA. The value of the mice pre-treated with anti-TNF-a
antibodies followed by treatment with c/s-UCA was not significantly different from
the positive control, but the statistics were not included to compare the value with
mice which were treated with cis-UCA alone. A previous report indicated a
complete recovery of the CH response in C3H/HeN mice which had been pre-treated
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with anti-TNF-a prior to UVB-irradiation (Yoshikawa and Streilein, 1990). Cis-
UCA was given intradermally in the study of Kurimoto and Streilein (1992) and
either that or the different strains of mice may account for the difference in the results
of that study and the present one. Alternatively there may be a difference between
the DH response to HSV and a CH response, and the mechanism ofUV-induced
suppression of the different responses (Kripke and Morison, 1986). Further
evidence in support of this theory was reported by Kim et al. (1990). In that study
supernatants produced by UVB or UVA irradiated KC were selective in their ability
to suppress CH and DH responses, suggesting that the two responses were indeed
different, and the mechanism ofUV-induced suppression of the two responses may
occur by different mechanisms.
Both intradermal injection of TNF-a and UVB irradiation were shown to result in a
reduction of the number of Ia+ cells in the epidermis (Vermeer and Streilein, 1991).
The effects of both UVB and TNF-a could be reversed be pre-treating the mice with
neutralising anti-TNF-a antibodies (Vermeer and Streilein, 1991). Similarly
intradermal injection of cis-UCA resulted in a reduction in the number of Ia+ cells
and those which remained had lost their dendritic processes (Kurimoto and Streilein,
1992). TNF-a antibodies blocked the reduction in the number of epidermal Ia+ cells
but had no effect on the retraction of the dendrites (Kurimoto and Streilein, 1992).
Therefore UCA may have two distinct effects on epidermal cells: the first, the loss
of la bearing cells from the epidermis, dependent on the production of TNF-a, and
the second, being the retraction of the dendritic cell processes, which is independent
of TNF-a. Thus UCA may have effects on LC which are independent of TNF-a and
it is these effects which may have important implications for the induction of a DH
response to a replicating virus.
Simon et al (1991) reported that TNF-a was capable of specifically suppressing the
antigen presentation of keyhole limpet hemocyanin (KLH) by enriched epidermal LC
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to KLH specific CD4+ Thl cells in vitro in a similar manner to UVB (Simon et al.,
1992). However anti-TNF-a did not protect LC from the loss of antigen presenting
cell function induced by UVB or restore the ability of the cells to present antigen to
KLH specific Thl cells. Thus the authors suggested that the mechanism of
impairment in the APC capacity of LC by TNF-a and UVB are different.
Preliminary data indicates that cL-UCA is also capable of selectively abrogating the
ability of purified LC to present KLH to Thl cells (Dr P D Cruz, personal
communication). It would be of interest to examine whether anti-TNF-a had any
effect on the altered APC function induced by cis-UCA.
In addition it would be of importance to examine what effects, if any, UCA isomers
have on TNF-a production. As outlined in Chapter 3 there is evidence that cif-UCA
may act through a histamine-like receptor. Histamine has been reported to suppress
the production of TNF-a via H2 receptors (Vannier et al., 1991) and therefore it is
possible that cis-UCA may also suppress the production of TNF-a by certain cell
populations. Thus, within the skin, there may exist a balance between one effect of
UVR, the induction of TNF-a, and another, the production of cis-UCA which under
certain circumstances may suppress the production of TNF-a. Thus, UVB may
mediate some of its suppressive effects via TNF-a but this is unlikely to be the only
pathway by which UVR induces suppressed immune responses.
4.3.2 The Time Course of the DH Response to HSV
Mice which had been infected with HSV or sensitized with uninfected Vero cells ten
days earlier were challenged with 10 pi of inactivated HSV antigen by intradermal
injection of each ear pinna. Ear measurements, taken every hour thereafter,
revealed that there was a significant ear swelling within one hour of antigen
challenge. Ear measurements were not taken at earlier times as the 10 pi 'blip'
formed by the injection of the HSV antigen may affect the background
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measurements. One hour after antigen challenge there was no longer any visible
evidence of the injected fluid.
These results are very similar to those reported by Van Loveren et al. (1983) who
found an initial ear swelling response two hours following antigen challenge with a
range of contact sensitizers in immune mice. However the peak response was
detected earlier, one hour after challenge with HSV antigen compared with the CH
response, which may indicate that there is a difference in the mechanisms involved in
CH and DH responses. The initiator cells, responsible for the one hour swelling,
produce antigen-specific non-IgE factors which sensitize mast cells for the release of
the vasoactive amine serotonin at the local site of antigen challenge (Van Loveren et
al., 1983). 5HT initiates DH by acting on endothelial cells which allows the
recruitment of the DH effector cells, responsible for the swelling at 24-48 h.
Examination of the initiator population, responsible for the one hour swelling,
revealed that the cells were antigen specific but not MHC restricted, irradiation
insensitive and induced within one day of the initial sensitization. This is in contrast
to the later acting effector cell (at 24 h) which is antigen specific and also MHC
restricted, irradiation sensitive and induced three to four days following initial
sensitization (Van Lovern et al., 1984).
Further studies revealed that the initiator cells were an extremely unusual phenotype
for an antigen specific cell; Thy-1+, CD5+(Ly-1+), CD4", CD8", CD3", slg",
CD45RA+ (not found on mature T cells), Macl+, IL-2R" and I1-3R"1" (present on
pre-B and pre-T cells) (Herzog et al., 1989). The recruited effector cells (at 24 h),
in contrast to the initiator population were Thyl+, CD5+, CD4+, CD8" and CD3+
(Herzog et al., 1989). Therefore, it has been proposed that the DH response
consists of at least two separate, but connected cascades, with local 5HT release
being the connecting factor. It is possible that the DH initiating cells are activated
locally and do not circulate.
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Mukheijee et al., 1986 reported that mice challenged with purified protein derivative
of tuberculin (PPD) four days after sensitization also exhibited a DH-initiating
response one hour following antigen challenge, which was followed by the classical
DH response 24 h later. These authors also found that splenic DC which were
pulsed with PPD did not sensitize for DH. PPD-pulsed splenic DC induced antigen
specific/MHC-restricted late acting T cells, but not the DH-initiating cells. When
mice were sensitized with PPD-pulsed DC followed by PPD-pulsed macrophages
PPD-specific DH initiating cells were induced within one day which permitted the
expression of the late acting DH cells induced by the DC.
It was therefore interesting to find that ds-UCA and UVB suppressed the initial one
hour peak and also the 24 h peak . Thus UVR or cis-UCA prior to infection with
HSV reduces the number of functioning DH initiating cells in the skin. It may be
that UV or cis-UCA alters the macrophage/DC population of the epidermis resulting
in modified sensitization of the DH initiating cell. In humans there is evidence that
the epidermis is re-populated with a macrophage population following UV-irradiation
(Baadsgaard et al., 1990c; Cooper etal., 1985) and there is also preliminary
evidence that this may also occur in the mouse (Duraiswamy et al., 1992). It is
possible that there is an alteration in the migration of T cells to and from the skin
following UVB or cis-UCA treatment which may be due to an altered expression of
adhesion molecules or homing receptors or other mechanisms, perhaps as a result of
altered cytokine production.
Further work is required to determine whether UV or cis-UCA alters the number of
DH initiator cells present at the time of infection and subsequently the number of
sensitized T cells following the primary HSV infection, or activated on subsequent
antigen challenge. In the model ofDH response to HSV employed in this study,
infection was subcutaneous. Therefore it would be of interest to determine whether
the DH initiator cell populations are found in the LN, whether they are actively
105
recruited to this site and if they preferentially home to the skin. The results in Table
4.5 indicate that there may be a reduced number of ATPase+ cells which migrate
from the epidermis on antigen challenge in the groups which exhibited a suppressed
DH response i.e. mice which had been UV-irradiated or treated with cis-UCA prior to
HSV infection. It would also be of interest to examine other cell populations present
during the elicitation phase of the DH response in mice which had been pie-treated
with UVR or UCA isomers. These populations might include T cell subsets,
macrophages and mast cells.
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CHAPTER 5
THE EFFECT OF UCA ISOMERS ON ANTIGEN




Having established that cis-UCA reduced the number of epidermal ATPase4" cells
(Chapter 3), and to complement the studies examining the effects of phototherapy on
epidermal antigen presentation in humans reported in Chapter 6, the following study
aimed to examine the effect of UCA isomers on antigen presentation of Con A and
HSV by macrophages and LC to T lymphocytes in a murine model. The initial
experiments were designed to establish the optimal conditions for murine
lymphoproliferation assay and to examine the effect of treatment in vitro or in vivo
with UCA isomers on responses to Con A or HSV. Subsequently, a model of
antigen presentation of HSV or Con A to T cells was developed. Peritoneal
macrophages (PM), splenic adherent cells (AC) or epidermal cells (EC) were tried as
antigen presenting cells (APC) with the ultimate aim of determining the effect of
UCA isomers in vitro and in vivo on the ability of the cells to present antigen.
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5.2 RESULTS
5.2.1 Optimization of the Lymphoproliferation Assay
Initial experiments were performed to optimize the conditions for in vitro LPR using
Con A as a mitogen in whole LN or spleen cell suspensions. Mice were killed, LN
and spleens collected into PBS and single cell suspensions prepared. The cells were
finally resuspended at a concentration of 5 x 105 cells ml"1. Two hundred |il of cells
were placed in each well of a flat bottomed 96 well microtitre plate. To quintuplicate
wells Con A was added at concentrations ranging from 0 to 20 (ig ml'1 (final
concentration). The plates were incubated for three to five days pulsing with 3H-
thymidine over the final 24 h of culture. Variations of this experiment were set up
on five different occasions and suggested that in the spleen cell cultures 5-7 (ig ml"1
of Con A and four days of culture resulted in optimal uptake of 3H-thymidine.
However results were highly variable, and significant proliferation of LN cells was
measured on only one occasion. Collecting the LN into TCM plus 10% FCS did
improve the responses of the cells.
Further manipulations of the system involved using different dimensions of plates,
sources of serum in the TCM and cell numbers (Table 5.1). The number of cells
appeared to be crucial to the proliferation; thus 105 cells per well was not sufficient
but 2 x 105 was. Proliferation was much greater in round bottomed plates compared
with flat bottomed (Table 5.1). A number of different serum sources, at varying
concentrations, were employed some of which are outlined in Table 5.1. The results
shown in Table 5.1 are those of LN cells but a similar pattern was obtained using
splenic cells.
In addition to the experiments using Con A mice were infected with HSV
epidermally, followed by a secondary subcutaneous infection. Ten days after the
secondary, infection spleens and LN were removed and the lymphoproliferative
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response (LPR) in vitro to UV-inactivated HSV measured. Similar results to those
outlined in Table 5.1 were obtained. The assay was very sensitive to the source of
serum; FCS at 10% resulted in much more efficient proliferation than newborn calf
serum (NBCS) or horse serum (HS) which had previously been employed in the
laboratory. Different batches of serum from the same company also varied in their
ability to support a proliferative response. Thus a batch of FCS which resulted in
optimal incorporation of 3H-thymidine was selected (Gibco Ltd., Paisley, UK).
Table 5.1
Optimization of the Conditionsfor the Mitogenic Response ofLN Cells to Con A
Serum Dimension of Number of Nothing 7 |ig ml-1





5% FCS (1) Flat 1 x 105 182 ± 21.3 1994±101
10% FCS (1) Flat 1 xlO5 304 ±125 350 ± 92.7
5% FCS (1) Flat 2x 105 416 ±44.3 353 ±43.9
10% FCS (1) Flat 2x 105 313 ±41.2 11 635 ±2887
5 % FCS (1) Round 2x 105 90.6 ± 17.6 634 ± 169
10% FCS (1) Round 2x 105 771±167 127 669 ± 17807
5% FCS (2) Flat 2x 105 203 ±48.6 884 ±119
10 % FCS (2) Flat 2x 105 443 ±62.1 146 863 ± 4 598
5% HS (1) Flat 2x 105 174 ±27.7 2 998 ±1465
10% HS (1) Flat 2x 105 97.6 ± 11.4 13 548 ±4 254
5% HS (2) Flat 2x 105 122 ±25.5 237 ± 79
10% HS (2) Flat 2x 105 236 ± 32.0 319 ±119
5% NBCS Flat 2x 105 106 ±17.7 22 585 ± 4 704
10% NBCS Flat 2x 105 178 ±21.4 73 616± 15 529
(1): serum from Northumbria Biologicals, UK
(2): serum from Gibco Ltd., Paisley, UK
However the assay system did give highly variable results and was plagued by
contamination of cultures. The contaminating organism was identified as a
Pseudomonas species which was resistant to penicillin, streptomycin and gentamicin,
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which was likely to have originated from the mice. It was sensitive to carbenicillin,
and this antibiotic was subsequently incorporated into the TCM (100 p.g ml-1) used
for all murine assays. This was sufficient in most experiments to inhibit the growth
of the organism.
5.2.2 The Effect of cis-UCA in vitro on Lymphoproliferative
Responses to HSV or Con A.
UCA isomers at varying concentrations were added to lymphoproliferation assays for
the duration of the culture and the effect on the response to Con A or HSV
determined. Cis- and trans-UCA were both dissolved in DMSO at 10 mg ml"1, and
diluted further in TCM. An appropriate volume ofDMSO in TCM was always
added to parallel cultures as a control. This experiment was carried out on four
separate occasions using both LN and spleen cells. The addition of 1, 10 or 100 jig
ml"1 of either UCA isomer to either LN or spleen cells did not result in consistent
reproducible effect on the in vitro lymphoproliferative response to Con A or HSV.
Table 5.2 illustrates the data from two experiments using spleen cells.
Ill
Table S2
The Effect ofcis-UCA in vitro on Lymphoproliferative Responses Using Spleen Cells
Experiment 1 Experiment 2
Stimulus Additions to Culture Mean cpm Mean cpm
(±sem) (±sem)
Vero DMSO Vehicle (2 pi) 11 117 ± 910 8 098 ±893
Con A DMSO Vehicle (2 pi) 89 597 ± 13 326 87 003 ± 18 922
HSV DMSO Vehicle (2 pi) 62 549 ±9 056 76 232 ± 5 080
Vero 1 pg ml*1 m-UCA 25 952 ±2111 8 452 ± 1 356
Con A 1 pg mL1 cis-UCA 79 924 ±5 429 80 268 ± 5 908
HSV 1 pg ml-1 m-UCA 49 558 ±4 575 89 027 ± 2 627
Vero DMSO Vehicle (10 pi) 15 300 ± 1 956 8 231 ±521
Con A DMSO Vehicle (10 pi) 104 634 ±3 492 83 527 ± 9 074
HSV DMSO Vehicle (10 pi) 45 501 ± 12 057 45 801 ±2 641
Vero 10 pg ml-1 m-UCA 12 342 ±2 182 4 026 ±518
Con A 10 pg ml-1 m-UCA 100 930 ±3 891 79 627 ±5 123
HSV 10 pg ml"1 m-UCA 12 314 ±9 385 68 209 ± 5 807
5.2.3 The Effect of Treatment with UCA Isomers In Vivo on
Lymphoproliferative Responses
Mice were injected subcutaneously with 100 pg of cis- UCA five hours before
subcutaneous infection with HSV. Control mice were pre-treated with the
appropriate dilution of DMSO. Ten days after infection the mice were killed, LN
and spleens removed and single cell suspensions prepared. The effect of pre-
treatment with m-UCA on LPR to HSV using LN cells is shown in Table 5.3;
similar results were obtained with spleen cells. Experiment one indicated that pre-
treatment with cis-UCA in vivo suppressed LPR. However this experiment was




The Effect ofcis-UCA on LPR to HSVor Con A. Mice were injected with cis-UCA
five hours before infection with HSV. Ten days later the LNand spleens were
removed and the in vitro PLR to HSVor Con A measured. The results below
represent the mean value often wells using LN cells.
Experiment 1 | Experiment 2
Stimulus Pre-treatment Mean cpm % Mean cpm %
(± sem) Suppr¬ (± sem) Suppr¬
ession ession
Vero Vehicle 6968 ± 463 — 729 ±122 —
Con A Vehicle 41237 ±1812 — 44 180 ±9 579 —
HSV Vehicle 10527 ±659 — 1 803 ± 345 —
Vero 100jug civ-UCA 3803 ± 236 45.4 1 193 ±481 0
Con A 100 pg c/v-UCA 12443 + 849 69.8 21 706 ±11 133 50.9
HSV 100 pg cis-UCA 3458 ±286 67.2 2 648 ±526 0
5.2.4 Antigen Presentation of HSV or Con A by Epidermal Cells
A number of experiments were conducted to examine the effects of civ-UCA in vitro
and in vivo on antigen presentation. These experiments were highly variable,
largely due to contamination problems and inconsistent LPR ofwhole spleen and LN
preparations. The inconsistency of the LPR made it impossible to examine
suppression of the response, or antigen presentation to TEC derived from whole
preparations which themselves did not respond to the antigen. The mice suffered
from eye infections during this time period and it is possible that many of the
problems encountered in this section was due to the poor condition of the animals
used in the system. (Parallel cultures of human PBMC populations, employing the
same culture medium were free of contamination and responded to the antigen
preparations as shown in Chapter 6). Therefore despite desperate attempts (at least
15 experiments) to study the effects of cis-UCA on antigen presentation in an in vitro
LPR no reproducible results were obtained.
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5.3 DISCUSSION
As discussed in section 1.3.4, UVR causes profound changes in the morphology and
numbers of epidermal LC. This may result in altered antigen presentation, which
may in turn, lead to suppression of selected immune responses to antigens
encountered shortly after irradiation. The results outlined in Chapter 3 indicate that
cis-UCA induces similar morphological damage of epidermal ATPase"1" cells as that
after irradiation, and therefore it was of interest to determine whether similar
functional changes in epidermal antigen presentation take place following treatment
with cis-UCA. Unfortunately the question remains unanswered, as enormous
difficulties were experienced in developing a consistent and sensitive assay which
were not overcome.
If a reliable in vitro lymphoproliferation assay system in response to HSV could have
been established, a number of important questions could have been answered. It
would be of interest, for example, to establish whether APC treated (in vitro or in
vivo) with cis-UCA have the same capacity to present antigen as APC treated with
trans-UCA. Intravenous injection of mice with cis-UCA (50-100 (ig) resulted in
suppressed antigen presentation by splenic DC seven days after injection (Noonan et
al., 1988). However, after in vivo treatment with cis-UCA it would be possible to
find out whether any effect on antigen presentation was restricted to the site of cis-
UCA application, or if it was systemic. It was planned to study not only the total
proliferative response of T cells but also to investigate which subsets of cells
responded. This could be done by phenotyping the proliferating cells with
monoclonal antibodies to CD4 or CD8 and analysing by flow cytometry. In addition
by assaying the cytokines produced by the cells in vitro, it would be possible to
distinguish Thl (which produce 11-2 and IFN-y) from Th2 cells (which produce IL-4).
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It has been reported that purified hapten derivatised LC, which are irradiated in vitro,
induce anergy ofThl cells, such that on subsequent stimulation with hapten
derivatised LC which have not been UV-irradiated, no proliferation was detected
(Simon et al., 1992). Cis-UCA may also induce anergy and preliminary evidence
from P. Cruz (personal communication) indicates that this may be the case. In these
experiments FACS purified, hapten derivatised LC which were pulsed with cis-UCA
in vitro preferentially induced proliferation of Th2 clones, and induced anergy in Thl
clones.
This area of study merits further investigation.
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CHAPTER 6
THE EFFECT OF PHOTOTHERAPY ON IMMUNE FUNCTION
IN PATIENTS WITH PSORIASIS
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6.1 INTRODUCTION
Psoriasis is a chronic inflammatory skin disorder which is characterised by
hyperproliferation of the epidermis and accumulation of inflammatory cells,
particularly T lymphocytes, monocytes and neutrophils. There are many clinical
forms of the disease, chronic plaque psoriasis being the most common (Fig 6.3).
With few exceptions the patients studied in this chapter, and also Chapter 7, were
suffering from chronic plaque psoriasis. Details in this introduction are confined to
chronic plaque psoriasis.
Psoriasis is a multifactorial disease which affects approximately two percent of the
population ofWestern countries. It affects all races, males and females equally.
The exact aetiology of the disease remains a controversial issue but there is good
evidence that it is an inherited disorder. It is significantly more prevalent amongst
relatives of psoriatics, and twin studies reveal a 72% concordance between
monozygotic twins (Brandrup et al., 1978). A census study carried out in a closed
community in the Faroe Isles reported a 91% family occurrence in patients with
psoriasis (Baker and Fry, 1992). HLA typing of psoriasis patients revealed an
increased expression of certain class I antigens including B13, B17, B37 and CW6,
and also the class II antigen DR7 compared with non-psoriatic individuals (Russell et
al., 1972). As well as a genetic predisposition to psoriasis a number of
environmental factors may be also involved. These include epidermal injury
(Koebner phenomenon), streptococcal infections, stress and certain drugs.
Circumstantial evidence indicates that the immune system plays an important role in
the pathogenesis of psoriasis (reviewed by Baadsgaard et al., 1990a; Baker and Fry,
1992; Barker, 1991; Nickoloff, 1991a).
Activated T lymphocytes (ie IL-2 receptor"1" HLA-DR+) are found both in the
epidermis and dermis of active psoriatic plaques (Baker et al., 1984; Gottlieb et al.,
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1986; Gottlieb, 1988). Clinically uninvolved psoriatic skin also contains an
increased number of activated T cells. Resolution of plaques has been associated
with the appearance ofHLA-DR+ CD8+ T cells in the epidermis (Baker etal.,
1984). A population of T cells which bear the UM4D4 surface marker has been
isolated from psoriatic plaques; this molecule is expressed on a minority (20%) of
peripheral blood T cells but on the majority (75%) of T cells in lesional skin. The
monoclonal antibody to UM4D4 consistently induces proliferation of UM4D4 T cell
clones (Baadsgaard et al., 1990c ). The mechanism of T cell activation in psoriasis
remains unknown.
The interaction between lymphocytes and epidermal cells, mediated by cytokine
production and/or intercellular adhesion, is likely to play a key role in the induction
and perpetuation of psoriatic lesions. Interleukin-8 protein, which is not found in
normal epidermis, is present within the psoriatic scale and epidermis (Nickoloff et
al., 1991). 11-6 is also increased in psoriatic skin (Grossman et al., 1989). 11-6 and
11-8 are both stimulatory for KC proliferation in vitro (Grossman et al., 1989), and
in addition IL-8 is a potent T cell and neutrophil chemoattractant (Nickoloff et al.,
1991). It is also interesting to note that Il-la activity is decreased and nonfunctional
II-1(3 is increased in psoriatic epidermis compared with normal skin (Cooper et al.,
1990). TGF-a and its receptor are also enhanced in psoriatic epidermis (Elder et al.,
1989; Nanney etal., 1986). TGF-a is produced by, and is required for growth by,
epithelial cells, and therefore may also be important in stimulating growth of the
epidermis in psoriasis.
IFN-y, a product of activated T cells, has been identified in the serum and suction
blister fluid from psoriatic lesions (Gomi et al., 1991). IFN-y has a range of
immunological activities. Of particular interest in psoriasis is its ability to induce
ICAM-1 expression on KC. The presence of epidermal T lymphocytes, which
express the LFA-1 ligand, correlates well with the expression of ICAM-1 and
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therefore IFN-ymay be important in the trafficking of T cells into the lesional
epidermis (Griffiths et al., 1989). Psoriatic KC may have a decreased response to
locally produced IFN-y. For example, psoriatic KC do not appear to be as
susceptible to the growth inhibitory effects of IFN-y (Baker et al., 1988; Barker et
al., 1991) or the expression of FILA-DR (Barker etal., 1991; Terui etal., 1987) as
normal KC.
Nickoloff et al., (1991) proposed TNF-a as a key mediator in psoriasis. It is
produced by dermal dendrocytes, keratinocytes and epidermal LC, and induces IL-
8, ICAM-1 and TGF-a production by KC. Nickoloff et al. (1991) further
demonstrated the expression of IL-8 on KC immediately above the TNF-a positive
dermal dendrocytes. However TNF-a is inhibitory for normal KC proliferation
(Detmar and Orfanos, 1990; Pillai etal., 1989) and injection of TNF-a into the
mouse tail model of psoriasis resulted in a reduction of the mitotic index and
formation of the granular layer (Nagano et al., 1980). Furthermore in a recent study,
systemic administration of TNF in three psoriasis patients resulted in a substantial
resolution in two patients who had extensive psoriasis recalcitrant to therapy
(Takematsu et al., 1991).
It remains to be determined whether any dysregulation in cytokine production is a
primary cause or a result of the disease process. Fig 6.1. (adapted from Baker and
Fry, 1992) represents a possible model for the role of the immune system in the
pathogenesis of psoriasis. However it is also possible that the defect lies in the
response of KC to stimulation by cytokines other than IFN-y or that altered antigen
presentation by psoriatic EC may result in epidermal T cell activation and the




A Model of the Immunopathology ofPsoriasis. Presentation ofantigen by LC, for
example, to T cells leads to the synthesis ofctytokines which stimulate KC
proliferation and expression ofadhesion molecules by KC and endothelial cells. KC
in turn are stimulated to secrete their own cytokines, which may maintain the
psoriatic process.
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UVR is widely employed by dermatologists in the treatment of a number of
dermatosis, one of the most common being psoriasis. Patients usually receive whole
body irradiation with either UVB or UVA (plus oral psoralens; PUVA) in cabinets
shown in Fig 6.2. UVB and PUVA therapy can both be very effective in the
treatment of psoriasis as illustrated in Fig 6.3 (Henseler et al., 1981, Melski et al.,
1977). These treatments are largely empirical and little is known of their mechanism
of action. It is possible that they may act, at least in part, by modulating immune
responses.
As discussed in Chapter 1, in animal models, UVR results in suppression of selected
immune responses to antigens encountered shortly after exposure. The
immunological consequences ofUV irradiation in man are much less well
characterized (reviewed by Baadsgaard, 1991; Morison, 1989) and have been
confined mainly to suppression of contact sensitivity responses at UV-exposed sites
(Friedman et al., 1989; Halprin et al., 1981; Hersey et al., 1983a; Sjoval and
Christensen, 1986; Yoshikawa et al., 1990). However, a recent report indicates
that theUVR-induced suppression of CH may be sytemic, if the dose is
A.
erythemogenic (Cooper et al., 1992). It is well recognised that UV irradiation
produces transient alterations in the numbers, ultrastructure and morphology of LC
(reviewed by Cruz and Bergstresser, 1991). This is associated with suppressed in
vitro alloactivation by epidermal cells (Cooper et al., 1985) and reduced antigen
presentation (Ashworth et al, 1989; Austad and Braathen, 1985). There is
evidence for re-population of human skin with APC which preferentially activate
suppressor cells (Baadsgaard et al., 1990b). In addition to its effects on APC, UV
irradiation may alter circulating human T cell subsets temporarily, but the nature and
magnitude of such changes are variable. The majority of work in humans has also
employed UV regimens which bear little resemblance to those used therapeutically.
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Fig 6.2
AWaldmann Upright Cabinet as Used For Whole Body Irradiation in Phototherapy
Fig 6.3
The Efficacy ofPhototherapy. The rightpanel shows apatient with chronicplaque
psoriasis before therapy and the leftpanel shows the same subjectfollowing a course
ofPUVA therapy
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The aim of the work described in this chapter was to examine the effects of standard
courses ofUVB or PUVA therapy on various parameters of systemic and cutaneous
immunity in patients with psoriasis. These were compared with psoriasis patients
receiving topical coal tar dressings. In addition, where possible immune parameters
assayed in psoriatic subjects were compared with those in normal individuals. The
immunological parameters monitored included:
(i) several humoral components : circulating autoantibody profiles, immunoglobulin
isotypes and specific HSV antibody titres, complement C3, C4 levels and activity
(CH50)
(ii) full blood counts and the relative percentages of circulating PBMC subsets
(iii) the LPR to the mitogen Con A and to HSV using AC from peripheral blood and
EC from suction blister roofs as antigen presenting cell (APC)
(iv) the total UCA content and the relative % of cis-UCA in the epidermis and suction
blister fluid
(v) TNF-a content of suction blister fluid.
HSV was chosen as a convenient test antigen since about 80% of adults show
acquired immunity and, in addition, exposure to UV is an important factor in HSV




6.2.1 Study Design and Clinical Details
Three groups of patients with chronic plaque psoriasis were studied, one group
received UVB therapy, one group received PUVA therapy and the control group
consisted of subjects receiving topical coal tar dressings. In most instances samples
of blood, urine, epidermis and oropharyngeal secretions were collected. The
sample times and the assays performed are illustrated in Fig 6.4.
Figure 6.4.
Study Design. Patients were recruited on the basis ofa positive LPR to HSV. The
samples outlined below were collected in the early morning, immediately before
commencing treatment, following four weeks of treatment (48 h after irradiation)
and in patients receiving UVB or PUVA again four weeks after the final irradiation.
Throat swabs, plasma, suction blisterfluid, Finn Chambers and tape strips were









(iv) full blood counts
(v) autoantibodies
HSV Ig levels
Phenotyping of PBMC subsets












At each visit the patients were assessed and the Psoriasis Area and Severity Index
(PASI) calculated. In addition at each visit routine tests, including full blood counts,
biochemical profiles, liver function and dip stick urinalysis, serum immunoglobulin
isotypes, complement levels (C3, C4, and CH50) and auto antibody profiles were
determined in the Royal Infirmary of Edinburgh hospital laboratories. The presence
ofHSV-specific antibodies in plasma were determined by ELISA (see section
2.3.10).
In addition, the relative percentages of PBMC subsets was also assessed in the
patients described in Chapter 7 (28 subjects in total). The subjects discussed in
Chapter 7 who attended in Edinburgh also underwent the same routine laboratory
tests and epidermal UCA analysis studies carried out as those patients described here
(ie group A, five patients receiving coal tar treatment; group B, six subjects
receiving UVB; group F, four normal individuals receiving a standard course of
UVB received by psoriasis subjects, with the exception that only their arms were
exposed and the rest of their bodies remained draped). The normal subjects
receiving a standard course ofUVB had blister roofs raised on their arms before
commencing UV and 48 h after the last irradiation (approximately 6 weeks) as part of
another study but it was possible to collect blister fluid for UCA and TNF-a analysis
from them for use in this study. The data obtained from these subjects are also
included in the relevant sections in this chapter and only their NK cell study results
are described in Chapter 7.
Table 6.1 summarizes the clinical details of the subjects investigated in this chapter.
Although the absolute dose of UVR received varied between patients, a clinical
improvement in psoriasis and a reduction in PASI occurred during treatment in every
case. The routine laboratory profiles performed at each visit (full blood counts,
plasma urea, glucose and electrolytes, liver function, dip-stick urinalysis,
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autoantibodies) were within normal limits for each subject and their values were not
influenced by treatment (data not shown).
S
Serum immunoglobulin isotypes and complement were also meaured; two subjects
had slightly elevated IgE levels (between 150-180IU ml"1) and several had slightly
raised concentrations of serum immunoglobulin isotypes and/or complement
components, ahnnrmalifie.s anneared to be consistent for that individual and
neither the extent of the psoriasis nor the type of therapy influenced them
significantly (Fig 6.5). At no time did any subject have a positive autoantibody test.
C3 and C4 levels and CH 50 activity were found to be within normal limits and again
UV therapy had no effect on these parameters (Table 6.5). This was also the case for
the total numbers of white cells and lymphocytes (Table 6.5), and also the total
numbers ofmonocytes, eosinophils, basophils, myeloid and promyeloid cells as










































































































































The Effect ofPhototherapy on Immunoglobulin Levels. The graphs represent the
mean data from (a) 15 psoriasiasis subjects receiving topical coal tar (b) 17 psoriasis
patients receiving UVB (c) 4 psoriasis patients receiving PUVA and (d) 4 normal
individuals who received a standard course ofUVB therapy, before treatment (B),
following four weeks of treatment (D) andfour weeks after the last treatment (A).
(b)
20 n














The Effect ofPhototherapy on Complement andFull Blood Counts. Complement
levels and activity (C50) were determined before, during and after UVB treatment
(group B and F) and also PUVA therapy (group C). Psoriatic subjects who received
coal tar dressings had samples taken before treatment and also four weeks later.
The results shown are mean±sem for the group.
COMPLEMENT BLOOD COUNT
n C3 C4 C50 WC LC
(g I"1) (g I"1) (% HNP) (x 109) (x 109)
Group A
Before 15 1.22 ±0.04 0.26 ±0.02 136 ± 26.8 7.30 ± 0.44 1.97 ±0.21
During 15 1.16 ±0.04 0.26 ±0.01 128 ± 15.7 6.81 ±0.54 1.93 ±0.19
GrouD B
Before 16 1.17 ±0.06 0.25 ± 0.01 123 ± 13.6 6.40 ± 0.34 1.92 ±0.10
During 16 1.19 ±0.06 0.26 ±0.16 112 ±9.2 6.31 ±0.39 1.88 ±0.14
After 16 1.21 ±0.06 0.29 ± 0.02 123 ± 12.4 6.50 ± 0.39 2.06 ±0.15
GrouD C
Before 4 1.23 ±0.10 0.28 ± 0.05 165 ±21.6 5.32 ±0.16 3.22 ± 0.99
During 4 1.12 ± 0.10 0.24 ± 0.06 101 ± 10.7 5.50 ± 0.07 1.91 ±0.18
After 4 1.27 ±0.14 0.24 ± 0.05 92.8 ± 0.05 5.04 ± 1.50 2.04 ±0.10
GrouD F*
Before 4 1.00 ±0.08 0.20 ±0.03 106 ±7.52 5.20 ± 0.35 1.32 ± 0.12
During 4 0.93 ± 0.04 1.17 ±0.02 150 ± 47.4 4.95 ± 0.80 1.56± 0.14
After 4 0.95 ± 0.04 0.19 ±0.02 132 ± 30.4 5.88 ±2.00 1.35 ±0.12
n: number in group
* Normal individuals who received a course ofUVB identical to that received by
psoriasis subjects.
6.2.2 HSV Infection
The patients described in this chapter were selected on the basis of a positive LPR to
HSV, with an SI greater than three (24 patients in total). Only two of the patients
suffered recrudescent perioral HSV infections during UVB (group B) and none
during PUVA (group C) therapy. One recrudescence during UVB was associated
with a (i-haemolytic streptococcal infection which was the probable trigger, the other
followed a mild UVB-induced facial burn a few days after commencing therapy.
Three subjects from group A suffered recrudescent perioral infections: two were
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associated with mild upper respiratory tract infections and the third occurred when
the patient was "tired and run down". One subject was found to be shedding HSV
asymptomatically, by virus isolation from the oropharynx, prior to the commencing
UVB therapy. HSV antibody titres remained high in all subjects and varied little
during the therapy (data not shown). (LPRs to HSV are outlined in table 6.4).
6.2.3 Phenotyping of PBMC
Preliminary experiments were carried out to determine the the optimal concentration
of each antibody, which gave the highest and most consistant staining of PBMC. It
was found that 10 |il neat or 50 |il of 1:10 dilution of the antibody per pellet of 5 x
105 cells was optimal for all the antibodies used, with the exception of DA6.231
which still gave consistent results at 1:100. The anti-IgG FITC conjugated antibody
had been previously titrated (co-workers in lab) and 50 |il (per 5 x 105 cells) of a 1:40
dilution reduced the background non-specific binding while maintaining the positive
staining.
At each visit PBMC were stained with a range of monclonal antibodies and the
relative percentage of each subset was determined by florescence flow cytometry.
No significant differences in the percentages of PBMC subsets between patients with
psoriasis and normal controls were observed (Table 6.3). As there were only four
normal subjects, data from a further nine controls were taken from a concurrent study
in which the same monoclonal antobodies, staining protocol and flow cyometer were
used (Charleson et al., 1992). These show similar values to those shown in Table
6.3, i.e. percentages of positive cells (mean ± 1 standard deviation) CD3 45 ± 7,
CD4 33± 11, CD8 24 ± 7, CD la 3± 1.9, CD 57 16 ± 9, MHC II 21 ± 6. No
significant alterations occurred during therapy, although there was a slight decrease
in the percentage of CD3+ and CD4+ cells in groups B and C (p > 0.05; paired t
test). CD 19 staining was performed in four of the subjects in group B only, but no
modulation in the percentage of CD19+ cells was observed.
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Table 6.3
The Effect ofUV Therapy On The Percentage ofPBMC Subsets Assessed by Flow
Cytometry.
Group No Marker Cell % Positive % Positive % Positive
Subjects Subset Cells Before Cells After Cells 4
(n) Treatment 4 Weeks of Weeks Post-
Treatment Treatment
A 3 CD la LC 4.5 ± 0.8 3.7 ±0.5 ND
B 7 6.0 ± 0.4 5.3 ± 1.0 6.6 ± 2.0
C 4 4.8 ± 1.0 4.2 ± 1.4 5.2 ± 1.2
F ND ND ND ND
A 10 CD 3 Pan T 55.5 ±3.7 56.1 ±3.2 ND
B 9 54.2 ±3.9 47.3 ± 3.3 53.8 ±3.3
C 9 50.9 ± 3.5 54.4 ±3.8 52.7 ± 5.4 A
F 4 46.7 ± 14.8 53.6 ± 13.4 48.1 ± 16.6
A 10 CD 4 Th 38.8 ±3.6 39.7 ± 4.9 ND
B 9 41.5 ±7.2 35.4 ±4.5 42.3 ± 4.9
C 9 36.3 ± 2.4 36.1 ±2.9 27.6 ± 3.2 *
F 4 35.5 ± 3.7 40.0 ± 13.4 28.9 ±4.9
A 10 CD 8 Tc 15.7 ± 1.4 17.4 ±1.4 ND
B 9 18.1 ± 1.7 16.4 ±2.1 18.1 ±2.1
C 9 22.0 ± 2.7 25.1 ±3.4 25.7 ± 5.5 *
F 4 15.8 ±3.8 18.2 ± 1.3 14.4 ±2.4
A 11 CD 57 NK 9.17 ± 1.3 12.5 ± 2.6 ND
B 9 11.4 ± 1.5 13.0 ±1.9 10.1 ±1.2
C 9 17.7 ±3.6 19.2 ± 2.7 15.9 ±2.9
F 4 10.7 ±1.5 11.6 ±2.6 11.3 ± 1.8
A 10 DPJDQ, MHC 14.9 ± 1.6 15.2 ±3.3 ND
B 9 DR II 17.7 ±2.9 16.3 ± 1.8 14.8 ±2.1
C 9 15.9 ± 1.7 17.3 ±2.5 17.5 ±5.6*
F 4 12.7 ±5.0 15.6 ±2.4 20.6 ±4.1
Group A; psoriasis patients receiving coal tar
Group B; psoriasis patient s receiving UVB therapy
Group C; psoriasis patients receiving PUVA therapy
Group F; normals receiving a course of UVB
A n - 1 * n - 3
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6.2.4 In vitro Lymphoproliferative Responses to HSV
Prior to treatment 10 ml of blood was collected, the PBMC isolated and screened for
LPRs to HSV; the patients were selected on the basis of a positive test (SI > 3).
LPRs to Con A and HSV were monitored during treatment in seven patients from
group A (coal tar paste), six from group B (UVB) and three from group C (PUVA).
The mean data for each group (± sem) are outlined in in table 6.4.
Table 6.4
The Effect ofPhototherapy on LPRs to Con A and HSV. The table shows the mean
cpm (±sem) and stimulation indices (SI) for each group.
Nil Con A SI Vero HSV SI
Group A (n=7)
Before 1572A± 35682± 31.5 ± 1361 ± 10093± 7.1 ± 1.9
451 7 647 11.7 429 2495
During 1248A± 38747 ± 37.6 ± 1057 ± 7587 ± 8.0 ± 1.4
242 5.7 5.7 195 1 491
Group B (n = 6)
Before 1650 + 50134± 35.8 ± 2017 ± 15403 ± 8.6 ± 1.2
341 9341 11.8 370 2017
During 3866 ± 42376± 12.2*± 3644 ± 23027 ± 6.2 ±
1381 8 539 3.2 1043 8 003 0.76
After 1 677 ± 1 67 861 ± 49.7 ± 2563 ± 18030± 7.7 ± 1.2
381 12287 18.4 427 4545
Group C (n = 3)
Before 2610 ± 46618± 28.8 ± 1292 ± 8171 ± 8.5 ± 1.8
1337 1136 14.5 526 816
During 1075 ± 41684± 52.2 ± 831 ± 8152 ± 11.2 ±
302 10 044 27.2 294 2294 6.6
After 1608 + 39906 ± 25.7 ± 1757 ± 12920± 10.4 ±
628 13291 2.3 99.7 5981 4.0
*
p = 0.023 compared with before therapy (Wilcoxon signed ranks test)
An = 3
There was no statistically significant modulation of in vitro LPR to HSV or Con A
during therapy in any group on comparison of the mean cpm (p > 0.05; Wilcoxon
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signed ranks test). However the background counts of unstimulated PBMC
increased in five of the six UVB treated patients (mean cpm for the group of six
1650 ± 341 increasing to 3866 ±1381) during therapy, and returned to normal (1677
± 428) four weeks after the last irradiation. This resulted in a significant suppression
in the SI to Con A (p = 0.023; Wilcoxon signed ranks test) and was not found in
patients in group A or C.
6.2.5 Antigen Presentation of HSV by EC or AC
The aim of the following section was to examine the effect of phototherapy on the
ability of EC and AC to present HSV antigen to TEC. The initial experiments
attempted to generate a standard T cell population prior to the onset of therapy for
each patient and then to examine the effects of UV treatment on antigen presentation
to these cells. Initially TEC were prepared and stored frozen, then thawed and their
ability to proliferate when stimulated with AC or EC plus antigen measured. This
approach had only limited success as outlined below, and therefore an attempt to
generate T cell clones from each patient was attempted. Finally it was resolved to
study the ability of APC to stimulate TEC prepared prepared on the same day.
Initially TEC were resuspended in 10% FCS and 10% DMSO in RPMI at 2 x 106
cells mT1 and aliquoted into 1 ml samples. They were placed in a polystyrene box at
-70°C for approximately lh, until frozen, and then placed under liquid N2. The
cells were rapidly thawed at 37°C and placed on ice. To 1 ml of cells, 0.2 ml of ice
cold medium was added every 30 seconds for 3 min. This was repeated with 0.4 ml
and then 0.8 ml of medium. The cells were washed twice, a viable cell count
performed and a lymphoproliferation assay performed with either no further additions
or with Con A, mock infected Vero cells or HSV antigen. Autologous AC from
blood were added to the TEC at cell numbers of 1, 3 and 10% of the TEC and
incubated without antigen or with HSV or Vero control antigen as described in
2.3.12. The uptake of 3H-thymidine was measured over the final 24 h of a six day
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2.3.12. The uptake of 3H-thymidine was measured over the final 24 h of a six day
culture and compared with the whole PBMC population or fresh TEC cells. In an
attempt to achieve consistent results, a number of freezing mixtures were used
including 15, 50 and 75% autologous plasma or FCS in 10% DMSO and TCM. It
was found that 75% FCS in TCM and 10% DMSO resulted in the most efficient
recovery of cells following freezing. However it was still not sufficient to yield
consistent stimulation of the frozen TEC (fTEC) by adherent cells in the
lymphoproliferation asay. A number of different thawing techniques was also
employed. The proliferation assay conditions were also manipulated; fTEC were
subsequently cultured in round or flat bottomed plates, pulsed or harvested over a
range of different time courses. In total, variations of this experiment were carried
out on sixteen different occasions using cells from seven psoriatic and two normal
subjects. Satisfactory antigen presentation by AC to fTEC cells was obtained on
only six occasions. However, even in these instances, if fTEC were thawed at a
later date and fresh autologous AC used to present HSV or Con A, highly variable
results were obtained; this included two normal healthy individuals who were
receiving no medication.
On five separate occasions a programmed cell freezer (Planar Products Ltd, London)
was employed to freeze the cells. The temperature was lowered by 1°C min"1 until
-40°C was reached. The cells were placed under liquid N2. On three occasions this
yielded satisfactory results on the day of freezing, but the results were variable when
AC were added at various times thereafter. In addition it was found using various
culture conditions, despite satifactory antigen presentation by AC, EC would not
function as APCs to fTEC despite satifactory presentation of HSV or Con A to fresh
TEC. It was finally decided to abandon this approach.
The second approach to generate a constant population of T cells prior to the patients
commencing therapy was to generate T cell clones for each patient. The method
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this was not a practical proposition. Often only two weeks notice was given that a
patient was to commence UV therapy, and this was not sufficient time to generate
HSV T cell clones and to conduct the first antigen presenting function experiment.
This method was also therefore abandoned.
Finally, EC suspensions were prepared from suction blister roofs of patients in
groups B and C. The ability of EC, and also AC purified from PBMC, to present
HSV antigen to fresh autologous TEC was assessed. The purification procedure
employed (see 2.3.8) was sufficient to abrogate the antigen presenting function of the
TEC on most, although not all occasions. Since the background cpm for the TEC
varied slightly between samples obtained from the same patient on different
occasions, this value was subtracted from the cpm generated by the TEC stimulated
by EC or AC to determine the stimulation attributable to the APC.
Satisfactory and consistent functional depletions of T cell responses were achieved in
four of the group B patients on all three occasions. The ability of AC and EC to
present HSV before, during and after UVB was compared and the results from one
such experiment are shown in Fig 6.6. AC were unaffected in their ability to present
HSV to TEC by UVB radiation but epidermal antigen presentation was abrogated
during UVB therapy, recovering 4 weeks after the last treatment This was also true
of the other three patients monitored in the same way in this group, with the
exception of EC from one subject which did not recover completely four weeks after
therapy was completed.
The same experiment was carried out with four group C patients but no consistent
effect on HSV presentation by AC or EC was obtained. However it was clear from
the results of two of the patients that, four weeks after PUVA therapy had finished,
the EC had not regained their ability to present HSV (data not shown).
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Figure 6.6
The Effect ofUVB Irradiation on Antigen Presentation ofHSV by (a) adherent cells
from blood or (b) epidermal cells. LPRs ofone patient with psoriasis to Vero
control antigen (open bars) and HSV antigen (closed bars) before, during and after













Initially, 4 successive tape strips were taken from the buttock (assumed to be
unirradiated prior to therapy). However this method was later abandoned in
preferance to Finn Chamber sampling because the latter was less invasive, not prone
to the same degree of sampling error and removes the total epidermal UCA content.
The samples were analysed by HPLC, and representative traces are shown in Fig 6.7.
The epidermal UCA results outlined below represent Finn Chamber sampling unless
otherwise stated.
A preliminary experiment was conducted to compare the UCA content, and the
percentage of the c/s-isomer, in the epidermis and suction blister fluid obtained from
uninvolved forearm skin of untreated psoriasis patients with that from normal
subjects (Table 6.5). The mean UCA content and the relative percentage of the cis-
isomer in suction blister fluid was not significantly different between the two groups,
although it should be noted that nine out of twelve psoriatic patients had no detectable
cis-UCA, whereas six out of seven of the normal individuals did. The epidermal
content of the psoriasis patients was significantly elevated compared with the normal
subjects (Table 6.5). The relative percentage of each isomer did not differ between
the two groups.
Table 6.5
UCA Content ofEpidermis and Suction Blister Fluid in Normal Skin and Uninvolved
Psoriatic Skin
Normal
n Total UCA % cis-
(mean ± sem) UCA
Psoriatic
n Total UCA % cis-





11 2.3 + 0.3 17.9 ±2.8
7 97.8 ±11.6 3.2 ±1.0
22 7.6 ±1.5* 21.9 ±4.7
12 106.5 ±14.5 2.1 ±1.2
* significantly different from normal epidermis (Student's unpaired t test, p < 0.01)
n = number of patients
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Figure 6.7
Chromatograms of (a) standard UCA solution and (b) Finn chambers
- 0CA_CAL.018\DAT00101-DTI 270 ma 0.02 ADF
cia/trans 0.67/0.96og
- OCA_CAL.018\DAT00202.DTI 270 ma 0.02 AOF
da/trans 2.68/3.83ng
-- DCA_CAL,.018\DAT00303.DTI 270 ma 0.02 ADF
cia/trana 10.72/15.31og
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The effect ofUV-therapy on UCA content of the epidermis and blister fluid is shown
in Table 6.6. Finn Chambers were collected from a group of normal individuals (F)
who received a standard course ofUVB, on their arms, in Edinburgh before
commencing treatment, following four weeks of irradiation and four weeks after the
last irradiation. Blister fluid was also collected from these subjects before treatment
and 48 h after the last irradiation (approximately six weeks). In both groups B
(psoriasis patients receiving UVB) and F (normal subjects receiving UVB irradiation)
UV exposure tended to increase the total UCA content of the epidermis, but this was
not statistically significant (p > 0.05; paired t test). After four weeks of therapy the
percentage of cw-UCA had increased significantly in both groups. Similar results
were obtained from four successive tape strips as shown in the table below.
Table 6.7
The Effect ofUVB Therapy on Epidermal UCA Content as Sampled by Tape
stripping. The values equal the mean ± sem for each group.
n Before During After
Group A
Total UCA 4 0.11 ±0.04 0.15 ±0.01 ND
(nM cm"2)
% Cis UCA 10.2 ±3.0 2.8 ±1.9 ND
GrouD B
Total UCA 10 0.14 ±70.3 0.15 ±0.041 0.09 ± 0.03
(nM cm"2)
% Cis-VCA 15 16.7 ± 3.0 52.5 ±4.0 13.3 ±4.0
GrouD C*
% Cis-UCA 4 15.7 ± 11.5 46.8 ± 11.8 23.0 ± 19
n: number of subjects per group
* tape strips from two of the subjects in this group had folded onto each other,
and therefore it was impossible to extract the total UCA from these.
As shown in Table 6.6 the concentration of UCA in suction blister fluid remained
relatively constant throughout the study. The percentage of cis-UCA increased









































































































































































































Only a few samples were available for UCA analysis from group C (PUVA). Two
out of three subjects showed a slight increase in epidermal UCA during therapy, with
the percentage of cA-UCA increasing in all three subjects after four weeks of therapy
(from 35.4% ± 14.2 to 46.1 % ± 12.5; mean ± sem). Two of these subjects had
elevated percentages of cis-UCA before irradiation commenced (44.95 and 53.5%
respectively). Suction blister fluid from two of the PUVA patients showed no
alteration in the total UCA content during treatment but an increased percentage of
cis-UCA was detected following four weeks of therapy and, as with the psoriasis
subjects receiving UVB treatment, this remained elevated four weeks after the last
treatment.
The correlation (Kendall's coefficient of concordance) between total epidermal UCA
(or cA-UCA) and suction blister fluid UCA (or cA-UCA) compared with the PASI
was calculated. No correlation between the severity of psorasis and the epidermal
UCA was found but there was a negative correlation between the PASI and the % cis-
UCA in the suction blister fluid (Fig 6.8).
Figure 6.8
The % ofcis-UCA present in (a) suction blisterfluid and (b) the epidemis in psoriasis
patients treated with UVB or PUVA therapy and its correlation with the PASI score



































Due to the limited volume of the sample available from each subject, only 100 |il of
blister fluid or the standard was added to each well of the ELISA plate instead of the
recomended 200 pi (section 2.3.16). This lowered the sensitivity of the test from 7.5
pg ml"1 to approximately 16 pg ml"1.
TNF-a was detected in the majority of samples. Patients with psoriasis from groups
A-C had slightly elevated levels (95.6 ± 10.1 pg ml"1; mean ± sem; n=9) compared
with normal subjects (58.7 ± 15.3 pg ml"1; n=7; four group F subjects and 3
additional normal subjects), but this did not reach statistical significance (p > 0.05;
Student's t-test).
As shown in Fig 6.9, there was little change in TNF-a concentration during coal tar
therapy (group A) but three patients from group B showed increased TNF-a
concentrations during UVB therapy although four showed a decrease. Three out of
four normal subjects (group F) showed increased TNF-a in blister fluid during
therapy. No paired samples from group C were analysed.
There was no correlation between the concentration of cis-UCA and TNF-a in the

































































































In this study several immunological parameters were assessed in patients suffering
from chronic plaque psoriasis and, where possible, compared with those in normal
subjects. The effect of phototherapy or coal tar therapy was then measured by
comparing samples from the patients taken before, during and after treatment.
6.3.1 Humoral Immunity
Since certain reports, although not all, have indicated that abnormalities in
complement components (Acevedo and Hammer, 1989; Rosenberg et al., 1990)
and immunoglobulin levels, particularly IgA (Guilhou et al., 1976) may occur in
patients with psoriasis, patients were tested before therapy for circulating
complement components and immunoglobulin levels, as well as haematological,
autoantibody, urinary and biochemical profiles. All of these routine measurements
were within normal limits with the exception of a small number of psoriatic subjects
who had slighdy elevated immunoglobulin or complement levels which did not vary
with disease severity. Although deposition of complement and immunoglobulins
appears to occur in established lesions and may be involved in recruiting polymorphs
into plaques, they appear to be secondary phenomena (reviewed Bos 1988). It is
possible that elevation of complement levels relate to particular types of psoriasis,
while the lack of correlation between the clinical improvement of psoriasis and
increased levels of circulating immunoglobulin argues against their being primarily
related to the development of skin lesions (Baker and Fry 1992).
Neither UVB nor PUVA therapy had a measurable effect on any of these parameters.
Hersey et al., (1983a) reported that exposure to sunlight had no effect on circulating
complement or immunoglobulin levels, although Livden et al., (1977) detected
slightly decreased circulating IgG titres in normal subjects exposed to four weeks of
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UVB or UVA radiation, and a slight increase in IgM and C3 levels following UVB
irradiation.
6.3.2 Circulating PBMC
Although some reports have indicated abnormalities in circulating lymphocyte
subsets in patients with psoriasis, others found no differences from normal subjects
(David etal., 1990; De Pietro et al., 1981; Kokelj etal., 1984). This was also the
case in the present study in which analysis was by flow cytometry using monoclonal
antibodies to T cells (CD3, CD4, CD8), LC (CDla), B cells (CD19), natural killer
cells (CD57) and MHC Class II antigens (Table 6.5); the patients full blood count
also remained normal and did not fluctuate during the study.
The effect ofUV irradiation on circulating blood cells is controversial and, indeed, it
is possible that any detected changes are only transient. Thus some authors reported
a temporary decrease in circulating T cells after UVB or PUVA therapy but others
found no modulation in circulating PBMC following a variety ofUV regimens (see
section 1.3.4 and discussed by Mutzas et al., 1991). Differences in the type ofUV
source, wavelength, duration or dose ofUV radiation, as well as the time of
sampling may explain these apparent differences. The results of this study
demonstrated an insignificant reduction in the percentage of circulating CD3+ and
CD4+ cells following UVB or PUVA therapy but no alteration in any of the other
subsets. No changes were noted in the normal subjects receiving UVB, or in
patients receiving tar.
6.3.3. HSV Infection
Most studies of the immunosuppressive effects of UV irradiation in man or
experimental animals have focussed on immune responses to antigens, usually
contact sensitizers, which are encountered for the first time shortly after irradiation.
The present study was different in that subjects were already infected with HSV
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before starting therapy. In addition, although erythemal exposure to UV is a
common triggering factor for orofacial recrudescent HSV infection (Spruance et al.,
1991; Vestey etal., 1989), the role of suberythemal doses of UV, such as those
employed in phototherapy, in HSV pathogenesis is unknown.
Volunteers were observed for signs of orofacial HSV recrudescences at each visit and
had oropharyngeal swabs taken for virus isolation before, during and after therapy.
Ten patients receiving coal tar (group A), ten receiving UVB (group B) and 4
receiving PUVA (group C) were found to be HSV carriers on the basis of
lymphoproliferative responses in vitro. One subject from group B was shedding virus
asymptomatically before therapy and only two others suffered recrudescent lesions
during therapy; one following a mild burn produced by UVB irradiation but the other
was not associated with therapy. Thus suberythemal phototherapy was not generally
a triggering factor for HSV recrudescences nor for inducing reactivation of latent
virus with asymptomatic shedding into the oropharynx. However the oropharyngeal
swabs were taken at one time point only during therapy and, as virus is detectable for
about two to five days in each recurrent episodes, it is possible that shedding may
have occurred outwith the sample points.
It has already been reported that patients with psoriasis develop normal
lymphoproliferative responses to HSV (Kapp et al., 1988). Four weeks of UVB or
PUVA therapy caused no significant modulation in the lymphoproliferative response
to HSV, or in HSV-specific antibody titres in any individual. However PBMC
cultured alone tended to show an increased 3H-thymidine uptake during UV




When peripheral blood AC were used as accessory cells in the lymphoproliferation
assays, no alteration in antigen presenting ability as a result ofUVB or PUVA
therapy was detected. However, this was not the case when EC were used as
accessory cells. This resulted in markedly lowered proliferative responses in patients
during UVB (6.6) or PUVA therapy. The responses were restored in most
individuals four weeks after UVB irradiation had finished although they remained
depressed four weeks after PUVA therapy.
Few studies have examined the effects ofUV irradiation on human epidermal antigen
presentating function and none following such typical regimens used for the
treatment of psoriasis. In vitro irradiation of human EC suspensions with UVB
(Austad and Braathen., 1985; Czernielewski et al., 1985) UVA or PUVA (Mork et
al., 1987) resulted in suppressed allo-activation and antigen presentation by the cells.
Cooper et al. (1985) demonstrated a depressed antigen presentation by LC
immediately after irradiation of normal subjects with 2-4 MEDs ofUVB but this was
followed by an enhancement in antigen presentation due to an influx of
T6"Dr+ cells into the epidermis. Similarly PUVA therapy has been reported to
suppress the antigen presenting capacity of human epidermal cells, (Ashworth et al.,
1989), with loss of LC, although on a per cell basis those which remain function
normally.
6.3.5 UCA Determination
Cis-UCA is formed from the naturally occurring trans-isomer on UV irradiation of
skin, up to a maximum value of about 60% of the total UCA which represents a
photostationary state (Norval et al., 1989a). In mice, the percentage of civ-UCA
declines steadily following a single UVB exposure until a background level is
reached after 14 days (Norval et al., 1988). An analysis of the UCA content of
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human epidermis and suction blister fluid and percentage of the cis-isomer during and
after phototherapy had not been undertaken before. The total epidermal UCA
content was measured using Finn Chamber samples, which extracts all the UCA
from human epidermis and gives an equivalent value to successive tape strips (Jansen
etal., 1991).
Patients with psoriasis had approximately three times more UCA in their epidermis as
normal subjects (Table 6.5). The value obtained for psoriatic epidermis was similar
to that reported recently by Snellman et al., (1992). It is possible that the increased
UCA detected reflects the mild epidermal thickening which occurs even in
"uninvolved" skin sites in psoriasis. Alternatively, since UCA is formed in one step
from histidine by the action of histidase, increased histidine may be available in
psoriasis due, perhaps, to increased epidermal cell turnover or keratohyalin granule
degradation which would account for increased UCA. In addition abnormalities in
histidase activity have been detected in patients with psoriasis (Reavan et al., 1965).
During and after UVB exposure, the total epidermal UCA content of the psoriasis
patients remained relatively constant while that of normal subjects doubled during
irradiation, returning to near the starting value 4 weeks after the last dose. All
irradiated groups showed an increase in the percentage of cis-VCA in the epidermis
which returned to normal 4 weeks after the last treatment. In a previous study four
weeks of heliotherapy (sunbathing in the Canary Islands) for psoriasis produced
similar effects on epidermal UCA despite using very different UV regimens
(Snellman et al., 1992). An increase in the % of c/s-UCA occurred in the small
number of PUVA patients studied, during therapy.
It has been proposed that photosensitizing agents may play a role in the isomerization
ofUCA (De Fabo et al, 1991; Schwarz etal., 1987). It is not known whether 8-
methoxypsoralen will affect the isomerization of UCA in vivo. However in this
study, in vitro irradiation of a solution of trans-UCA, in the presence of 8-
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methoxypsoralen, in the PUVA cabinet had little effect on the production of cis-
UCA over a range of irradiances. For example following irradiation for 10 minutes
in the PUVA cabinet 13.9, 11.7, 11.7 and 6.3 % of cis-UCA was formed in the
presence of 0, 0.1%, 0.01% and 0.001% of 8-methoxpsoralen respectively. Others
have found that UVA irradiation of trans-UCA in the presence of psoralens had little
or a slightly protective effect on the isomerization (H. Morrison personal
communication).
Although cis-UCA has been suggested as a mediator of the immunosuppressive
effects ofUV irradiation, it is not known if the formation of cis-UCA in the
epidermis following UV irradiation contributes either directly or indirectly to the
impaired presentation of HSV by EC during phototherapy. Evidence to support a
direct effect comes from the measurement of the number of dendritic cells in murine
epidermis following cis-UCA treatment (discussed in Chapter 3).
UCA was detected in suction blister fluid from both psoriatic and normal subjects, at
similar concentrations. This differs from a previous report of reduced levels of UCA
in suction blister fluid from psoriasis patients (Juhlin et al., 1986). Phototherapy
did not affect the total concentration of UCA although the percentage of cA-UCA
increased. In contrast to the epidermis, this increase was maintained four weeks
after the last treatment in both groups B and C. These results are similar to those of
Pasanen et al., (1990). UCA is synthesized in the stratum corneum on activation of
histidase (Scott, 1981), and it is interesting that UCA isomers are found in blister
fluid which is likely to be formed mainly from a dermal exudate. The persistence of
an increased percentage of cis-UCA in blister fluid after it had returned to a low
percentage in the epidermis might indicate that cis-UCA persists in the dermis or near
the dermo-epidermal junction. It is possible that it may play a significant role in
immunomodulation there and, indeed, a comparison of UCA and the percentage of
cis-UCA in the epidermis and blister fluid samples from the psoriatic patients
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revealed an inverse correlation between percentage of ris-UCA in blister fluid and the
PASI (p = 0.031), while there was no correlation between the percentage of
epidermal cis-UCA and UCA, or of blister fluid UCA, with the PASI (p > 0.308).
6.3.6 TNF-oc Analysis
Finally, a small number of blister fluid samples were analysed for TNF-a. It was
present in measurable quantities in most samples before irradiation but UVB therapy
had no consistent effect on its concentration (Fig. 6.9). However it is possible that
any changes may occur rapidly after the start of phototherapy and may not be
sustained until our samples were taken, at least 48 h after irradiation. TNF-a is one
of the cytokines released by UV-irradiated KC which has important properties in
mediating the effects ofUVB on the immune system, at least in mice. It has been
shown, for example, to mediate the suppression of contact hypersensitivity induction
through local release in the skin but also to be involved in the enhanced expression of
contact hypersensitivity in UV-susceptible mice (Yoshikawa et al., 1992) It is not
known whether human skin responds similarly during phototherapy. TNF-a alters
adhesion molecule expression on KC and in the dermal vasculature, thus influencing
recruitment of inflammatory cells into both the epidermal and dermal compartments.
In psoriasis there is a characteristic T cell infiltrate and KC hyperproliferation, in
which dermal dendrocytes may play a central role, possibly mediated by the
production of TNF-a (Nickoloff et al., 1991).
Whether TNF-a and cis-UCA production in the skin are linked is unknown at
present, although Kurimoto and Streilein (1992) have reported recently that cis-UCA
may cause the local release of TNF-a within the murine epidermis with consequences
for the induction of CH. In addition, cis-UCA has been shown to down-regulate the
induction of cAMP by trans-UCA or histamine in dermal fibroblasts in vitro and thus
it is possible that cis-UCA, formed on irradiation, may regulate the activity of
cytokines through a secondary signalling system (Palaszynski et al., 1992).
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Although changes have been noted in this study, predominantly in epidermal APC
function and in cw-UCA content as a result of phototherapy, it remains uncertain
whether these modulations contribute to the effectiveness of the UV-based treatment
for psoriasis or if they are related to the disease process itself.
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CHAPTER 7
THE EFFECT OF UV-THERAPY, AND UCA-ISOMERS in vitro,




Natural killer (NK) cells represent an extremely heterogeneous population of
predominantly large granular lymphocytes (LGL). They have not, as yet, been
formally assigned to a single lineage or a distinct anatomical location of maturation.
However it has been suggested that NK cells are dependent on intact bone marrow,
and not on thymus for their differentiation (Lanier et al., 1986; Trinchieri and
Perussia, 1984). NK cells express both T cell markers eg CD2 and myeloid markers
eg CD1 lb (LFA-1) or CD16 (FcyR). The majority ofNK cells in peripheral blood in
humans are CD56+ CD16+ CD2+ CD1 lb+ CD3~. Other markers such as CD57,
CD3 and CD8 are only expressed on sub-sets ofNK cells (Mingari et al., 1987).
Figure 7.1 (adapted from Trinchieri, 1989) illustrates the range of markers found on
NK cells.
NK cells have therefore tended to be defined on a functional basis. Classically they
are considered to be spontaneously cytotoxic cells which lyse target cells in a non-
MHC restricted manner at the level of the target cell. Unlike specific cytotoxic T
cells, NK cells require no prior sensitization and do not appear to exhibit any
immunologic memory (reviewed by Trinchieri, 1989). Until recently it had not been
possible to demonstrate any clonally distributed specificity.
Despite this apparent lack of specificity, NK cells have been implicated in a number
of immunological processes. These functions include cytotoxicity against tumour
cells and virally infected cells (Herberman and Ortaldo, 1981), and resistance to
some microbial, fungal and parasitic agents (Hatcher and Kuhn, 1982; Murphy and
McDaniel, 1982; Nenecioni et al., 1983). NK cells also provide resistance against
allogeneic grafts (Kiessling et al., 1977; Warner and Dennert, 1982) and they may
play a role in immune regulation through the secretion of a number of cytokines. For
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example, stimulation of purified NK cells with IL-2 and CD 16 ligands induced high
levels ofmRNA accumulation, and release of IL-2 receptor (CD25) (Anegon et al.;
1988), IFN y (Kobayaski et al., 1989), TNF*(Anegon et al., 1988), GM-CSFand
CSF-1 (Anegon et al., 1988; Cuturi etal., 1989).
Figure 7.1.
Cell Markers Found On Human NK Cells Compared With B Cells, T Cells,
Monocytes and PolymorphonuclearNeutrophils (PMN). M positive cells, □ low
density positive cells and H activated cells only. The length ofeach filled bar within
each population indicates the approximate proportion ofcells expressing the
antigens. The position of the bar does not represent the true overlapping or



















The response of NK cells can be broken down into three sequential phases (Fig 7.2.
adapted from Trinchieri, 1989). The first is a rapid response on the interaction of



















cytotoxicity and release of granule contents. The second phase (10 min to 2 h)
involves the transcription and expression of genes encoding lymphokines and surface
activation markers including CD25. In the presence of IL-2, NK cells proceed to the
third phase which involves DNA synthesis, blast formation and proliferation. 11-2
and IFN are both potent enhancers of NK cell activity (Trinchieri et al., 1984;
Trinchieri and Santoli, 1978a). 11-2 is widely employed to induce the lytic effect of
NK cells from, for example, bone marrow cultures. However antibodies directed
against TNF-a and IFN abrogate the IL-2 dependent maturation. This suggests that
EL-2 may act through the induction of another cytokine (Karre et al., 1991).
The receptors involved in NK cell target cell recognition and interaction or the signal
transduction mechanism responsible for E (effector) cell activation remain unknown.
Interaction of E and target cells induces an increase in intracellular Ca+ which is in
approximate proportion to the sensitivity of the target cells to lysis, and thought to be
regulated by cAMP (Windebank et al., 1988). Both CD16 and CD2 have been
shown to act directly in the signal transduction and activation of the cytotoxic
mechanism (Cassatella et al., 1989; Schmidt et al., 1988). CD11 (LFA-1) and
CD 18 (LFA-J3 sub-unit) are also thought to be important in the NK cell cytotoxicity;
patients who suffer from a severe deficiency in the CD 18 chain are deficient in NK
cell activity (Kahl et al., 1984; Ross et al., 1985) and antibodies directed against
CD1 la block NK cell mediated cytotoxicity. It has also been reported that antibodies
directed against CD45 will block NK cell mediated cytoxicity, but they act at the
post-binding stage (Pawlec et al., 1985; Starling et al., 1987).
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Figure 7.2














The possibility exists that there is a distinct NK cell receptor which as yet remains
elusive. Evidence of education and clonal specificity of NK cells is now emerging
(reviewed by Moretta, 1992; Versteeg, 1992). Initially it was found that purified
alloreactive CD56+ CD3" precursors could be induced in allogeneic, but not in
autologous MLR (Ciccone et al., 1988). Further studies at a clonal level indicated
that clones which lysed autologous cells could not be generated and also that in a
given individual, NK cells were heterogeneous, since only a proportion of clones
could lyse normal target cells derived from any given donor (Ciconne et al., 1990b;
Suzuki et al., 1990). Large numbers ofNK cell clones (CD3~) from one donor were
assessed for their ability to lyse a panel of target cells derived from a range of
allogeneic donors. This study revealed the existence of four groups of alloreactive
clones, within which a homogeneous pattern of cytotoxic activity was found
(Ciccone et al., 1992). More than 60% of the clones did not lyse any of the target
cells tested which may indicate that a wider repertoire may exist. It may also be that
not all NK cells will recognize allogeneic cells. It is conceivable that the NK cell
repertoire may be somewhat limited in comparison to that of T or B cells.
A bank of target cells were derived from various members of different families. It
was found that the resistance to killing by NK cells was dominantly inherited by
target cells and co-segregated with the MHC class I region (Ciconne et al., 1990a)
which suggested that a particularMHC class I allele product protects against the NK
cell clone. Further evidence in support of the protective role of MHC class I
expression by target cells includes the observations that treatment of target cells with
IFN-y, which increases the expression ofMHC class I, protects against NK cell
cytotoxicity, or that many tumors express high levels of c-myc or N-myc oncogenes,
which switch off class I MHC expression, and render cells susceptible to NK cell
lysis. This was confirmed by the transfection of human MHC class I genes into an
HLA class I negative mutant cell line which restored the NK-resistant phenotype
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(Storkus, et al., 1989). It was found that transfection with seven out of eight genes
conferred resistance to NK cell lysis. Examination of the seven proteins identified an
epitope which was accessible to perhaps a protective peptide but this groove was not
accessible to peptides in the eigth product (Garette et al., 1989; Storkus et al.,
1991). It is therefore possible that MHC I plus a protective peptide, fitting this
groove, are recognized by the NK cell, and on recognition of this structure the signal
sent to the NK cell is "no lysis" and if this structure is altered in any way the signal is
"lysis" (Moretta et al., 1992; Versteeg, 1992).
A variety of target cell types, with varying degrees of susceptibility, have been
employed to measure NK cytotoxicity. The K 562 cell line employed in the
following study was derived from a patient with chronic myeloid leukemia and is
highly sensitive to NK lysis. This line lacks both MHC class I and II antigens.
UV irradiation results in a transient suppression in immune responses to antigens
which are encountered shortly thereafter (reviewed in section 1.3), including a
number of agents where NK cell activity may play a role in immunity, for example,
viruses such as HSV (Howie et al., 1986a) or MAIDS (Brozek etal., 1992), and
also tumor antigens (Fisher and Kripke, 1977) and allografts. In vivo exposure to
UV is directly correlated to the incidence of non-melanoma skin carcinomas both in
humans and also in animal models and is also thought to be a contributory factor in
the development of malignant melanoma. It is therefore of interest that in vitro UV-
irradiation of human PBMC results in a dose dependent suppression of NK cell
activity (Elmets et al., 1987; Schacter et al., 1983; Toda etal., 1986; Weitzen and
Bonavida, 1984). In addition, there is an indication that exposure to UV in vivo may
result in suppressed NK cell activity (Hersey, 1986; Hersey et al., 1987; Hersey et
al., 1988; Vianderetal., 1984).
As discussed in Chapter 6 psoriasis is a common hyperproliferative skin
disorder in which the immune system may play a critical role. A number of UV
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based regimens, UVB phototherapy or PUVA photochemotherapy, are employed
successfully in the management of psoriasis without their effects on immunity being
known clearly. Conventional broad-band UV sources such as the Sylvania UV6 emit
wavelengths from 270 nm to 370 nm. Wavelengths less than 300 nm are highly
erythemogenic, and as with those over 315 nm, are relatively ineffective
therapeutically (Young and van der Leun, 1975; Parrish and Jaenicke, 1981).
Therefore a narrow band (311-313 nm) source was developed (Philips TLOl) (Van
Weelden and van der Leun, 1988) which is very effective in the mangement of
psoriasis (Green et al., 1988; Larko, 1989; van Weelden et al„ 1990). The relative
output spectrum of these lamps are illustrated in Fig 2.1.
In this chapter the effect of therapeutic regimens of UV6 (broad-band), TLOl (311-
313 nm) or PUVA therapy on NK cell activity in patients with psoriasis was
examined. In addition, NK cell activity was determined in a group of psoriasis
patients who were receiving coal tar therapy. A group of 4 normal individuals who
received a course of UV6 identical to that received by psoriasis patients were assessed
in a similar fashion. NK activity was measured before irradiation, after 4 weeks of
treatment and four weeks after the last irradiation. Control groups who received no
UV-irradiation had samples taken at four week intervals. The effect of UCA isomers
on NK cell activity in vitro was also determined.
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7.2. RESULTS
7.2.1. Patients and Study Design
The clinical details of the subjects examined in the following study are outlined in
Table 7.1. A total of twenty six psoriasis patients were recruited; twenty were
suffering from chronic plaque psoriasis and the other six had guttate psoriasis. Five
in group A receiving coal tar dressings, six in group B receiving broad band UVB
therapy (UV6), were attending the Department of Dermatology, Royal Infirmary
Edinburgh. The nine patients in group C receiving narrow band UVB (311-312 nm,
TLOl), and six in group D receiving PUVA were attending the Photobiology Clinic,
Ninewells Hospital, Dundee. A further two control groups were recruited in
Edinburgh. These consisted of four normal individuals who received no treatment
(group E) and four individuals who received a standard course ofUVB treatment,
identical to that given psoriatic patients attending in Edinburgh (as part of another
study), except that only their arms were exposed, while the remainder of their bodies
were draped (Group F). At each visit the severity of the psoriasis was assessed, NK
cell activity determined and phenotyping of PBMC subsets carried out. All subjects
receiving a UV-based treatment in this cohort had blood samples taken before
commencing treatment, after four weeks of treatment and four weeks after the last
irradiation. (Patients attending in Edinburgh had the same routine laboratory tests
carried out as those described in Chapter 6 and also Finn Chamber sampling of the
epidermis for UCA was carried out.) Subjects who received no UV had samples
taken on two occasions at an interval of four weeks. In group A the first sample was





















































































































































































7.2.2. Typical Results Obtained in NK Cell Assay
With few exceptions in the experiments described the standard error of the mean
(sem) of cpm for quadruplicate wells in NK cell assays was always less than 10% of
the mean cpm. The maximum release ranged from 125 760-21 500 cpm and the
spontaneous 51Cr-release was less than 30% of the maximum release. Table 7.2
shows representative data from two typical experiments carried out on one of the
group F patients (normal subjects receiving UVB) before (experiment 1) and during
UVB therapy (experiment 2). The % specific release of 51Cr was calculated as
outlined in the Materials and Methods (section 2.3.13) and this was taken as a
measure of NK activity. Despite a marked difference in the maximum and
spontaneous release in Table 7.2, the relative % specific release was of the same
order.
7.2.3. NK Activity In Normal And Psoriatic Subjects
On comparing the NK cell activity of normal subjects (11 subjects) with those of
untreated psoriasis patients (26 patients) there was no statistical difference at any E:T
(effector to target cell) ratio (unpaired t-test). The mean data are shown in Table 7.3.
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Table 7.2.
Representative Data From Two Experiments Carried Out To Determine NK Cell
Activity on a Single Patient in Group F on Two Separate Occasions 4 weeks Apart.
E cells were incubated with 51Cr-labeled K562 target cells at a range ofE:T
(effector to target) cell ratios (40:1 to 1.3:1) in quadruplicate wells for 18h. The
radioactivity released into the culture medium was measured and the specific release
induced by E cells determined.
EXPERIMENT 1 EXPERIMENT 2
E:T Mean sem % Specific Mean sem % Specific
cpm 51Cr-Release cpm 51Cr-Release
1.3 11 827 555 14.4 24 338 842 10.1
2.5 14 198 98 22.9 25 322 852 11.4
5.0 14 904 317 25.4 31758 1 375 19.5
10 17 880 258 36.0 41905 1 183 32.3
20 22 162 594 51.2 54 647 1 842 48.5
40 27 652 812 70.8 64 342 895 60.7
Spont 7 773 419 NA 16 346 1 142 NA
Max 35 863 382 NA 95 378 2 068 NA
NA: not applicable
Spont: spontaneous release of 51Cr
Max: maximum release of 51Cr
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Table 7.3.
Mean NK Cell Activity (% Specific 51Cr-release) in Normal and Untreated Psoriatic
Subjects at Different Effector : Target (E:T) cell ratios.
NORMALS * PSORIATICS **
E:T Mean NK sem Range Mean NK sem Range P
Activity Activity
40 52.2 5.4 25.9 - 70.0 61.7 3.8 33.8 -100 0.105
20 42.7 5.0 13.2 - 58.4 52.8 3.6 26.1 -95.1 0.139
10 32.8 4.8 7.1-52.0 38.9 3.8 15.4 - 76.4 0.231
5.0 21.4 3.4 5.2 - 29.9 29.8 3.7 9.7 - 89.4 0.213
2.5 15.6 2.4 3.0 - 25.2 23.2 3.5 4.2-61.0 0.200
1.3 13.2 2.4 2.3-16.1 17.2 2.8 2.0 - 45.3 0.322
* (n=ll)
** (n=26)
p: determined by unpaired Student's t test
7.2.4. Effect Of Phototherapy On NK Cell Activity In Psoriasis
Patients.
All patients showed a marked clinical improvement (to minimal residual activity) in
the severity of psoriasis irrespective of the treatment used. It should be noted that,
although all samples were collected after four weeks of therapy, in most instances
patients required six weeks of therapy to achieve complete, or almost complete,
clearance of psoriasis.
Fig 7.3 illustrates the mean NK activity before, during and after therapy in the four
psoriasis groups. Coal tar treatment (group A) had no significant effect on NK cell
activity (Fig 7.3 (a)). Patients receiving broad band UV6 treatment (group B)
showed no significant alteration in NK activity after 4 weeks of therapy. However,
there was a marked reduction in activity 4 weeks after the last treatment in five out of
the six patients (Fig 7.3 (b)), which was statistically significant for the whole group
at all E:T ratios (p = 0.046; Wilcoxon signed ranks test).
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Six patients receiving TLOl(group C) showed a marked suppression in NK cell
activity following four weeks of therapy (Fig 7.3.(c)) eg the mean value for the group
falling from 66.8 ±7.1 to 42.0 ± 6.6 at an E:T ratio of 40:1. This was statistically
significant at all E:T cell ratios (p = 0.028; Wilcoxon signed rank test). Four weeks
after the last irradiation the mean NK value for the group had recovered significantly
(eg 50.9 ± 7.0 at the 40:1 E:T ratio; p = 0.043 Wilcoxon signed rank). However, it
still remained significantly suppressed compared with the original value prior to
irradiation in 5/6 patients (p = 0.043; Wilcoxon signed ranks test). Samples were
collected from 2 of the patients a further 4 weeks later, i.e. 8 weeks after the last
irradiation. The NK activity was again increased but had still not returned to the
original level. The individual data for these two patients are outlined in Table 7.4.
Table 7.4.
The Effect Of TLOl Therapy on NKActivity In 2 Psoriasis Patients. NK activity
was assessed before therapy, following 4 weeks of therapy and subsequently four and














85.6 79.5 76.4 62.5 61.0 45.3
52.8 42.8 24.4 13.4 8.8 7.0
57.8 49.1 45.8 34.5 31.8 20.1










78.6 64.0 43.1 25.4 16.0 10.6
42.0 43.0 23.0 11.7 5.2 4.9
54.4 39.5 24.5 18.0 17.0 8.2
58.9 48.6 36.7 23.4 12.0 7.2
E:T: effector to target cell ratio
NA: not applicable
Patient 1 received a total of 17 treatments (12.91 J cm-2)
Patient 2 received a total of 18 treatments (17.67 J cm"2)
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Figure 7.3.
The Effect ofUV Therapy on NK cell activity in Patients with Psoriasis. NK activity
was determined before (r), during (A) and after (o) either broad band UV6 (b),
narrow band TL01 (c) or PUVA (d) therapy. Patients receiving coal tar dressings
had samples taken on two occasions, before (b) and during (A) treatment (a). The
graphs represent the mean of5 patients in (a) and 6 patients in (b) - (d). The sem
shown for each group prior to treatment was approximately the same on subsequent
















































A further three patients were recruited into this group, but the results were not as
clear cut with these patients, as illustrated in Table 7.5.
Table 7.5.
The Effect OfTLOl Therapy In Three Psoriasis Patients Who DidNot Show














48.7 3.5 18.5 7.9 4.2 2.0
65.6 51.6 35.8 23.7 16.1 12.8
56.8 43.1 38.9 27.6 15.4 14.2










59.7 56.0 33.6 17.1 10.7 5.0
64.4 52.6 42.2 27.3 18.6 12.1









42.4 44.1 30.2 16.8 10.9 8.4
54.5 39.3 30.7 17.2 12.4 8.2
63.5 52.6 52.9 41.8 25.0 20.0
1 at four weeks of TLOl therapy
2 at six weeks ofTLOl therapy
E:T: effector to target cell ratio
NA: not applicable
It should be noted that patients 7-9 had all their samples taken and analysed on the
same day at each sample point. All three of these patients were suffering from
guttate psoriasis which was relatively mild in comparison to the other patients in the
study. Following 4 weeks of therapy there was no suppression in NK cell activity,
in fact it tended to increase. It was possible that these patients simply had not
received sufficiently high doses ofUV to induce suppression. All three patients had
received less than the mean dose of 8.0 J cm"2 UV received by the other six patients
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in this group, and therefore a further sample was taken from patient 7 and 8 two
weeks later when the patients had received six weeks of therapy. (Patient 9's skin
was completely clear following four weeks of treatment and therefore the NK activity
determined at four weeks of therapy was this subject's last treatment). As illustrated
in Table 7.5, both patients exhibited a reduced NK cell activity compared to the four
week sample point, but this was still not suppressed compared with the starting value
in patient 7. The final sample taken four weeks after the last treatment revealed an
enhanced NK cell activity compared with the original value assessed before the
therapy had commenced. Patient 8 had failed to attend a number of treatments in the
first four weeks of the therapy and therefore had a reduced number of exposures, and
subsequently a lower total irradiation dose. This patient also failed to attend on two
subsequent dates following the last treatment and therefore no further samples were
obtained. It should also be noted that at the first sample point during therapy no
significant improvement in the severity of the patient's psoriasis was observed.
Following four weeks of PUVA therapy, all six patients exhibited a marked
reduction in NK cell activity eg the mean NK cell activity for the group at the 40:1
E:T fell from 76.4 ±6.1 to 51.6 ± 8.0 (Fig 7.3.(d)). This was statistically significant
at all E:T cell ratios but more so at E:T ratios < 40:1 (p = 0.046 at 40:1 and p = 0.028
at E:T cell ratios < 40:1; Wilcoxon sign ranks test). Four weeks after the last
treatment the activity had recovered significantly (p= 0.028 at E:T ratios <40:1;
Wilcoxon sign ranks test) but remained significantly suppressed relative to the
original value at E:T ratios less than 40:1 (p = 0.028; Wilcoxon sign ranks test).
Three patients had their NK cell activity assessed four weeks later when they had
almost returned to normal (Table 7.6).
169
Table 7.6.
The Effect ofPUVA Therapy on NKActivity In 3 Psoriasis Patients. NK activity was
assessed before therapy, following 4 weeks of therapy and subsequently 4 and 8














57.8 50.0 31.3 24.8 10.7 7.8
29.7 23.3 12.3 6.5 0 0
46.2 34.0 24.7 13.4 7.1 4.8










67.6 46.8 28.8 20.1 18.1 18.5
32.0 29.3 3.2 2.7 0.7 0
41.9 33.4 24.0 19.7 15.3 10.6










69.0 64.6 42.3 27.1 17.7 9.5
71.4 40.1 27.0 8.0 8.0 6.4
56.2 49.4 37.1 21.7 14.8 12.3
71.4 66.6 46.8 38.9 17.7 9.8
E:T: effector to target cell ratio
NA: not applicable
Patient 1 received a total of 19 treatments (166.12 J cm-2)
Patient 2 received a total of 13 treatments (71.30 J cm2)
Patient 3 received a total of 19 treatments (166.12 J cm2)
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7.2.5 Effect of UVB Phototherapy on NK cell Activity in
Normal Subjects
Four normal subjects received a course ofUY6 phototherapy identical to that received
by psoriasis patients attending in Edinburgh, exposing only their arms. Control
subjects were normal individuals who received no UV-irradiation. NK activity was
assessed in the same manner in this group as for group A and B; psoriasis patients
receiving UV6 or coal tar therapy in Edinburgh respectively. Fig 7.4. illustrates that
the data for the non-psoriatic group were similar to those of the psoriasis patients.
Four weeks of UV6 treatment had little or no effect on NK cell activity. However
four weeks after the last irradiation the NK cell activity was suppressed in three out of




The Effect ofUV6 Treatment on NK Cell Activity in Normal Subjects. 4 control
subjects, receiving no treatment, had samples taken on two occasions at time 0 (p)
andfour weeks later (A), Fig (a). 4 subjects received a standard course ofUV6
treatment. NK activity was determined before (b), during (A) and after (o)
treatment; Fig (b). The figures represent the mean value for each group, the sem











































PBMC were stained with the same monoclonal antibodies employed in Chapter 6
which were directed against CD la, CD3, CD4, CD8, CD57 and MHC class II. No
significant alteration in any of the markers occurred as a result of therapy (Table 6.3),
including patients receiving TLOl therapy (data not shown).
In addition to these antibodies, a further two monoclonal markers directed against
CD 16 and CD56 were employed to determine the number of NK cells present in three
of the TLOl patients and four of the PUVA patients. An irrelevant antibody was
used to determine the background non-specific staining, which was approximately
1.1% of the total histogram (Fig 7.5 (b)).
Data were originally collected on a two parameter histogram measuring forward angle
light and 90° light scatter (Fig 7.5 (a)). Bit maps were drawn around both the
lymphocyte (H3) and monocyte/LGL (H4) populations and the percentage of cells
exhibiting fluorescent levels higher than the background were recorded for these
populations independently as well as the for the total cell population (H2). The
pattern of staining for patient 3 (Table7.7) in the the TLOl patient group with the
CD 56 antibody before and during therapy are shown in Fig 7.5 (c) - (f). The
percentage of cells stained with CD16 and CD56 for each patient are shown in Table
7.7. TLOl and PUVA treatment resulted in a reduced number of CD56+ cells in the
H4 histogram (which contains the LGLs) and a corresponding drop in the H2
histogram. The reduced number of large granular cells expressing CD56
corresponded well with reduced NK cell activity, with the exception of patient 3 in
the TLOl group (Table 7.7). The three PUVA patients also displayed an increase in
the number of cells expressing the CD 16 marker when examining the H4 histogram.
This was not observed with the TLOl patients.
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Figure 7.5
Fluorescent Flow Cytometry Analysis ofPBMCfrom Patient 3 in the TLOl Group
Stained with the anti-CD56 Antibody. Data were originally collected on a two
parameter histogram measuring forward angle light and 90'light scatter (Fig 7.5 (af
Bit maps were drawn around both the lymphocyte (H3) andmonocytelLGL (H4)
populations and the percentage ofcells exhibiting fluorescent levels higher than the
background were recordedfor these populations independently as well as thefor the
total cellpopulation (H2). An irrelevant antibody was used to determine the
background non-specific staining, which was approximately 1.1% of the total
histogram (Fig 75 (b); cell number Y axis, plotted against log fluoresced axis.
Fig (c)-(f) show the cell number plotted against log fluorescence; (c) and (d)
represent the pattern ofstaining before and during therapy in the H2 histogram and
















The Effect ofTLOl (Group D) or PUVA (Group C) Therapy on Circulating NK Cells
Assessed by Flow Cytometry. The % ofCD56 and CD16 cells was determined
before, during and after therapy. The H2 histogram contains all PBMC while the
CD56 CD16 % NK Cell
H2 H4 H2 H4 Activity*
GROUPD
Patient 1
Before 13.4 49.9 44.7 72.0 79.5
During 3.5 7.8 34.9 64.4 42.8
After 32.7 57.1 17.8 24.9 49.1
Patient 3
Before 30.0 88.1 21.1 43.2 70.5
During 14.7 31.5 24.2 45.6 47.7
After 12.0 18.9 13.0 13.4 63.7
Patient 5
Before ND ND ND ND 28.6
During 5.2 8.3 12.64 ND 5.1
After 9.3 62.7 21.4 ND 31.0
GROUPC
Patient 2
Before ND ND ND ND 46.8
During 20.6 33.3 13.5 ND 29.3
After 34.8 78.7 17.3 19.5 33.4
Patient 3
Before 15.0 79.5 13.3 14.5 73.8
During 5.2 25.0 17.9 29.3 27.6
After 16.7 55.6 8.9 11.9 30.0
Patient 4
Before 12.0 83.4 18.7 18.5 75.6
During 13.3 33.3 30.5 52.8 41.3
After 20.2 66.7 8.6 14.7 86.2
Patient 5
Before 13.2 84.0 34.1 33.6 95.1
During 6.4 26.2 36.1 57.4 76.6
After 28.6 88.0 ! 28.3 35.6 86.6
*NK activity at E:T ratio of 20:1
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7.2.7 The Effect of in vitro UV-Irradiation of PBMC on NK Cell
Activity.
The results in section 7.2.4.-7.2.5. demonstrated that four weeks of both PUVA and
TLOl, but not UV6 therapy resulted in a significant modulation of NK activity and
possibly the numbers of circulating NK cells. However it was impossible to say
definitively whether this was a dose dependent or a wavelength dependent
phenomenon. The aim of the following experiments was to compare the effect of in
vitro irradiation of PBMC with different wavelengths ofUV on NK cell activity to
determine whether any effects observed were wavelength dependent.
In a preliminary experiment, PBMC were isolated from a normal healthy donor,
washed and resuspended in PBS with no indicator. Monolayers of the cells (106 cells
per well of a flat bottomed 96 well plate) were then irradiated with increasing doses
of UVB from a single TLOl lamp in vitro as outlined in section 2.3.14. Cell
viability remained between 95-100%, as determined by trypan blue exclusion,
following irradiation. The ability of these cells to lyse labelled K562 cells at an E:T
cell ratio of 40:1 and 20:1 was subsequently quantified. The results of this
experiment are illustrated in Fig 7.6. Irradiation of PBMC with UVB of 311-313 nm
resulted in a dose dependent suppression of NK cell activity.
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Figure 7.6.
The Effect of in vitro Irradiation ofPBMC With Narrow Band TL01 (311-312 nm) on
NK Cell Activity. PBMCs were irradiated with increasing doses ofTLOl andNK
activity measured at E:T ratios of40:1 ft) or 20:1 (o).
UY Dose (mj cm 2)
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The effect of irradiation with monochromatic UV radiation ranging from 270-360 nm
was examined. This experiment was carried out twice with PBMC isolated from two
healthy donors on each occasion. The results obtained in one experiment, treating
cells with either 50 or 100 mJ cnr2 ofmonochromatic UV, are outlined below.
Similar results were obtained with PBMC from the other donors. The NK cell
activities measured at each wavelength over a range of E:T cell ratios are shown in
Fig 7.7.
The percent residual NK activity following irradiation (percentage NK activity of
irradiated cells expressed as a percentage of the activity of unirradiated cells) for this
subject at E:T cell ratios of 40:1 and 20:1 are illustrated in Fig 7.8; the results at the
lower E:T ratios were similar. It can be concluded from Fig 7.7 and Fig 7.8 that the
lower UV wavelengths, below 310 nm in this instance are the most potent at
suppressing NK cell activity in vitro, and lOOmJ cm-2 of a given wavelength did not
appear to induce a significantly greater suppression in NK cell activity than 50 mJ
cm-2.
To determine whether the suppressive effect of UV-irradiation was specific for NK
cells, UV irradiated PBMC from two subjects were cultured for three days in the
presence of 5 |ig ml"1 of Con A, a T cell mitogen, and the control cells without
Con A. The cultures were pulsed with 3H-thymidine during the final 24 h of culture
and the uptake determined. The stimulation indices were calculated and the results
from donor three are outlined in Fig 7.9.
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Figure 7.7.
The Effect ofMonochromatic UV-Irradiation ofPBMCs on NK Cell Activity. PBMC
were irradiated with (a) 50 mJ cm'2 or (b) 100 mJ cm'2 ofmonochromatic UV
























































ResidualNK Cell Activity Following Irradiation With (a) 50 mJ cm'2 or (b) 100 mJ
cm'2 ofMonochromatic UV. The residual NK cell activity is shown at E:T cell ratios






The Effect ofMonochromatic UVR on in vitro LPR to Con A. PBMC were irradiated
with 50 (□) or 100 (H ) mJ cm~2 ofmonochromatic light and the uptake of3H-
thymidine determined over the final 24h ofa three days culture with nil or 5 pg ml'1
Con A. The stimulation indices (SI) for one subject at each wavelength are
illustrated below.
0 111 fill 1,1 111 1,1 I 1,1 I 1,1 i—I— t
0 360 350 330 320 310 300 290 270
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183
7.2.8 The Effect of UCA isomers on NK Cell Activity in vitro
The results outlined previously in this chapter demonstrated that UVR in vitro and
also in vivo resulted in suppression of NK cell activity. The following series of
experiments was undertaken to determine the effects ofUCA, a proposed mediator of
UV-induced immunosuppression, on NK cell activity in vitro. It was important to
establish that incubation of labelled target cells with UCA isomers had no effect on
the background release of 51Cr from the cells. The concentrations of UCA isomers
employed were relatively high, up to 10"2 M cis-UCA, and therefore it was also
necessary to also establish that any suppression in NK cell activity was not due to
toxicity. This was determined by trypan blue exclusion. The LPR to Con A and
HSV were also measured to test whether any suppression was specific to NK cell
activity.
Serial tenfold dilutions of cis (10_1M to 10~8 M) or trans (10"2 to 10"8) UCA in PBS
were prepared. Ten pi of the appropriate concentration of UCA were added to 0.5 ml
of E cells. The cells were then added to wells of 96 well plate and approximately 15
minutes later, labelled target cells were added at an E:T cell ratio of 40:1. This
resulted in a final concentration of 10"3M to 10"10 M cis or 10~4 M to 10~10 M trans
-UCA when the target cells were added. One hundred pi of 10"1 M cis- or 10"2 M
trans-UCA were added to 0.4 ml of cells, containing the same number of cells as 0.5
ml above, resulting in the final concentrations of 10~2 and 10"3 M respectively.
The percentage suppression in NK cell activity induced by cis-UCA was determined
over a range of concentrations for 12 subjects; seven normal individuals and five
untreated psoriasis patients. UCA-isomers had the same effect on PBMC from
psoriatic or normal subjects and therefore Fig 7.10. represents the mean (± sem)
suppression in NK activity of groups of six to eleven of these individuals . The
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effect of trans-UCA was determined in four normal subjects in the same fashion (Fig
7.10.).
Figure 7.10.
The Effect of (a) cis-JJCA or (b) trans-UCA on NK Cell Activity in vitro. Graph (a)
represents the mean ±sem of6-11 subjects and (b) represents the mean ±sem for
four subjects. *p<0.05 and **p<0.01 compared with the mean of the same
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Treatment with ris-UCA resulted in a dose dependent suppression of NK cell activity
which was statistically significant at the higher concentrations of 10"2M to 1(H M
(p < 0.05 at 10'2 and 10"4and p < 0.01 at 10~3 M: paired t-test). Trans-UCA was
slightly suppressive at higher concentrations but this was minimal in comparison to
cis-UCA, and was not statistically significant.
To test that the addition of UCA-isomers during the incubation of E and target cells
did not effect the spontaneous release of 51Cr from the target cells on four separate
occasions, one hundred p.1 of medium containing the appropriate concentration of
UCA isomer was added to ten wells containing the labelled targets, resulting in a
final concentration of 10"2 M to Kh10 M. The cells were incubated for 18 h and the
supernatant assayed for 51Cr. Control cultures of PBMC with or without UCA
isomers were added to labeled target cells in parallel to confirm that the target cells
were lysed as normal. The result from one experiment is shown in Fig 7.11. E cells
induced normal target cell lysis and incubation of target cells with UCA isomers
caused no significant alteration in the background release of 51Cr.
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Figure 7.11
The Effect of UCA-isomers on Spontaneous 5^Cr-Release from Target Cells.
Labeled target cells were culturedfor 18h with medium containing cis (E2) or trans
(H) UCA from 10'2 and 10M (respectively) to 10~10 M. The mean cpm ±sem of
SlCr-released into the medium at each concentration from one experiment are shown.










Cis-UCA at relatively high doses resulted in suppression ofNK cell activity. To
determine whether this was merely a toxic effect on E cells they were incubated with
UCA isomers and the number of viable E cells present determined by trypan blue
exclusion. Viability was between 90-100%. The cells were also stained overnight
with propidium iodide and the number of cells in the S + G2M stage of division
quantitated by flow cytometry using the S-fit DNA analysis programe (Coulter
Electronics Ltd, Luton, UK). Fig 7.12. illustrates the typical staining pattern.
There was no difference in the number of dividing cells (Table 7.8.). Therefore
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Fig 7.12
Propidium Iodide Staining. Fig (a) represents PBMC culturedfor 18h with no UCA
and Fig (b) represents cells incubated with 10'3M cis-UCA













The Effect ofUCA Isomers on The Percentage ofCells InS + GfM Determined by
Propidium Iodide Staining and Annalysis by Flow Cytometry.







neither cis- or trans-UCA, even at relatively high concentrations, were lethal to the
cells.
Having established that neither UCA isomer was toxic to the cells the next aim was to
determine whether UCA affected the function of cell populations other than NK cells.
The effect of UCA on lymphoproliferation was examined. UCA isomers, in similar
concentrations to those used in the NK assay, were added to quintuplicate wells of
PBMC along with sub-optimal concentrations of Con A (1.5 fig ml-1) or HSV
antigen (0.1 pfu cell"1) and the effect on proliferation determined. The experiment
was carried out on two separate occasions using PBMC from two normal healthy
donors known to be HSV carriers. It was found on both occasions that neither UCA
isomer produced any consistent, or dose dependent effect on the number of cells
taking up 3H-thymidine. (The results of one such experiment are shown in Table
7.9.) This again suggests that the in vitro dose dependent suppression ofNK cell
activity by cis-UCA is not merely a toxic effect, and appears to be specific to the
function of NK cells.
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Table 7.9.
The Effect OfUCA homers on Lymphoproliferative Responses to Sub-optimal
Concentrations ofCon A or HSV. The sem ofcpmfor quintuplicate wells was always
less than 10% of the mean
Con A HSV
Concentration cpm SI cpm SI
(-Log M)
Nil 9023 14.5 12 998 4.3
Trans-UCA
14 8 172 13.1 10 458 3.5
12 8 205 13.1 11 750 3.9
10 8 606 13.9 11 184 3.7
8 7 041 11.3 11 328 3.8
6 7 960 12.8 8 623 2.9
4 7 351 11.8 10 665 3.6
Cis-UCA
14 7 824 12.5 13 206 4.4
12 7 572 12.1 10 528 3.5
10 7 512 12.0 10 457 3.5
8 7 278 11.7 10 459 3.5
6 3 098 5.0 10 038 3.3
4 8 960 14.4 10 007 3.3
'"Jo Con A, cpm == 624
Vera control antigen, cpm = 2 999
From the results outlined it appears that cis-UCA selectively affects NK cell activity.
UCA was added to both the E and target cells for the duration of the assay and
therefore it was impossible to establish whether it was the effector or target cells
which were directly affected by UCA. It is possible that UCA may alter the target
cells resulting in resistance to NK cell lysis. On three occasions 51Cr-labelled target
cells were cultured for 30 min at 37°C with 0, 10~9, 10~6 or 10"3 M cis-\JCA. The
cells were washed three times in PBS and their susceptibility to lysis by PBMC at an
E:T cell ratio of 40:1 tested. The results from one such experiment are outlined in
Table 7.10.
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Pulsing target cells with cis-UCA for 30 min had no significant effect on their
susceptibility to NK cell mediated lysis. A similar experiment was conducted
pulsing the E cells rather than target cells with cis-UCA. PBMC pulsed with 0, 10"3,
10"6 and 10"9 M cis-UCA produced 37.1, 35.9, 43.0 and 35.8 % specific cytotoxicity
repectively when assayed. Therefore no significant effect on NK cell activity was
observed when E or target cells were pulsed with cis-UCA.
Table 7.10
The Effect ofPulsing 51Cr-Labelled K562 cells with cis-UCA on their Susceptibility
to NK cell Mediated Lysis
51Cr-release






Nil 4 366 21 614 12 106 47.6
9 4 307 19 665 12 157 51.1
6 5 595 21 251 13 869 52.8
3 4 383 20 817 13 231 53.8
7.2.9 The Effect of Histamine on NK cell Activity in vitro
As outlined in Chapter 3, UCA isomers appear to act through histamine-like
receptors. As cis-UCA produces a dose dependent suppression of NK cell activity in
vitro it was therefore of interest to determine whether (a) histamine had any effect on
NK cell activity in vitro, and (b) whether histamine receptors were involved in the
cfs-UCA induced suppression. Several preliminary experiments were carried out to
investigate this possibility.
Addition of histamine to NK assays, using the same protocol as that employed to
examine the effects of UCA on NK cell activity, produced highly variable results.
This experiment was carried out using PBMC from four healthy donors. Any
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suppression observed was minimal and was not always dose dependent. The mean
results are illustrated in Table 7.11. Histamine had no effect on the spontaneous or
maximum 51Cr-release either.
Table 7.11.
The Effect ofHistamine on NK Cell Activity in vitro.
Concentration Number of % Suppression NK sem
(-Log M) Subjects Cell Activity
6 3 19.9 11.3
5 3 12.4 10.2
4 4 11.2 2.3
3 2 30.2 5.5
The effect of histamine on LPR to sub-optimal concentrations of Con A and HSV was
also examined in two of the subjects, known to be seropositive for HSV, in exactly
the same way as UCA in section 7.2.6. The results from one such experiment are
shown inTable 7.12. As found with UCA, no significant (p > 0.05; Student's t test),
or dose dependent suppression in LPR to either Con A or HSV was observed.
Table 7.12.
The Effect Of Histamine on Lymphoproliferative Responses to Sub-optimal
Concentrations ofCon A or HSV. The sem ofcpm for quintuplicate wells was always






14 8 566 13.7 13 146 4.4
12 8 298 13.3 12 423 4.1
10 8 967 14.4 14 222 4.7
8 9 213 14.8 8 971 3.0
6 6 585 10.6 11 839 3.9
4 7 788 12.5 12 278 4.1
No Con A, cpm = 624
Vero Control Antigen, cpm = 2 999
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The possibility remained that c/j-UCA might act upon NK cells through a histamine-
like receptor. Therefore the possibility to blocking the effects of cA-UCA by the
addition of either an HI, H2 or H3 antagonist to the NK assay was tested. PBMC
were pre-incubated for 30 min at 37°C with the antagonist before adding m-UCA and
the labelled target cells. Both the antagonist and UCA were present for the duration
of the assay. Terfenadine (HI antagonist) alone (10*4 M) was toxic to K562 cells,
resulting in 83.1% release of 51Cr, with no PBMC present. Thioperamide (highly
specific H3 antagonist, Arrang et al., 1987) had no effect on the spontaneous 51Cr-
release by the K562 (data not shown), but suppressed NK cell activity at higher
concentrations (Table 7.13.). (R)-a-methylhistamine (H3 agonist, Arrang et al.,
1987) had no effect on spontaneous 51Cr-release (data not shown), it also suppressed
NK cell activity (Table 7.13.). Since these compounds appear to inhibit NK cell
activity directly they were not suitable for use in competion assays with UCA.
Table 7.13.
The Effect ofThioperamide (H3 antagonist) and (R)-a-methylhistamine (H3 agonist)
on NK Cell activity in vitro
Concentration % Specific Cytotoxicity












7.3.1. The Effect of UVR on NK Cell Function in vivo
Suppressed NK cell activity has been reported in patients with generalized pustular
psoriasis (von Zunbusch type) and to a lesser degree, psoriasis vulgaris (Kaminski et
al„ 1984). On the other hand Hunyadi et al., (1981) also reported normal NK cell
activity in a group of patients with psoriasis vulgaris. In the present study no
statistically significant difference in NK cell activity was observed in twenty patients
with chronic plaque psoriasis, and six patients with guttate psoriasis, compared with
eleven normal healthy individuals.
Three highly effective therapeutic UV-based regimens used in the management of
psoriasis resulted in significant suppression ofNK cell activity. In addition, in vitro
treatment with cis-, but not trans-UCA, resulted in a dose dependent suppression in
NK cell activity.
All patients showed a marked clinical improvement in the severity of psoriasis
irrespective of the treatment employed. However only subjects receiving UV-based
treatments exhibited any suppression in NK cell activity (Fig 7.3. and 7.4.). This
suggested that the modulation in NK activity resulted from UV-exposure and not
merely as a consequence of an improvement in psoriasis.
All six patients receiving PUVA therapy exhibited a marked suppression in NK cell
activity as did the majority of patients receiving TLOl treatment (Fig 7.3(d) and (c)
respectively). Three patients in the TLOl group did not follow the pattern displayed
by the other subjects in this group (Table 7.5.). All three had guttate psoriasis which
was relatively mild in comparison to the other patients in the study, which may have
been an important factor. In addition it was possible that those patients had not
received a sufficiently high dose ofUV to induce suppression of NK activity.
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Therefore two of the patients had samples taken on the last day of their treatment,
after six weeks of therapy. The third patient had only four weeks of treatment. UV
therapy is given in incremental doses and therefore the total dose was considerably
greater than that received following four weeks of treatment (Table 7.5.). The NK
activity at the six week sample point was significantly suppressed compared with that
at the four weeks in both subjects, but not compared to the value obtained prior to
treatment. It is tempting to speculate that there was something odd about the NK
assay prior to treatment which yielded low NK values for these subjects. It has also
been suggested that humans, as well as animals have a genetic predisposition to UV-
induced immunosuppresion (Yoshikawa and Streilein, 1990), and it is possible that
these subjects are UV-resistant. However the samples taken from patients 7 and 8
after four and six weeks of therapy suggested the effects on UV-induced suppression
ofNK cell activity was dose dependent.
Follow up samples taken from the TLOl and PUVA groups four weeks after the last
treatment revealed that the NK activity had not returned to normal. Therefore
samples were obtained from two of the TLOl and three of the PUVA patients four
weeks later. Eight weeks post-irradiation both, TLOl patients displayed a marked
increase in NK activity compared with the previous sample point. However, it had
not yet been completely restored to the original value. Similarly, two of the three
PUVA patients still had slightly suppressed NK cell activities relative to the starting
value.
7.3.2 UV-induced Immunosuppression ofNK Cell Activity May
Be Dependent on the Dose or Wavelength of Irradiation
A dose dependent suppression in NK cell activity following solarium exposure was
reported by Hersey (1986). Normal subjects were exposed to 30 min of solarium
radiation (approximately 1 MED) on two, six and twelve consecutive days. At least
six consecutive days exposure was required to induce suppression of NK activity,
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and the suppression was more pronounced following twelve days. Follow up
samples were taken up to twenty one days after the last irradiation. The NK activity
of the subjects who had received twelve whole body exposures remained suppressed
at this time point. Subjects who only received UV on their back exhibited no
significant suppression in NK cell activity.
One previous study (Viander et al., 1984) looked at the effects of PUVA therapy on
NK cell activity in a group of patients with a number of skin disorders, 50% of whom
had psoriasis vulgaris. A diminution in NK cell activity was observed during PUVA
therapy however this tended to return to normal at the higher E:T cell ratios if the
therapy was continued beyond 25 irradiations.
Given that UV-induced suppression of NK activity is possibly dose dependent and
that the recovery time could be up to eight weeks, it was of interest in the present
study to find that both psoriasis patients and normal subjects receiving broad band
UVB (UV6) treatment exhibited no significant modulation in NK cell activity
following four weeks of therapy but did four weeks after completion of the six week
course (Fig 7.3(b) and 7.4(b) respectively). It is therefore possible that a dose
sufficient to induce NK cell suppression had not been received following four weeks
of treatment but had after six weeks especially since the patients received incremental
doses. The TLOl and UVA sources do not emit the highly erythemogenic
wavelengths (less than 300 nm) and therefore patients treated with them receive
higher doses of UV in a shorter period of time than those receiving the broad band
UVB. For example the mean cumulative UV6 dose in psoriasis patients following
four weeks of therapy in this study was 1.8 J cm-2 compared with 8.0 J cm-2 of TLOl
or 21.6 J cm-2 of UVA. It is therefore possible that the dose ofUV required to
suppress NK cell activity in vivo was only attained following five or six weeks of
UV6 exposure. Furthermore this is suggested by the results from group F (normal
subjects undergoing broad band UVB irradiation of their arms only) as, although a
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reduction in NK cell activity was recorded in most individuals four weeks after the
last irradiation, it did not reach statistical significance.
Suppression in NK activity following UVR in vivo was more marked when the
melanoma target cell line MM200 was employed in the studies of Hersey (Hersey,
1986; Hersey et al., 1987), in comparison with the K562 cell line (used in this
study). It would be of interest to test the NK activity of patients following four
weeks of UV6 therapy against the MM200 cell line.
In addition to the total dose ofUV received, it is possible that the incident
wavelengths are also of significance in producing suppression of NK cell function.
In this respect Hersey et al. (1983a) reported that twelve one hour exposures of
sunlight exposure, in a two week period, had only minimal effects on NK cell
activity. Further studies by this group revealed that two weeks irradiation of healthy
volunteers with solarium lamps resulted in suppression ofNK cell activity (Hersey, et
al., 1983b). The proportion of UVA to UVB emitted by solarium lamps is higher
than that of natural sunlight. It is estimated that subjects exposed to solarium lamps
receive approximately three times more UVA than those exposed to natural sunlight
(Hersey, et al., 1983a). Solarium exposure remained suppressive even if subjects
applied a sunscreen which blocked UVB (Hersey et al., 1987) or if Mylar sheeting,
which inhibits the transmission of 99% ofUV with a wavelength below 315-317 nm,
was placed between the source and the subject (Hersey et al., 1988). Hence it was
hypothesized that wavelengths in the UVA range (320-400 nm) were solely
responsible for the observed suppression in NK cell activity. It is possible that this is
a direct effect since UVA radiation can penetrate the epidermis and reach the dermis,
where in theory it may directly affect NK cells as they circulate through the
capillaries of the skin.
However, the TLOl source used in this study, which emits narrow-band UV (311-
313 nm), also resulted in significant suppression ofNK cell activity. Therefore, it is
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not only UVA which is responsible for the suppression. Indeed, in vitro, it is the
shorter UV wavelengths which cause maximum suppression in NK cell activity (Figs
7.7. and 7.8.; Schacter et al., 1983). In vivo a balance between the longer
wavelengths which penetrate the epidermis but are relatively inefficient at
suppressing NK activity and the relatively non-penetrating shorter wavelengths which
suppress NK cell activity may exist. In vitro irradiation of PBMC with shorter
wavelengths of UV results in suppressed LPRs as well as NK cell activity (Fig. 7.9.;
Schacter et al., 1983) and therefore if UV acts directly on NK cells as they pass
through the skin T cell activity may also be affected. Unfortunately LPR were not
assayed in PUVA or TLOl patients in this study. However the patients receiving
UV6 or PUVA therapy in Chapter 6 exhibited no significant alteration in LPR to the
mitogen Con A or HSV antigen. This may indicate that the effect of UV-irradiation
on NK cells in vivo is not a direct effect on cells circulating through the skin.
It would be of interest to test the dose dependency theory by taking samples more
frequently from the patients receiving TLOl or PUVA therapy during the first four
weeks of therapy and also to obtain samples from subjects receiving UV6 treatment
during the final stages of treatment. TLOl and PUVA patients were recruited in
Dundee and therefore this was not practical and unfortunately time did not permit a
second cohort of UV patients to be recruited.
7.3.3 Possible Mechanisms of UV-Induced Suppression of NK
Cell Activity
The suppression in NK cell activity took at least four to eight weeks to recover in this
study. Others have reported that the suppression is still detectable at 14 (Hersey, et
al., 1988) or 21 days (Hersey, 1986). This may suggest that UV-irradiation induces
permanent functional damage to circulating cells.
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Alternatively, it is possible that a soluble mediator is released from epidermal cells on
UV-irradiation, which enters the circulation and results in suppressed NK cell mediated
cytotoxicity. Kim etal., (1990) and Brodie and Halliday (1991) have both reported
soluble suppressive factors produced in mice on UV irradiation, which are potential
candidates. C/s-UCA is another possible candidate. As discussed in Chapter 6 it is
not confined to the stratum-corneum and elevated levels persisted for four weeks
following irradiation in suction blister fluid. PGs, which are produced on UV
irradiation have also been shown to inhibit human NK cell activity (Koren and Leung,
1983). Epidermal cells release a factor which augments NK cell activity in vitro , EC-
derived NK cell activity-augmenting factor (ENKAF) (Luger et ai, 1985), thought to
be IL-6. UVR has been shown to increases the expression of IL-6 which enhances
NK cell activity. It would be of interest to examine whether increased IL-6 is found
sytemically following UVR and how long it persists if so. The effect of UVR on the
production of other cytokines may be of relevance. IL-2 and IFN-y are both potent
NK cell augmenting factors. In mice, Th-1 cells are characterized by their ability to
produce 11-2 and IFN-y, whereas Th-2 cells produce IL-4. In murine models there is
very good evidence to support the selective stimulation of Th-2 in preference to Th-1
cells following UVR (Araneo, etal., 1989, Cruz and Bergstresser, 1991) and
preferential induction of Th-2 cells could lead to a reduction in the production of IL-2
and IFN-y by activated T cells. II-1 production is elevated following UVR in both
mice (Gahring, etal., 1984) and humans (Granstein and Sauder, 1987; Oxholm, et
al, 1988), and has been implicated in UVR-induced changes in immune responses
(Robertson, et al 1987; Krutmann et al, 1990). Araneo et al., (1989) also found
that administration of recombinant IL-1 (3 facilitated a similar change in cytokine
production to UVR. Therefore, it is possible that such a switch in cytokine
production following UVR may have implications for NK cell maturation or activity.
It would certainly be of interest to examine the cytokine production profile from
epidermal cells and stimulated peripheral blood T cells from
m
patients receiving UV treatment. It is possible that one or a combination of these
factors may be responsible for UV-induced suppression of NK cell activity.
Whether the defect in NK cell function in vivo is reversible remains unknown. It
would be of interest to see if treatment of PBMC derived from patients with
suppressed NK cell activity as a result of UVR with cytokines such as IL-2, IFN,
TNF-a would restore the NK cell activity. Culturing UVB or PUVA irradiated
PBMC with IL-2 partially reversed the suppression in NK activity of (Toda et al.,
1986). UVB or PUVA are known to induce reactive oxygen species (ROS) which
cause tissue damage; ROS produced by KC contributes to the formation of sunburn
cells. Cells treated with UVB or PUVA in the presence of superoxide dismutase
(SOD), an antioxidant which scavenges superoxide anions, were partially protected
from UV-induced suppression ofNK cell activity.
It is possible that UVR affects the expression of the adhesion molecules or receptors
involved in the binding of E and target cells, or possibly E cells and monocytes
which may regulate NK cell activity. However the suppression ofNK cell activity
induced by in vitro irradiation of human PBMCs occurs at the post binding stage
(Elmets et al., 1987; Weitzen and Bonavida, 1984). It would be interesting to
determine whether the suppressive effect ofUV on NK cell function in vivo also
occurs at the post-binding stage. The number of E and target cell conjugates formed
before and during irradiation could be determined using fixed numbers of PBMC and
target cells in a single cell binding assay as employed by Elmets et al., (1987) or by
two colour staining of E and T cells and analysis by flow cytometry (Cavarec et al.,
1990).
Hersey, et al., (1988) reported minimal changes in the number of circulating CD 16
positive cells in the whole PBMC population following solarium exposure. No
change in circulating CD57 cells was observed in this study which implies that the
total number of circulating NK cells remains unaltered. However preliminary data
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indicated that the number of LGLs expressing CD56 correlates with the measured NK
cell activity in patients receiving TLOl or PUVA therapy (Table 1.1.). CD56 is
thought to be an activation marker expressed on some NK cells (very few T cells
express this molecule) (Trinchieri, 1989). CD45 also appears to be required for NK
lytic activity and antibodies directed against CD45 block NK cell function at the post
binding stage of activity (Pawelec et al., 1985; Starling et al., 1987). It would
therefore be of interest to examine NK cell surface proteins in more depth in these
patients.
In murine models both macrophages and T cells which suppress NK cell activity
have been described (Trinchieri, 1989). Monocytes have been demonstrated to play
a regulatory role in NK cell activity in vitro in humans through a direct cell to cell
interaction (Hellstrand and Hermodsson, 1990). It has also been suggested that NK
cells themselves may also function as immunoregulators which may regulate their
own activity (D'Amore and Golub, 1985). It is therefore possible that the UV-
induced suppression of NK cell activity observed is induced indirectly by another cell
population.
7.3.4 The Effect of UCA Isomers on NK Cell Activity in vitro
Treatment with cis- but not the trans-UCA resulted in a dose dependent suppression
of NK cell activity (Fig 7.4.). However this effect was statistically significant only at
relatively high concentrations (10~2 to 10~4 M). If the effects of cis-UCA are receptor
mediated, a significant effect on NK cell activity may be expected at concentrations
less than 10"4 M. It is possible that an 18 h assay, as employed in this study, is too
long an incubation period. This time course may be sufficient to cause
desensitization of the receptor. Alternatively enrichment ofNK cells may be
required to reveal the effects of cis-UCA at lower concentrations. Trypan blue
exclusion and propidium iodide staining demonstrated that such high concentrations
of UCA did not cause cell death, and these findings were confirmed by the discovery
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that UCA isomers did not cause suppression of LPR to Con A or HSV (Table 7.9.).
Other groups have also reported that cis-UCAhas no effect on in vitro
lymphoproliferative responses (Noonan et al., 1988; Higaki et al., 1986). Despite
the apparent lack of effect on LPR it is possible that different populations of cells are
induced in the presence of UCA isomers. It would therefore be of interest to
phenotype the responding cells in the presence of each UCA isomer in comparison to
those with no UCA, and also to assay the cytokines produced by these cells.
The second messenger system(s) involved in NK cell mediated lysis ofNK cells
remains to be identified. An increase in intracellular Ca2+ is associated with NK cell
activation and this is thought to be regulated by c-AMP (Windebank et al., 1988). It
is therefore sigificant that cis-UCA,but not the isomer, results in a dose
dependent suppression of NK cell activity in vitro (Fig 7.4.), as a's-UCA has been
shown to down-regulate the induction of c-AMP by trans-UCA or histamine. It is
possible that as-UCA may down regulate the second mesenger system involved in
NK cell activation.
Another alternative is that cis-UCA does not act directly on the NK cell but does so
via another cell present in the PBMC population. As discussed earlier, monocytes
and T cells have been shown to exert suppressive effects on NK cells and enrichment
for NK cells might indicate whether as-UCA, or indeed UVR acts directly on NK
cells or if the effects are mediated by another cell population. It is impossible to say
definitively whether UCA, which is present in the culture medium throughout the
incubation, affects the target cells or the E cells. However pulsing the target cells
with UCA did not result in suppressed NK cell activity. It is possible that the timing
or temperature at which the pulsing was carried out was not optimal. The negative
result obtained in this experiment should have been complemented by the converse
experiment, i.e. pulsing the E cells, to see if this resulted in suppression ofNK cell
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activity. It is also possible that cis-UCAmust be present through out the incubation
to have an effect.
Finally, the relevance of these findings for the in vivo situation should be considered.
The concentrations of UCA employed in the in vitro assay appear to bear little
resemblance to those which might be expected physiologically. However, as
discussed previously, the conditions in the in vitro assay may not been optimal for
the suppression ofNK cell activity. Epidermal cis-UCA appears to migrate from the
epidermis to the dermo-epidermal junction where it can be detected in blister fluid.
Cw-UCA is retained in this compartment at least four weeks after UVR (Fig 6.8)
indicating that it may remain in the circulation certainly as long as NK cell activity is
suppressed. It would be possible to test the effect of UCA on NK cell activity in
vivo in a murine model. Animals could be treated with a range of doses of UCA-
isomers, including those which might be expected following UVR, epidermally and
subcutaneously as in the DTH system and the ability of LN or spleen cells to lyse an
NK susceptible target cell eg YAK cells determined. Alternatively the mice could
be treated with a monoclonal antibody which specifically recognizes UCA and not
trans- before UVR and assaying NK cell activity. In addition UCA possibly acts
through histamine receptors (discussed in Chapter 3). Matheson and Reeve, (1991)
also reported that mice treated with cimetidine (H2 receptor antagonist) had a reduced
number ofUV-induced tumours compared to untreated mice. It would therefore be
of interest to pre-treat either mice or humans with H-l or H-2 blockers before UV-





Man is exposed to greater amounts of solar UVR as world travel increases and ozone
depletion occurs. In addition, exposure to artificial UV sources such as those used
therapeutically in the management of a number of skin disorders and for cosmetic
reasons in tanning parlours, make it imperative to understand what effects this may
have biologically.
It is known that UV-irradiation results in suppression of selected immune responses.
The suppression may be local or systemic depending on the dose and wavelength of
the irradiation and the site of subsequent antigen challenge. Variation in the host
response also appears to be important as genetic susceptibility of the
immunosuppressive effects ofUVR has been documented in inbred strains of mice,
and has been suggested that such variation may also occur in man. Thus the effects
ofUV on immune responses are complex and it is difficult to distinguish initiating
events from those occurring secondarily. One result of UV-irradiation is
isomerization of the naturally occurring rrans-isomer of UCA to cis-UCA, which
mimics many of the effects ofUV on the immune responses. The mechanism of
action of UCA is not clearly understood. The approaches used in the present study
add to the current knowledge of the mechanism of cis-UCA induced
immunosuppression, and indicate directions for further studies. Much of what is
known about the effects ofUV on the immune system is derived from experimental
animals, and equivalent studies in man have been few, thus far.
The results outlined in Chapter 3 indicate that ci's-UCA may act through histamine-
like receptors. Both the histamine HI and H2 receptor antagonists abrogated the cis-
UCA-induced reduction in epidermal ATPase4" cells and also the suppression of the
DH response to HSV. Previously it had been indicated that cis-UCA may have more
than one effect; cfr-UCA applied epidermally before HSV infection induced two
subsets of T cells (L3T4+ Ly2" and L3T4 Ly2+) which suppressed the DH response
to the virus, while transfer of epidermal cells from mice skin-painted with cis-UCA
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to naive mice at the time of HSV infection induced only one subset of T suppressor
cells (L3T4+ Ly2~). Thus cis-UCA may act through two different receptors, for
example one possibly located locally in the skin (eg HI) and the other (eg H2)
systemically (as discussed in section 3.3). Alternatively there may be a distinct UCA
receptor, which cimetidine and terfenadine (H2 and HI receptor antagonists
employed in this study) partially antagonise. A key direction for future work is to
identify the cell populations which carry UCA/histamine receptors, and to distinguish
by binding studies whether UCA acts through a receptor which is distinct from a
characterized histamine receptor. To determine the cell signaling mechanism which
cis-UCA may affect would also be worthy of further study. Cis-UCA was found to
result in a dose dependent suppression of NK cell activity of human PBMC (Chapter
7) and it is therefore possible that an NK cell enriched cell population may be a
suitable source of cells for such a study.
A time course study of the DH response to HSV in immune animals revealed that the
kinetics of the responses were similar to the CH response reported by Van Lovern et A
al., (1983) (Chapter 4). However, during the CH response, the initial response
peaked two hours following antigen challenge but the primary peak during the DH
response in the present study occurred one hour after antigen challenge. The slightly
different kinetics of the response may indicate a difference between a CH and DH
response, as previously suggested (Kim et al., 1991). It may be that the immune
response to a replicating virus is different to a single exposure to a sensitizing
chemical applied epicutaneously. It would be of interest to determine if similar
kinetics of the DH response were measured if the mice were initially sensitized with
inactivated virus.
It was even more intriguing to discover that pre-treatment of the mice with c/s-UCA
or UVR, prior to the primary infection with HSV, resulted in suppression of both
phases of the elicitation of the DH response when the mice were subsequently
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challenged. Thus ds-UCA or UVB may alter the induction or subsequent activation
of the early acting DH initiating cell. It has been reported that UV-irradiated LC
induce anergic responses of Thl cells. It may be that a similar phenomenon occurs
with the DH initiating cells. In the experiments outlined in Chapter 4 the primary
infection with live HSV was subcutaneous and therefore sensitized cells would
require to migrate to the skin where they are activated locally on antigen challenge.
Alternatively cis-UCA or UVB may affect the migration of these cells to the skin
following sensitization. Further work is required to understand the mechanism of
suppression of the initiating DH response (one hour after antigen challenge in
immune animals).
It has been reported that UVR of sensitized animals results in an enhanced elicitation
of the CH response. All experiments conducted in the present study, and previously
in the laboratory, focused on the effects ofUVR and UCA-isomers on primary
immune responses. Another area for examination would be to study
immunomodulation by UVR or UCA isomers in mice which were already infected
with HSV. In humans latently infected with the HSV, sub-erythemal doses of UV
employed therapeutically had little effect on LPR or antibody responses to the virus
(Chapter 6). In addition there did not appear to be any effect on reactivation of the
virus, unlike erythemal doses ofUV which frequently cause HSV reactivation
(Spruance et al., 1991). It is possible that only erythemal doses ofUV result in
systemic suppression of CH responses in man (Cooper et al., 1992).
The results in Chapter 4 which focus on the role of TNF-a in UV or cis-UCA induced
suppression ofDH responses to HSV indicate that UCA is not the sole mediator of
UV-induced immunosuppression. Pre-treatment ofmice with neutralising
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anti-TNF-a antibodies prior to UVB irradiation blocked the subsequent suppression
ofDH responses to HSV, but had no effect on suppression induced by cis-UCA. As
discussed in Chapter 4, it is possible that the timing or dose of cA-UCA administered
does not mimic that of the production of cis-UCA following UVB in vivo. UVB-
irradiation ofmice, however, has been shown to induce DC migration from the
epidermis to the DLN but cA-UCA did not (Moodycliffe et al., 1992). TNF-a has
been shown to induce DC migration (Cumberbatch and Kimber, 1992) and a genetic
susceptibility to the effects ofUVR in mice is associated with polymorphism in the
Tnfa loci. Therefore a primary pathway of induction of immunosuppression may be
through the induction of the production of TNF-a following UVR. Cis-UCA
however does not appear to act through such a mechanism and it appears that it is
more likely to act through a histamine-like receptor. It cannot be ruled out that such
an interaction would not result in altered cytokine production by these cells and
therefore another possible area of investigation would be the effect of UCA isomers
on cytokine production, particularly TNF-a, which may resolve this debate.
As raised in Chapter 5 it would be interesting to examine the effect of UCA-isomers
on antigen presentation, particularly that of epidermal cells. These experiments
should be infinitely easier to study in mice than in man. However recently a method
to culture human LC from cord blood has been reported (Caux et al., 1992). As
phototherapy of patients with psoriasis was shown to result in the abrogation of
antigen presentation by epidermal cells, and as the percentage of cri-UCA also
increased, it is possible that cw-UCA may play a role in down regulating antigen
presentation. It would be of interest to determine the effect of in vitro treatment of
cultured LC with UCA-isomers on their APC function and cell surface marker
expression.
Phototherapy resulted in suppression of NK cell activity. NK cells play an important
role in tumour rejection and also in controlling the outcome of infection with viruses.
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It should therefore be of concern that UV efficiently suppresses their activity. Cis-
UCA suppresses the activity of human NK cells in vitro, but it would be interesting
to establish whether this interaction happens in vivo. Such experiments may be
conducted in experimental animals, by studying the effects of treatment ofmice in
vivo with UCA isomers. One other possibility would be to investigate the effect of
phototherapy on NK cell activity of subjects who were taking histamine receptor
blockers, assuming that cis-UCA acts through a histamine receptor.
Fig 8.1 illustrates a proposed model of UV-induced immunosuppression. UV-
irradiation of the epidermis is likely to have multiple effects on immune responses.
One effect may be the induction of TNF-cXwhich induces DC migration to the DLN.
This may result in altered antigen presentation by the DC, resulting in suppressed
cellular immunity. One other effect is the isomerization of UCA resulting in the
formation of the immunosuppressive cis-isomer. C/s-UCA may then act locally
resulting a reduction and possibly altered function of ATPase+ cells, as demonstrated
in section 3.2.1. Ci's-UCA may also have systemic effects. It has been
demonstrated that there is suppression of the initiation phase during the elicitation of
the DH response to HSV. The early acting initiating cell must be present at the local
site of antigen challenge and therefore cis-UCA or UVR may alter the activation or
recirculation of this population of T cells. This may be indirectly through APC or a
direct receptor mediated effect on the cells themselves. It is possible that TNF-a
and cis-UCA interact with different APC populations. It has been suggested that
monocyte/macrophages are the APC which induce sensitization of the DH initiating
cell population and monocytes may also regulate NK cell function. Therefore the
effect of cis-UCA on monocyte/macrophage function should be examined.
The results of this study have added to the elucidation of the mechanisms of UV-
induced immunosuppression. However many questions remain to be answered.
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S/pm-Cl
UROCANIC ACID JJ1AY ACT THROUGH A HISTAMINE-LIKE RECEPTOR IN THE SKIN. J. W. Gilmour*
and M. Norval , Department of Medical Microbiology, University of Edinburgh Medical
School, Edinburgh EH8 9AG, and T.J. Simpson, School of Chemistry, University of
Bristol.
Ultraviolet radiation (UV) transiently suppresses the immune response. The
putative mediator of this suppression is urocanic acid (UCA), a major constituent of
the stratum corneum, formed by a one step deamination from histidine (as is histamine).
On UV-B irradiation, isomerisation of the naturally occurring trans-isomer to the cis-
isomer takes place. Cls-UCA has been shown to mimic some of the effects of UV in
inducing suppressed immune responses. In this study we have shown that skin painting
with cis-UCA significantly reduced the number of murine epidermal ATPase+ cells, adding
to our previous finding that cls-UCA administered before herpes simplex virus (HSV)
infection suppressed the delayed hypersensitivity (DH) response to the virus in a
murine model. The effects of two histamine receptor antagonists, cimetidine (H-2
receptor antagonist) and terfenadine (H-1 receptor antagonist), on the action of cis-
UCA were then examined. When ears were painted with cls-UCA together with either
histamine receptor antagonist, no significant reduction in ATPase"1" cells was observed.
In addition, if cis-UCA was administered epidermally or subcutaneously together with
one of the histamine receptor antagonists before HSV infection, little suppression of
the DH response to the virus was observed. Thus histamine receptor antagonists
reduced or abrogated two of the suppressive effects of cls-UCA. These data therefore
suggest that cis-UCA may act through a histamine-like receptor in the skin.
S/pm-C2
UVB INDUCES SUPPRESSION OF THE EARLY INITIATING PHASE OF CONTACT HYPERSENSITIVITY TO
PICRYLCHLORIDE. Yvonne Sontag*Johan Garssen'*, Frank R, de Gruiir *, Jan C. van der Leun*, Willem A.
van Vloten*" and Henk van Loveren'*) Dept. of Dermatology, Utrecht University, Utrecht and *) RTVM, Biltho-
ven, The Netherlands.
Murine type IV reactions depend on the sequential activities of 2 different antigen(Ag)-specific T cells (H. van
Loveren et al., Lymphokines 14:405-429. 1987). The early acting T cell produces an Ag-specific, non-MHC re¬
stricted factor that mediates Ag-dependent local serotonin release from mast cells. The resulting increased vascular
permeability -measurable as a swelling 2 hrs after challenge- enables the influx of circulating, late acting Ag-specific,
MHC-restricted T cells. These "classical" To™ cells produce lymphokines that attract the 24-hr perivascular infiltrate
of non-specific inflammatory cells. Thus, the 2-hr response is an obligatory step towards the 24-hr response. The
question is whether UVB can suppress the initiating phase of Type IV reactions. In the present study the influence of
different doses of UVB radiation on the early and late phases of contact hypersensitivity (CHS) to picrylchloride (PCI)
was studied. In duplicate experiments DBA/2 mice (5 per group) were irradiated for 16 or 32 seconds (suberythemal
doses) on the shaved backs with a Kromayer UVB lamp for 4 consecutive days. Four days later mice were sensitized
on the shaved abdomens with 5% PCI. Animals were challenged with 0.896 PCI on the ears 4 days after sensitization,
and ear swelling was measured 2, 4, 24 and 48 hrs after challenge. There is a biphasic response, with maximum
swellings at 2 and 24 hr. The 2-hr swelling was almost completely suppressed and the 24-hr swelling by about 50 %
in UVB-treated mice. Dose-dependency was indicated. These results suggest that the known suppression of CHS
responses by UVB may be due to suppression of the early initiating phase of CHS.
S/pm-C3
MODULATION OF ICAM-1 EXPRESSION ON HUMAN ANTIGEN PRESENTING CELLS" BY UV RADI¬
ATION. CA Elmets, WS Mirando and J Krutmann. Depts of Dermatology, Case
Western Reserve Univ, Cleveland, Ohio and Univ of Freiburg, Germany.
UVB radiation inhibits the capacity of antigen presenting cells (APC) to
initiate helper T cell mediated immune responses. The mechanism by which
this occurs has not been fully elucidated, although recent evidence suggests
that a reduction in the expression of the adhesion molecule ICAM-1 plays an
important role in the deleterious effects of UV radiation on APC. The
purpose of this study was to examine this issue further by attempting to
correlate the effect of UV radiation on antigen presentation with its effect
on surface expression of ICAM-1 among different cell populations. Both
monocytes and freshly prepared Langerhans cells lost their capacity to
stimulate autologous T cells in in, vitro T cell proliferation assays fol¬
lowing exposure to 100 J/m2 UVB. Similar UV doses inhibited ICAM-1 expres¬
sion by >60% on these cell types. In contrast, the antigen presenting
function of B-lymphoblastoid cell lines was resistant to UVB doses up to 400
J/m2. In this cell type, surface expression of ICAM-1 was not reduced by UV
radiation. In monocytes, an increase in ICAM-1 mRNA was not observed in
unirradiated or in UV-irradiated cells, indicating that the decrease in
ICAM-1 expression was not mediated by transcriptional mechanisms. These
results support the hypothesis that UV radiation acts to inhibit the func¬
tion of APC by reducing the surface expression of ICAM-1. At least in mono¬
cytes, this effect appears to be through post-transcriptional mechanisms.
1
THE EFFECT OF UV THERAPY ON IMMUNE FUNCTION IN
PATIENTS WITH PSORIASIS
J.W. Gilmour1, J.P. Vestey2, M. Norval1*
1 Department of Medical Microbiology, University of Edinburgh Medical School, Edinburgh
2 University Department of Dermatology, Royal Infirmary of Edinburgh
"Correspondence to Dr M. Norval, Department of Medical Microbiology, University of




Ultraviolet radiation (UVR) is known to suppress some cell-mediated immune responses to
antigens encountered during or soon after exposure. Phototherapy is widely used in psoriasis
and this study was undertaken to monitor changes in a range of immunological parameters
during standard courses of treatment with the aim of ascertaining whether such modulations
contribute to the effectiveness of therapy. In this study the responses of 17 patients with
psoriasis undergoing UVB and 4 PUVA were compared with 15 patients receiving coal tar
treatment and 4 normal subjects undergoing UVB irradiation. In each case samples were
taken before starting therapy, after 4 weeks of therapy and finally 4 weeks after completing
it. Serum immunoglobulin isotypes and complement components were within normal ranges
in most of the psoriasis patients and remained unchanged throughout therapy. Similarly,
percentages of subsets of peripheral blood mononuclear cells (PBMC) were normal and were
unaltered by treatment. Patients, already infected with herpes simplex virus (HSV) as
demonstrated by a positive lymphoproliferation test in vitro, were monitored for
asymptomatic HSV shedding and HSV recrudescences during therapy. There was little
evidence that phototherapy caused reactivation of the virus. No significant alteration in
lymphoproliferative response to HSV and to the mitogen, concanavalin A, was observed
during therapy. Epidermal cells and blood adherent cells were used to present HSV to PBMC,
depleted of adherent cells and enriched for T cells, in a lymphoproliferative assay. The
functional antigen presenting ability of adherent cells remained unchanged throughout therapy
while that of epidermal cells was suppressed during UVB irradiation and recovered, in most
instances, after UVB therapy had been completed. The epidermis of patients with psoriasis
contained about three times the quantity of urocanic acid (UCA) of normal subjects while the
UCA concentration in suction blister fluid did not differ between the two groups. During
UVB irradiation, the percentage of cis-UCA rose in both the epidermis and suction blister
fluid of all subjects and it remained elevated in the blister fluid after therapy had
finished. Tumour necrosis factor-a was measured in suction blister fluid and its
concentration did not alter consistently as a result of therapy. Whether any of the
immunological parameters measured and the changes noted contribute to the effectiveness of
phototherapy in the treatment of psoriasis remain uncertain.
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INTRODUCTION
Psoriasis is a multifactorial, genetically determined disease which affects approximately 2%
of the population of Western countries. Its aetiology is controversial but there is evidence
that immunological mechanisms play an important role1,2. Ultraviolet-B (UVB) irradiation
and psoralen photochemotherapy (PUVA) are both widely employed, effective treatments for
psoriasis. However their use is largely empirical and little is known of their mechanism of
action. It is possible that they may act, at least in part, by modulating cutaneous immune
responses.
In animal models, UV irradiation results in suppression of selected immune responses to
antigens encountered within a short period after exposure. The immunological consequences
of UV irradiation in man are less well characterized and have been confined mainly to
suppression of contact sensitivity responses in UV-exposed sites3"5. A recent report
indicates that the suppression may be systemic, if the dose of UV is erythemagenic6. range
It is well recognised that UV irradiation produces transient alterations in the numbers,
ultrastructure and morphology of Langerhans cells (LC), the main antigen presenting cell
(APC) of the epidermis6,7. This is associated with suppressed in vitro alloactivation by
epidermal cells8 and reduced antigen presentation9,10. There is evidence for re-population
of human skin with APC which preferentially activate suppressor cells11. In addition to its
effects on APC, UV irradiation may alter circulating human T cell subsets temporarily, but
reports of the nature and magnitude of such changes are variable.
UV irradiation also modulates the expression of various cytokines which are likely to be
important in the pathogenesis of psoriasis. Tumour necrosis factor-a (TNF-a) may be of
particular interest in this context since human keratinocytes produce it during inflammatory
reactions and its synthesis is enhanced by UV irradiation12. In one preliminary study,
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systemic administration of TNF-a resulted in resolution of lesions in 2 out of 3 patients
with psoriasis13. In mice there is evidence for a genetic susceptibility to the
immunosuppressive effects of UV irradiation; polymorphism at the Tnfa and Lps loci may
govern susceptibility to UVU. Recently a genetic susceptibility to UV induced
immunosuppression in man has also been suggested15.
A further mechanism for UV-induced immunosuppression involves urocanic acid (UCA).
UCA is a major component of the epidermis and undergoes isomerization from the naturally
occurring trans to the cis-isomer on UV irradiation. Cis-UCA was proposed as a mediator of
immunosuppression in 198316 and, since then, has been shown to mimic many of the effects of
UV irradiation in a variety of experimental animal models17.
The present study was designed to examine the effects of standard courses of UVB and PUVA
therapy on a range of parameters of systemic and cutaneous immunity in patients with
psoriasis in an attempt to ascertain whether the success of phototherapy could be attributed
to modulations in immune responses. The results were compared with two control groups: the
first consisted of normal subjects who were given a standard course of UVB phototherapy
and, the second, patients with psoriasis who received topical coal tar paste treatment instead
of UV irradiation. Assays included several humoral components, phenotypic profiles and
counts of peripheral blood mononuclear cells (PBMC), UCA isomers and TNF-a analyses, and
jn vitro lymphoproliferative responses to concanavalin A (Con A) and herpes simplex virus
(HSV). HSV was selected as a convenient test antigen for study as about 80% of adults show
evidence of acquired immunity and, in addition, exposure to UV is an important factor in




Thirty-six patients with chronic plaque psoriasis who were attending the Dermatology
Department at the Royal Infirmary of Edinburgh were investigated. Otherwise all subjects
were in good general health and taking no medication. Fifteen of the patients did not
receive UV therapy and acted as controls (group A). They were treated with increasing
concentrations (1-4%) of topical coal tar paste under stockinette dressings. Seventeen
subjects received UVB phototherapy (group B) and four PUVA (group C). One other control
group D consisted of 4 non-psoriatic individuals who were receiving UVB as part of another
study.
At each visit the patients were assessed and the Psoriasis Area and Severity Index (PASI)
calculated. Samples were taken from group A subjects on two occasions: once immediately
before starting treatment and secondly four weeks later. Samples were taken from subjects in
groups B and C on three occasions: before starting treatment, four weeks after starting
treatment (48h after irradiation) and finally four weeks after the last irradiation. In most
instances samples consisted of blood, oropharyngeal secretions, epidermis and urine. Group
D subjects had only blood and epidermal samples taken, before irradiation and 48h after the
last irradiation. All samples were collected in the early morning and at each visit routine
tests, including full blood counts, biochemical profiles, liver function and dip stick
urinalysis were undertaken. Serum immunoglobulin and complement levels (C3, C4 and
CH50) and autoantibody profiles were determined and HSV-specific antibodies measured in
plasma by ELISA, as described previously19.
UV Irradiation
All subjects were of skin types II or III. Patients in groups B and C received the UVB
regimen normally used for psoriasis in Edinburgh. They were irradiated with incremental
doses of UVB starting with 37 mJ cm"2 in a Waldmann 1000 UVB cabinet containing 26
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Sylvania UV6 tubes, emitting 0.93 mW/cm2 UVB and 0.03 mW/cm2 UVA thrice weekly until
clear (4-6 weeks). Group C subjects were irradiated twice weekly in a Waldmann 6001 PUVA
cabinet with bulbs emitting 2 mW/cm2 UVA and 0.3 mW/cm2 UVB. They received 0.8 mg
kg"1 body weight of 8-methoxypsoralen orally 2 h before each irradiation. The minimal
phototoxic dose for each patient was calculated and, at the first treatment, they received 70%
of that dose followed by doses increased by 20% at each subsequent treatment, up to a total of
20 treatments or until their skin was clear.
HSV Isolation
Oropharyngeal swabs were collected into 5 ml Eagle's minimal essential medium containing 5%
newborn calf serum. The samples were stored at -70°C until being assayed for plaque
forming units (pfu) in monolayers of Vero cells, as described previously19.
HSV Antigen
HSV was cultured in Vero cells and UV-inactivated virus prepared as the test antigen, as
described previously20. Mock infected Vero cells were used as the control antigen.
Preparation of PBMC. Adherent Cells (AC) and T Enriched Cells (TEC)
This method has been described previously19,20. Briefly, 50 ml venous blood was collected
into preservative-free heparin and PBMC isolated by centrifugation on lymphopaque
(Nyegard Ltd., Birmingham, UK). The cells were washed three times and resuspended in
RPMI 1640 medium (Gibco Ltd., Paisley, UK) supplemented with antibiotics and 15%
autologous plasma (tissue culture medium, TCM). The PBMC were incubated in tissue culture
flasks (Becton Dickinson, Plymouth, UK) for lh at 37°C and the non-adherent cells washed
off. AC were scraped off using a cell scraper (Costar Corporation, Cambridge, MA, USA)
and resuspended in TCM at 5 x 10s ml"1. TEC were prepared by passage of the non-adherent
cells over a nylon wool column. They were washed and resuspended in TCM at 5 x 10s ml"1.
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Preparation of Epidermal cell (EC) Suspensions and Suction Blister Fluid
The method employed has been described previously20. In brief, suction blisters were raised
under a negative pressure of 150 mm Hg from uninvolved skin on the medial aspect of the
forearm. The blister fluid was collected and stored at -70°C for UCA and TNF-a analyses.
The roofs were removed and incubated in 0.5% trypsin (T2021, Sigma, UK) at 37°C for lh
and gently agitated to prepare a single cell suspension. Autologous plasma was added to 15%,
and the cells were then washed and resuspended at 5 x 10s ml"1 in TCM.
Fluorescent Flow Cytometry
The method for staining and analysis has been described previously19. Murine monoclonal
antibodies were directed against CDla, CD3, CD4, CD8, CD19 (Dakopatts, High Wycombe,
UK), CD57 (Beckton-Dickinson, California, USA) and MHC Class II antigens (DP, DQ and
DR; DA6.231, a gift from Dr K. Guy). CDla is expressed on cortical thymocytes, LC, a B
cell subset and some dendritic cells; CD19 on all B cells; and CD57 on natural killer cells,
T and B cell subsets.
Lvmphoproliferation Assay
PBMC or TEC were plated at 200gl/well into 96-well round bottomed tissue culture plates
(Falcon) and, either AC or EC were added to groups of five adjacent wells containing TEC to
form 0, 0.3%, 3% or 10% of the total cell number. The cells were either incubated alone or
with 5ng ml"1 Con A, 1 pfu/cell inactivated HSV, or an equivalent number of mock infected
Vero cells (102 ml"1). The cells were incubated for six days at 37°C in 5% C02 in a
humidified incubator, pulsed with 0.75 gCi 3H-thymidine per well during the final 24h of
culture, harvested onto glass fibre paper and counted in toluene-based scintillation fluid.
The stimulation index (SI) for each culture was calculated as:
geometric mean count per min (coml test
geometric mean cpm control
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UCA Analysis
Filter paper discs soaked in 0.1 M KOH were applied to uninvolved skin on the inner forearm
for 30 min and held in place under Finn Chambers21. The samples were stored in the dark at
-70°C and used for the quantification of total epidermal UCA and the relative concentrations
of UCA isomers by HPLC22. Suction blister fluid was also analysed by HPLC.
TNF-g Quantification
The amount of TNF-a in suction blister fluid was determined using an ELISA kit (Research
and Diagnostic Systems, Minneapolis, USA) with 100^1 sample or standard per well.
Statistical Analysis
Data were analysed using parametric or non-parametric tests, Student's t test and Wilcoxon's
signed-ranks test respectively, where appropriate. All errors quoted are standard errors of





Table 1 summarizes the clinical details of the subjects investigated. Although the dose of
UV irradiation received after four weeks of therapy varied between patients, a clinical
improvement in psoriasis and a reduced PASI occurred in every case. The routine laboratory
profiles performed at each visit (full blood counts, plasma urea, glucose and electrolytes,
liver function, dip-stick urinalysis, autoantibodies) were within normal limits for each
subject and their values were not influenced by treatment (data not shown). Serum
immunoglobulin and complement levels were also measured; two patients with psoriasis had
slightly elevated IgE levels (between 150-180 IU ml"1) and several had slightly raised
concentrations of serum immunoglobulin isotypes and/or complement components. These
abnormalities appeared to be consistent for the individual and neither the type of therapy
given, nor the extent of the psoriasis influenced them significantly (data not shown).
HSV Infection
For this part of the study, 22 patients from Groups A, B and C were selected on the basis of a
positive lymphoproliferative response to HSV with an SI greater than 3 (9 group A, 9 group B
and 4 group C). Only two patients suffered recrudescent perioral HSV infections during
UVB (group B) and none during PUVA (group C) therapy. One recrudescence was associated
with a /1-haemolytic streptococcal throat infection which was probably the triggering factor.
The other followed a mild UVB-induced facial burn a few days after starting therapy. Three
subjects from group A suffered recrudescent perioral HSV infections: two were associated
with mild upper respiratory tract infections and the third when "tired and run down". One
patient was found to be shedding HSV asymptomatically prior to UVB therapy by virus
isolation from the oropharynx. HSV antibody titres remained high and varied little in
individual subjects during the study (data not shown).
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Phenotvning of PBMC
No significant differences between the percentages of PBMC subsets in patients with psoriasis
and normal controls were observed (Table 2). As there were only 4 normal subjects, data from
a further 9 controls were taken from a previous study in which the same monoclonal
antibodies and flow cytometer were used23. These show similar values to the ones in Table 2,
i.e. percentages of positive cells (mean + 1 standard derivation) CD3 45 + 7, CD4 33 + 11, CD8
24 + 7, CDla 3 + 1.9, CD57 16 + 9, MHC Class II 21 + 6. No major alterations occurred
during treatment, although there were slight reductions in percentages of CD3+ and CD4+ cells
in groups B and C which were not statistically significant (p > 0.05; paired sample t test).
CD19 staining was performed in four of the patients in group B only, but no modulation in
the percentage of CD19+ cells during therapy was observed.
In vitro Lvmphoproliferation Responses to HSV
Proliferative responses of PBMC to HSV and Con A were monitored during treatment in 7
patients from group A, 6 from group B and 3 from group C, all of whom had positive
lymphoproliferative responses to HSV before starting therapy. There was no consistent or
statistically significant modulation of in. vitro lymphoproliferative responses to HSV during
therapy, and Con A-induced responses were high throughout (SI > 10) (data not shown).
However the background counts of unstimulated PBMC increased in five of the six UVB
treated patients from group B (mean cpm 1650 + 341 increasing to 3866 + 1381) during
therapy, and returned to normal (1667 + 428) four weeks after the last treatment. This was
not found in the patients from groups A and C.
Antigen Presentation of HSV by EC or AC
EC suspensions were prepared from suction blister roofs of patients in groups B and C. The
ability of EC, and also AC purified from PBMC, to present HSV antigen to autologous TEC,
depleted of APC, was assessed. The purification procedure employed was sufficient to
abrogate the antigen presenting function of the TEC on most, although not all, occasions.
Since the background cpm for TEC varied slightly between samples from the same patient.
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this value was subtracted from the cpm generated by the TEC stimulated by EC or AC to
determine the stimulation attributable to the APC.
Satisfactory and consistent functional depletions were achieved with four of the group B
patients on all three occasions of sampling. The ability of AC and EC to present HSV before,
during and after UVB therapy was compared and the results from one subject are illustrated
in Fig. 1. AC were unaffected in their ability to present HSV to TEC by UVB but epidermal
antigen presentation was abrogated during UVB therapy, recovering 4 weeks after the last
treatment. This was also true of the 3 other patients monitored in the same way except that
EC from one patient did not recover completely four weeks after therapy was completed.
The same experiment was attempted with four group C patients but no consistent effect on
HSV presentation by AC or EC to TEC during PUVA therapy was obtained. However it was
clear from the results of two patients that, four weeks after PUVA therapy had finished, the
EC had not regained the ability to present HSV (data not shown).
UCA Quantification
A preliminary experiment was undertaken to compare the total amount of UCA and the
percentage of cis-UCA in the epidermis and suction blister fluid obtained from uninvolved
forearm skin of untreated psoriasis patients with that of normal subjects (Table 3). The mean
UCA content and % cis-UCA in blister fluid did not differ between psoriasis patients and
normal individuals, although 9 out of 12 psoriasis patients had no detectable cis-UCA.
whereas 6 out of 7 normal subjects had low levels. The epidermal UCA content of psoriasis
patients was significantly higher than that of normal subjects. However the relative
percentage of each isomer did not differ between the two groups.
The effect of therapy on the UCA content of the epidermis and suction blister fluid is shown
in Table 4. In both groups B (UVB-treated psoriasis patients) and D (normal subjects
receiving UVB), UV exposure tended to increase the total epidermal UCA content, but the
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difference was not statistically significant (p > 0.05, paired sample t test). However after
4 weeks of UVB therapy, the percentage of cis-UCA within the epidermis increased
significantly in both groups B and D. The concentration of UCA in suction blister fluid
remained relatively constant in each group throughout the study (Table 4). There was a
significant increase in the percentage of cis-UCA in blister fluid of groups B and D during
UVB therapy. This remained significantly elevated four weeks after the last irradiation in
Group B; no equivalent samples were available from group D subjects.
Only a few samples were available for UCA analysis from group C (PUVA cohort). Two out
of three subjects showed a slight increase in epidermal UCA during therapy, with the
percentage of cis-UCA increasing in all three subjects after four weeks of irradiation (from
35.4% + 14.2 to 46.1% + 12.5; mean + SEM). Two of the group had relatively high
percentages of cis-UCA before irradiation started (44.9% and 53.8% respectively). Suction
blister fluid from two PUVA patients showed no significant alteration in total UCA
concentration following PUVA but an increased percentage of cis-UCA which remained
elevated four weeks after the last treatment, as found in group B (Table 4).
TNF-a Analysis
Due to the limited volume of suction blister fluid available from each subject, only 100/xl of
the sample or standard was added to each well of the ELISA plate instead of the recommended
200/xl. This lowered the sensitivity of the test from 7.5 pg ml"1 to approximately 16 pg ml"1.
TNF-a was detected in the majority of the samples. Patients with psoriasis from groups A-C
had slightly elevated levels (95.6 pg ml"1 + 10.1; mean + SEM; n = 9) compared with normal
subjects (58.7 + 15.3 pg ml"1; n = 7; 4 group D subjects and 3 additional normal subjects),
but this difference did not reach statistical significance (P > 0.05).
As shown in Fig.2, there was little change in TNF-a concentration during coal tar therapy
(group A) but three patients from group B showed increased TNF-a concentrations during
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UVB therapy while four showed a decrease. Three out of four normal controls receiving
UVB (group D) showed increased TNF-a in blister fluid during the therapy. No samples
from group C were analysed.
There was no correlation between the concentrations of cis-UCA and TNF-a in blister fluid.
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DISCUSSION
In this study several immunological parameters were assessed in patients suffering from
chronic plaque psoriasis and, where possible, compared with those in normal subjects. The
effect of phototherapy or coal tar therapy was then measured by comparing samples from the
patients taken before, during and after treatment.
As certain reports, although not all, have indicated that abnormalities in complement
components24 and immunoglobulin levels, particularly IgA25 may occur in patients with
psoriasis, patients were tested before therapy for circulating complement components and
immunoglobulin levels, as well as haematological, autoantibody, urinary and biochemical
profiles. All of these routine measurements were within normal limits with the exception of
a small number of psoriatic subjects who had slightly elevated immunoglobulin or complement
levels which did not vary with disease severity. It is possible that high complement levels
relate to paricular types of psoriasis, while the lack of correlation between clinical
improvement of psoriasis and increased levels of circulating immunoglobulin argues against
their being primarily related to cutaneous manifestations of the disease1.
Neither UVB nor PUVA therapy had a measurable effect on any of these parameters. Hersey
et al.26 reported that exposure to sunlight had no effect on circulating complement or
immunoglobulin levels, although Livden et al.27 detected slightly decreased circulating IgG
titres in normal subjects exposed to four weeks of UVB or UVA radiation, and a slight
increase in IgM and C3 levels following UVB irradiation.
Although some reports have indicated abnormalities in circulating lymphocyte subsets in
patients with psoriasis, others found no differences from normal subjects, for example28.
This was also the case in the present study in which analysis was by flow cytometry using
monoclonal antibodies to T cells (CD3, CD4, CD8), dendritic cells (CDla), B cells (CD19),
natural killer cells (CD57) and MHC Class II antigens (Table 2). The effect of UV
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irradiation on circulating blood cells is controversial and, indeed, it is possible that any-
detected changes are only transient. Thus some authors reported a temporary decrease in
circulating T cells after UVB or PUVA therapy but others found no modulation in circulating
PBMC following a variety of UV regimens (reviewed in29). Differences in the source,
wavelengths, duration or dose of UV, as well as the time of sampling may explain these
apparent differences. Our results demonstrated an insignificant reduction in the percentage
of circulating CD3+ and CD4+ cells following UVB or PUVA therapy but no alteration in any
of the other subsets. No changes were noted in the normal subjects receiving UVB, or in
patients receiving tar.
Most studies of the immunosuppressive effects of UV irradiation in man or experimental
animals have focussed on immune responses to antigens, commonly contact sensitizers, which
are encountered for the first time shortly after irradiation. The present study was
different in that subjects were already infected with HSV before starting therapy. In
addition, although erythemal exposure to UV is a common triggering factor for orofacial
recrudescent HSV infection18, the role of suberythemal doses of UV, such as those employed
in phototherapy, in HSV pathogenesis is unknown.
Volunteers were observed for signs of orofacial HSV recrudescences at each visit and had
oropharyngeal swabs taken for virus isolation before, during and after therapy. Nine patients
receiving coal tar (group A), nine receiving UVB (group B) and 4 receiving PUVA (group C)
were found to be HSV carriers on the basis of lymphoproliferative responses in vitro. One
subject from group B was shedding virus asymptomatically before therapy and only two
others suffered recrudescent lesions during therapy; one following a mild burn produced by
UVB irradiation but the other was not associated with therapy. Thus phototherapy was not
generally a triggering factor for HSV recrudescences nor for inducing reactivation of latent
virus with asymptomatic shedding into the oropharynx. However the oropharyngeal swabs
were taken at one time point only during therapy and, as virus is detectable for about 2-4
days in each recurrent episode, it is possible that shedding may have occurred outwith the
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sample point.
It has already been reported that patients with psoriasis develop normal lymphoproliferative
responses to HSV in. vitro30. Four weeks of UVB or PUVA therapy caused no significant
modulation in the lymphoproliferative response to HSV, or in HSV-specific antibody titres in
any individual. However PBMC cultured alone tended to show an increased 3H-thymidine
uptake during UV irradiation which may indicate some non-specific activation due to
phototherapy.
When peripheral blood AC were used as accessory cells in lymphoproliferation assays, no
alteration in antigen presenting ability was found as a result of UVB or PUVA therapy.
However, this was not the case when EC were used as accessory cells. This resulted in
markedly lowered proliferative responses in patients during UVB (Fig.l) or PUVA therapy.
The responses were restored in most individuals four weeks after UVB irradiation had
finished although they remained depressed four weeks after PUVA therapy. Few studies have
examined the effects of in vivo UV irradiation on human epidermal antigen presentation in
vitro and none following typical regimens used for the treatment of psoriasis. In vitro
irradiation of human EC suspensions with UVB10, UVA or PUVA31 resulted in suppressed
allo-activation and antigen presentation by the cells. Cooper et al.8 demonstrated a
suppression of antigen presentation by LC immediately after irradiation of normal subjects
with 2-4 MEDs of UVB but this was followed by an enhancement in antigen presentation
caused by an influx of T6"Dr+ cells into the epidermis. Similarly PUVA therapy has been
reported to suppress the antigen presenting capacity of human skin9.
Cis-UCA is formed from the naturally occurring trans-isomer on UV irradiation of skin, up
to a maximum value of about 60% of the total UCA which represents a photostationary state32.
In mice the percentage of cis-UCA declines steadily following a single UVB exposure until a
background level is reached after 14 days22. An analysis of the UCA content of human
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epidermis and suction blister fluid and percentage of the cis-isomer during and after
phototherapy had not been undertaken before. Total epidermal UCA content was measured
in Finn Chamber samples which extract all the UCA from human epidermis and give an
equivalent value to successive tape strips21.
Patients with psoriasis had approximately three times more UCA in their epidermis than
normal subjects (Table 3). The value obtained for psoriatic epidermis was similar to that
reported recently by Snellman et al33. It is possible that the increased UCA reflects the
mild epidermal thickening of "uninvolved" skin sites in psoriasis. Alternatively, since UCA
is formed in one step from histidine by the enzyme histidase, increased histidine may be
available in psoriasis due, perhaps, to increased epidermal cell turnover or keratohyalin
granule degradation which would account for increased UCA. In addition abnormalities in
histidase activity have been detected in patients with psoriasis34.
During and after UVB exposure, the epidermal UCA content of the psoriasis patients
remained relatively constant while that of normal subjects doubled during irradiation,
returning to near the starting value 4 weeks after the last dose. All irradiated groups
showed an increase in the percentage of cis-UCA in the epidermis which returned to normal 4
weeks after the last treatment. In a previous study four weeks of heliotherapy (sunbathing at
southern resorts) for psoriasis produced similar effects on epidermal UCA despite very
different UV regimens33. Although cis-UCA has been suggested as a mediator of the
immunosuppressive effects of UV irradiation, it is not known if the formation of cis-I JCA in
the epidermis following UV irradiation contributes either directly or indirectly to the
impaired presentation of HSV by EC during phototherapy. Evidence to support a direct effect
comes from the measurement of the number of dendritic cells in murine epidermis following
cis-UCA treatment where a significant reduction was observed by analysis of ATPase+35 or Ia+
cells36.
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UCA was detected in suction blister fluid from both psoriatic and normal subjects, at similar
concentrations. This differs from a previous report of reduced levels of UCA in suction
blister fluid from psoriasis patients37. Phototherapy did not affect the total concentration
of UCA although the percentage of cis-UCA increased. In contrast to the epidermis, this
increase was maintained four weeks after the last treatment in both groups B and C. These
results are similar to those of Pasanen et al38. UCA is synthesized in the stratum corneum on
activation of histidase39 and it is interesting that UCA isomers are found in blister fluid
which is likely to be formed mainly from a dermal exudate. The persistence of an increased
percentage of cis-UCA in blister fluid after it had returned to a low percentage in the
epidermis might indicate that cis-UCA persists in the dermis or near the dermo-epidermal
junction. It is possible that it may play a significant role in immunomodulation there and,
indeed, a comparison of UCA and the percentage of cis-UCA in the epidermis and blister
fluid samples from the psoriatic patients revealed an inverse correlation between percentage
of cis-UCA in blister fluid and the PASI (p = 0.031) while there was no correlation between
the percentage of epidermal cis-UCA and UCA, or of blister fluid UCA, with the PASI (p >
0.308).
Finally a small number of blister fluid samples were analysed for TNF-a. It was present in
measurable quantities in most samples before irradiation but UVB therapy had no consistent
effect on its concentration (Fig. 2). However it is possible that such changes may occur
rapidly after the start of phototherapy and may not be sustained until our sampling points,
at least 48 h after irradiation. TNF-a is one of the factors released from UV-irradiated
keratinocytes which has important properties in mediating the effects of UVB on the immune
system, at least in mice. It has been shown, for example, to mediate the suppression of
contact hypersensitivity induction through local release in the skin but also to be involved
in the enhanced expression of contact hypersensitivity in UV-susceptible mice40. It is not
known whether human skin responds similarly during phototherapy. TNF-a alters adhesion
molecule expression on keratinocytes and in the dermal vasculature, thus influencing
recruitment of inflammatory cells into both the epidermal/dermal compartments. In psoriasis
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there is a characteristic T cell infiltrate and keratinocyte hyperproliferation, in which
dermal dendrocytes may play a central role, possibly mediated by the production of TNF-a41.
Whether TNF-a and cis-UCA production in the skin are linked is unknown at present,
although Kurimoto and Streilein36 have reported recently that cis-UCA may cause the local
release of TNF-a within the murine epidermis with consequences for the induction of contact
hypersensitivity. In addition cis-UCA has been shown to down-regulate the induction of
cAMP by trans-UCA or histamine in dermal fibroblasts in vitro and thus it is possible that
cis-UCA. formed on irradiation, may regulate the activity of cytokines through a secondary
signalling system42
Although changes have been noted in this study, predominantly in epidermal APC function
and in cis-UCA content as a result of phototherapy, it remains uncertain whether these
modulations contribute to the effectiveness of the treatment for psoriasis or are related to
the disease process itself.
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LEGENDS FOR FIGURES
Fig.l. The effect of UVB irradiation on antigen presentation of HSV by (a) adherent cells
from blood or (b) epidermal cells. Lymphoproliferative responses (3H-thymidine
incorporation, geometric mean cpm) of one patient with psoriasis to Vero control
antigen (open bars) and HSV antigen (closed bars) before, during and after UVB
therapy. T enriched cells were constituted with either 10% adherent cells from
blood or 10% epidermal cells.
Fig.2. The effect of UVB irradiation on TNF-a concentration in suction blister fluid.
Samples were taken before, during and after UVB therapy for group B (7 patients
with psoriasis) and before and during UVB therapy for group D (4 normal subjects).
For group A (3 patients with psoriasis) one sample was taken before coal tar therapy








































































Marker 7. positive cells
before treatment
% positive cells





A CDla 4.5 + 0.8 3.7 + 0.5 NA
B 6.0 ± 0.4 5.3 + 1.0 6.6 ± 2.0
C 4.4 + 1.3 2.3 ± 2.2 4.0 ± 0.5
D ND ND ND
A CD3 55.5 ± 3.7 56.1 ± 3.2 NA
B 54.2 + 3.9 47.3 ± 3.3 53.8 + 3.3
C 58.8 + 2.7 54.1 + 6.5 52.3 + 8.6
D 46.7 +14.8 53.6 +13.4 48.1 +16.6
A CD4 38.8 + 3.6 39.7 +4.9 NA
B 41.5 + 7.2 35.4 +4.5 42.3 ± 4.9
C 42.1 + 2.4 38.2 + 5.0 31.7 + 2.9
D 35.5 + 3.7 40.0 +13.4 28.9 + 4.9
A CD8 15.7 + 1.4 17.4 + 1.4 NA
B 18.1 ± 1.7 16.4 + 2.1 18.1 ± 2.1
C 26.5 + 1.6 25.5 + 3.8 29.4 + 7.6
D 15.8 + 3.8 18.2 + 1.3 14.4 + 2.4
A CD57 9.2 + 1.3 12.5 + 2.6 NA
B 11.4 + 1.5 13.0 + 1.9 10.1 ± 1.2
C 10.8 + 1.5 14.3 + 1.5 11.1 ± 3.0
D 10.7 + 1.5 11.6 + 2.6 11.3 + 1.8
A MHC 14.9 + 1.6 15.2 + 3.3 NA
B class II 17.7 + 2.9 16.3 + 1.8 14.8 + 2.1
C 12.9 + 0.2 16.8 + 1.3 10.3 + 4.9
D 12.7 + 5.0 15.6 + 2.4 20.6 + 4.1
A n = 9; Bn=9; C n = 4; D n = 4
NA = not applicable
ND = not done
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Ultraviolet (UV) radiation suppresses a variety of immune responses but it is uncertain
whether this action contributes to the effectiveness of phototherapy for psoriasis. Urocanic
acid (UCA) has been proposed as a mediator of the immunological effects of UV. On
exposure the naturally occurring trans-isomer of UCA in the skin changes into the cis-isomer
which has been demonstrated to mimic many of the immunomodulatory effects of UV
irradiation. Natural killer (NK) cells play an important role in several immunological
processes and published evidence indicates that their activity is altered by UV irradiation.
To ascertain the effect on NK cells of phototherapy used in the treatment of psoriasis,
modulation of NK activity in psoriatic patients undergoing broad band UVB, narrow band
UVB or PUVA regimens was examined. This was compared with NK cell activity in
psoriatic patients treated with topical coal tar and in normal subjects receiving broad band
UVB.
The NK cell activity of psoriatic and normal subjects was the same over a wide range of
effector to target cell ratios. Almost all patients undergoing phototherapy exhibited
depressed NK cell activity during or after irradiation, although the timing of the depression
varied between the lamps used and may be related to dose. However patients treated with
topical coal tar showed unchanged NK cell activity throughout the therapy. The effect of
UCA isomers on NK cell activity in vitro was also determined. It was found that cis-UCA
induced a dose dependent suppression of NK cell activity while trans-UCA had hardly any
effect.
Thus it is possible that there may be a correlation between cis-UCA formation in the




Natural killer (NK) cells represent a heterogeneous population of large granular lymphocytes
which have not been assigned to a single lineage or distinct anatomical location of
maturation, and tend to be defined on a functional basis. The majority of NK cells in human
peripheral blood are CD56+ CD16* CD2+ CD1 lb+ CD3"; other markers such as CD57 are only
expressed on certain NK subsets (1). They are cytotoxic cells which detect and lyse target
cells in a non-MHC restricted manner, although MHC Class I alleles have been implicated
recently in target cell recognition (2).
There is evidence that NK cells play a substantial role in a number of immunological
processes. These functions include cytotoxic action against tumour cells and virally
infected cells (3) and resistance to some bacteria, fungal and parasitic agents (4,5). In
addition they may be involved in rejection of allogeneic grafts (6), and in immune regulation
through the secretion of a number of cytokines (7,8). The receptors involved in target cell
recognition by NK cells or the signal transduction mechanism responsible for effector cell
activation remain largely undefined.
In addition to the well recognized association between in vivo UV exposure and the incidence
of squamous cell carcinomas, a number of experimental models show that UV irradiation
results in transient suppression of immune responses to antigens which are encountered shortly
thereafter. These include systems where NK cell activity is thought to be important in
immunity, such as infections with herpes simplex virus (HSV) (9) and murine acquired
immunodeficiency virus (10), tumour development (11) and allograft rejection. It is of
interest that in vitro UV irradiation of human peripheral blood mononuclear cells (PBMC)
results in dose dependent suppression of NK cell activity (12-15). In addition, there is an
indication that exposure to UV and PUVA in vivo may result in suppressed NK cell activity
(16,17). Urocanic acid (UCA), found in the stratum corneum, has been proposed as a
photoreceptor and mediator of the immunomodulatory effects of UV radiation (18). On UV
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exposure, the naturally occurring trans-isomer of UCA undergoes a dose dependent
isomerization to cis-UCA which has been shown to mimic many of the effects of UV on the
immune system (reviewed in 19).
Psoriasis is a common, genetically determined, hyperproliferative skin disorder in which the
immune system is thought to play a critical role (20,21). UVB phototherapy and
photochemotherapy (PUVA) are successfully employed in the management of psoriasis.
However their use is largely empirical and little is known of their mechanisms of action or of
their possible effects on the immune system. Conventional broad band UV sources, such as
Sylvania UV6 tubes, emit wavelengths from 270-370 nm. Wavelengths less than 300 nm are
highly erythemogenic and, in common with those over 315 nm, are relatively ineffective
therapeutically (22,23). Therefore a narrow band (311-313 nm) source was developed (Philips
TL01) (24) which has proved effective in the management of psoriasis (25,26).
In the present study the effect of therapeutic regimens employing UV6, TL01 or PUVA
therapy on NK cell activity in patients with psoriasis was examined. This was compared with
the effect of coal tar therapy in psoriatic patients and with a course of UV6 irradiation in





Details of patients and normal subjects are summarized in Table 1: groups A, B, E and F
attended the Department of Dermatology, Royal Infirmary of Edinburgh, while groups C and
D attended the Photobiology Unit, Ninewells Hospital, Dundee. All subjects were in good
general health and taking no other photoactive or immunosuppressive medication. Those with
psoriasis had chronic plaque psoriasis except for three patients in group C who had guttate
psoriasis. Liquid paraffin/white soft paraffin (50/50) or emulsifying ointment were used as
non-UV absorbing emollients before and during therapy by all psoriatic patients including
group A.
Thirty mis venous blood was collected into preservative-free heparin in the early morning.
Samples were taken from subjects receiving UV-based therapy (groups B,C,D and F)
immediately before treatment started, after four weeks of therapy and four weeks after the
last irradiation. Group A patients were treated with increasing concentrations (1-4%) of
topical coal tar paste under stockinette dressings. Samples were taken from them before
treatment commenced and after four weeks of therapy. Group E consisted of normal subjects
who received no therapy: samples were taken from four of this group on two occasions, four
weeks apart.
UV irradiation
All subjects were of skin types II or III. Those in group B received the UVB regimen
normally used for treatment of psoriasis in Edinburgh. They were irradiated in a Waldmann
1000 UVB cabinet containing 26 Sylvania UV6 tubes emitting 42% in the UVA waveband,
57.6% UVB and approximately 0.3% UVC. Irradiance of the tubes was measured using a
filtered photodiode meter (27) which was calibrated against a spectroradiometer (model 742,
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Optronic Lab Inc), and the total output (250-400 nm) was 1.4 mW cm'2. Patients were
irradiated with incremental doses starting with 37 mJ cm"2, thrice weekly until clear (4-6
weeks). Those in group F were normal volunteers who received the same regimen for six
weeks except that only their arms were exposed while the remainder of their bodies were
draped.
Group C patients had their minimal erythema doses (MED) determined and an initial dose of
70% of MED was given. They were treated 3 times weekly and at each visit the irradiation
dose was increased by 40%; the increment was reduced or omitted depending on the
occurrence and severity of erythema. Treatment was stopped when psoriatic plaques had
resolved to the point of impalpability over all affected sites, excepting minimal residual
activity on knees or elbows (15-20 treatments). The irradiation, determined as for the UV6
lamps, was given in an upright cubicle incorporating 50 Philips TL01 100W fluorescent lamps,
and was 4.1 mW cm
Group D patients received PUVA in a Waldmann 6000 cabinet incorporating 62 Sylvania
FR74T12 fluorescent lamps (UVB = 0.2 mW cm"2, UVA = 11.7 mW cm"2). Irradiance was
monitored using a Waldmann PUVA meter calibrated at the Regional Medical Physics
Department, Durham. All patients had their minimal phototoxic dose determined, and the
first irradiation dose was 70% of this. Treatment was then given twice weekly with 40%
incremental doses (less in case of erythema) at each visit until minimal residual activity was
achieved (15-20 treatments).
Preparation of peripheral blood mononuclear cells (PBMC) and phenotvpine
PBMC were isolated by centrifugation on lymphopaque (Nyegard Ltd, Oslo, Norway). The
cells were washed three times and suspended in RPMI 1640 supplemented with antibiotics (28)
plus 10% fetal calf serum (tissue culture medium, TCM) at 4 x 106 ml'1.
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The method for phenotyping of PBMC using a Coulter EPICS "C" flow cytometer has been
described previously (29). The cells were stained with murine monoclonal antibodies to
CDla, CD3, CD4, CD8 (Dakopatts, High Wycombe, UK), CD56, CD57 (Beckton-Dickinson,
California, USA) and pan MHC Class II (DP, DR, DQ : DA6.231, a gift from Dr K. Guy).
An irrelevant antibody was used to determine the background non-specific staining which was
set to approximately 1% of the total histogram. Data were initially collected on a
2-parameter histogram measuring forward light scatter. Bit maps were drawn around both
the lymphocyte and the monocyte/large granular lymphocyte populations and the percentage
of cells exhibiting fluorescent levels higher than background were recorded for these two
populations independently.
NK cell assay
K562 cells were employed as targets in all experiments (29). One million cells were labelled
with 100 pCj sodium chromate (51Cr, Amersham International Ltd, England) for 4 h at 37*C.
They were washed three times in 0.01 M phosphate buffered saline pH 7.2, suspended in TCM
at 10s cells ml"1 and plated at 100/xl/well in round bottomed microtitre plates (Falcon, Becton
Dickinson, Oxford, U.K). Doubling dilutions of PBMC were carried out in TCM and 100/xl
of each dilution added to quadruplicate wells resulting in effector to target cell (E:T)
ratios from 40:1 to 1.25:1. Spontaneous 51Cr release was determined by adding 100/xl TCM to
quadruplicate wells and maximum release by adding 100/xl 2% acetic acid to quadruplicate
wells. The plates were incubated for 18 h at 37°C in 5% C02 in a humidified incubator, then
spun at 300 g for 5 min before removing 120/il supernatant for determination of counts per
minute (CPM) using a Packard liquid scintillation counter. The standard error of the mean at
each ratio was always less than 10% of the mean value.
Test CPM - spontaneous CPM
% specific 51Cr release was determined by 100X — —
Maximum CPM - spontaneous CPM
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Urocanic acid OJCA)
Iians-UCA was purchased from Sigma (Poole, Dorset). Cis-UCA was prepared and purified
after UV irradiation of a solution of trans-UCA as already described (31). Qs and
{ran§-UCA were dissolved in phosphate buffered saline at concentrations of 10"1M and
10"2M respectively and serial tenfold dilutions to 10"8M carried out in phosphate buffered
saline. 10^1 of each dilution was added to 0.5 ml PBMC at 10s cells ml"1. In addition lOOjil
of 10'1M £i£ or 10'2M trans-UCA were added to 0.4 ml PBMC at 1.25 x 10s ml"1. 100^1
UCA-treated PBMC were then added to the wells of a microtitre plate and 15 min later 1 OO/il
labelled target cells added at an E:T ratio of 40:1. This resulted in a final concentration
of cis-UCA of 10"2M to 10'1°M, and trans-UCA of of 10"3 to 10"1°M. Target cells were also
incubated alone with the UCA isomers.
Statistical analysis
Differences in NK cell activity of patients were determined by the Wilcoxon signed-ranks test
or Student's t test was used, where appropriate.
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RESULTS
NK cell activity in normal snhierts and patients with psoriasis
Before any treatment commenced, all 23 patients with psoriasis and 11 normal subjects
detailed in Table 1 were tested for NK cell activity. A comparison of the two groups showed
no statistical difference at any E:T ratio. For example, at an E:T ratio of 40:1, NK cell
activity of normal volunteers was 52.2 + 5.4 (mean + standard error of the mean, SEM)
compared with psoriatics 64.1 + 4.2 (p = 0.11; Wilcoxon signed-ranks test).
Effect of therapy on NK cell activity in normal subjects and patients with psoriasis
All patients showed a marked clinical improvement (to at least minimal residual activity) in
the degree of psoriasis irrespective of the treatment used. It should be noted that,
although a set of samples was collected after four weeks of therapy, in most instances
patients required six weeks of UV therapy to achieve complete or almost complete clearance
of psoriasis.
Fig. 1 illustrates the mean NK cell activity before, during and after therapy in all subjects.
Coal tar therapy (group A) had no significant effect on NK cell activity (Fig la). Patients
receiving broad band UV6 treatment (group B) showed no significant alteration in NK cell
activity after four weeks of therapy (Fig. lb). However there was some reduction in activity
four weeks after the last treatment in five of the six patients. This reduction was
statistically significant for the group at all E:T ratios (p = 0.046, Wilcoxon signed-ranks
test). Group C patients, receiving narrow band TL01 therapy, showed a marked depression in
NK cell activity after four weeks of therapy (Fig. lc); for example the mean value (+ SEM)
for the group fell from 66.8 + 7.1 to 42.0 + 6.6 at E:T ratio of 40:1. This reduction was
statistically significant at all E:T ratios (p = 0.028, Wilcoxon signed rank test). Four
weeks after the last irradiation the mean NK value for group C had recovered significantly;
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for example to 50.9 + 7.0 at E:T of 40:1 (p = 0.043; Wilcoxon signed-ranks test). However
it still remained significantly depressed compared with the original value prior to
irradiation in five out of six patients (p = 0.043 Wilcoxon signed-ranks test). Samples were
collected from two of the patients a further four weeks later, i.e. eight weeks after the last
irradiation. NK cell activity was again increased and had almost returned to the original
value. A similar pattern was observed in the six patients receiving PUVA therapy (group D,
Fig Id). Following four weeks of therapy, all exhibited a marked reduction in NK cell
activity; for example at E:T of 40:1 the activity fell from a mean (+ SEM) of 76.4 + 6.1 to
51.6 + 8.0. The reduction was statistically significant at all E:T ratios but more so if the
E:T was less than 40:1 (p = 0.046 at E:T of 40:1, and p = 0.028 at E:T less than 40:1). Four
weeks after the last treatment the activity had recovered but it remained significantly
suppressed relative to the original values at E:T less than 40:1 (p = 0.028). Three patients
had their NK cell activity assessed a further four weeks later when it had almost returned to
normal.
Two groups of normal subjects were also analysed. The first, part of group E, consisted of
four individuals who received no treatment. The second, group F, consisted of four
individuals who received a course of UV6 identical to that received by the psoriasis patients
in group B, except that only their arms were irradiated. Fig. le shows that there was no
fluctuation in NK cell activity in the group E subjects while Fig. If demonstrates that four
weeks of UV6 therapy had no significant effect on NK cell activity in group F subjects.
However four weeks after the last irradiation NK cell activity was suppressed in three
individuals. This suppression did not reach statistical significance (p > 0.05; paired
sample t test).
Phenotvping
PBMC from all the normal subjects and psoriasis patients were stained with monoclonal
antibodies against CDla, CD3, CD4, CD8, CD57 and MHC Class II antigens. There was no
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difference in any of the markers between normal subjects and patients, and no significant
alteration of the markers occurred as a result of therapy (data not shown).
In addition to these antibodies, a further monoclonal against CD56 was employed to determine
the number of NK cells present in three patients in Group C and four in Group D. In the
population of cells gated to include large granular lymphocytes and to exclude smaller cells,
there was a reduced percentage of CD56+ cells during therapy which rose after therapy had
finished [% CD56+ cells before therapy = 77.0 + 6.5 (mean + SEM), during therapy = 22.4 +
3.9, after therapy = 59.7 + 8.3].
Effect of UCA isomers on NK cell activity in vitro
The results above indicate that UV irradiation in vivo suppresses NK cell activity and the
following experiments were undertaken to determine the effects of UCA on NK cell activity
in vitro. Since the concentrations of UCA isomers used were relatively high various tests
were carried out to ensure that the isomers were not toxic. In the first place, on four
separate occasions, UCA isomers ranging from 10"2 to 10"10M were added to wells containing
labelled target cells which were then incubated for 18 h and the supernatant assayed for
release of 51Cr. No alteration in background release of 51Cr occurred at any concentration
of £i£ or trans-UCA. Secondly, effector cells were incubated with UCA isomers for 18 h and
the number of viable cells determined by trypan blue exclusion. This was always between
90-100%. Thirdly, the effector cells were incubated for 18 h with 10"3M 10"6M and 10"9M
cis or trans-UCA and then stained overnight with propidium iodide. The number of cells in
the S + G2M stage of cell division were quantitated by flow cytometry using the S-Fit DNA
analysis programme (Coulter Electronics Ltd, Luton, U.K.). Approximately 18% of cells
were in S + G2M, and this figure was not altered by the presence of UCA isomers.
The percentage suppression of NK cell activity induced by a range of concentrations of
cis-UCA in vitro at an E:T ratio of 20:1 was determined for 12 subjects; 7 normal volunteers
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and 5 untreated patients with psoriasis. Cis-UCA had the same effect on PBMC from all of
these subjects and Fig. 2a represents the mean suppression of NK activity in these
individuals. The effect of trans-UCA was measured in four normal subjects in the same
manner (Fig. 2b). Treatment with cis-UCA resulted in a dose dependent suppression of NK
cell activity which was statistically significant at concentrations between 10"2 and 10"*M.
Trans-UCA was slightly suppressive at higher concentrations but this was minimal in
comparison with cis-UCA and was not statistically significant.
Finally the effect of UCA isomers on the function of lymphocytes other than NK cells was
examined. A lymphoproliferation test was carried out in which UCA isomers, in
concentrations similar to those used in the NK assay, were added to quintuplicate wells
containing PBMC together with sub-optimal concentrations of concanavalin A (1.5 /rg/ml) or
HSV antigen (0.1 plaque forming unit/cell, UV inactivated), as already outlined (28). The
experiment was done on two separate occasions using PBMC from two healthy donors known
to be HSV carriers. In both cases, neither UCA isomer had any consistent or dose dependent
effect on lymphoproliferation (data not shown).
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DISCUSSION
Suppressed NK cell activity has been reported in patients with generalised pustular psoriasis
and to a lesser extent, with psoriasis vulgaris (31). In contrast, Hunyadi et al (32) found
normal NK cell activity in a group of subjects with chronic plaque psoriasis. Our study
included twenty patients with chronic plaque psoriasis and three with guttate psoriasis. No
significant difference in NK cell activity was observed in comparison with eleven normal
healthy subjects.
Coal tar treatment as well as three UV irradiation regimens commonly used in the management
of psoriasis caused a marked improvement in the severity of psoriasis in all cases. However,
only patients receiving UV exhibited any suppression in NK cell activity. This suggested
that the modulation in NK cell function resulted from UV irradiation and was not secondary
to clinical improvement.
Suppressed NK cell activity was found in all patients after four weeks of TL01 (group C) or
PUVA (group D) therapy. Four weeks after treatment had stopped, NK cell activity had
begun to recover although in neither group had it regained its initial level. The kinetics
of NK cell modulation were different when the broad band UVB (UV6) lamp was used (group
B). In this case, there was significant change in NK cell activity following four weeks of
therapy but suppression had occured four weeks after the completion of the course (Fig. 1).
It is possible that the suppression of NK cell activity by UV irradiation may be dose
dependent. As the TL01 and UVA sources do not emit the highly erythemogenic
wavelengths, patients received higher doses of UV in a short period of time compared with
group B (Table 1). Furthermore, this is suggested by the results from group F (normal
subjects undergoing broad band UVB irradiation of their arms only) as, although a reduction
in NK cell activity was recorded in most individuals four weeks after the last irradiation, it
did not reach statistical significance (Fig. If). A dose dependent suppression in NK cell
activity following solarium exposure has been reported (33). In that study normal subjects
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were irradiated with approximately one minimal erythemal dose for 2, 6 or 12 consecutive
days. At least 6 consecutive days of exposure were required to induce suppression of NK cell
activity and the suppression was more pronounced following 12 days. Those patients who
received 12 whole body exposures still demonstrated suppressed NK cell function 21 days
after the last irradiation. Another study examined the effects of PUVA therapy on NK cells
in a group of patients with a number of skin disorders, 50% of whom had psoriasis vulgaris
(17). A reduction in NK cell activity was observed during therapy although this tended to
return to normal at the higher E:T ratio, if the therapy was continued beyond 25 irradiations.
In addition to the total UV dose, it is possible that the incident wavelengths of UV are
important. In this respect Hersey et al (34) reported that 12 one hour exposures to sunlight
in a 2 week period had only a minimal effect on NK cell activity. However further studies
revealed that 2 weeks of irradiation with solarium lamps resulted in suppressed activity (35).
The ratio of UVA to UVB emitted by solarium lamps was estimated to be three times higher
than that of natural sunlight, and it was shown that the suppression of NK cell function still
occurred even if wavelengths in the UVB range were excluded (16,36). Hence it was
concluded that UVA wavelengths (320 - 400 nm) were solely responsible for the effects on
NK cells. However our present studies do not support this view since the TL01 source which
emits narrow band UVB (311 - 313 nm) produced suppression of NK cell activity during
therapy. In vitro, shorter UV wavelengths have been demonstrated to cause more suppression
of NK cell activity than longer wavelengths (14).
Hersey et al (36) reported minimal changes in the number of circulating CD16+ cells as a
result of irradiation and we observed no change in CD57+ cells, suggesting that the total
number of circulating NK cells remains unaltered. However preliminary tests indicated that
the percentage of large granular lymphocytes expressing CD56 was reduced in patients
receiving TL01 or PUVA therapy and this correlated with reduced NK cell activity. CD56 is
thought to be an activation marker expressed on NK cells and is found on very few T cells
(37).
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The mechanism whereby UV irradiation affects NK function is unknown. Possibly there
may be a direct effect on NK cells as they circulate through the dermal capillaries which
results in permanent functional damage. The recovery of activity may then be dependent on
the regeneration of cells from the bone marrow. It is also possible that there may be
modulation by another cell type, such as monocytes (38) or NK cells themselves (39).
Alternatively a soluble mediator may be released from epidermal cells on irradiation which
enters the circulation and affects NK cell function. Kim et al (40) and Brodie and Halliday
(42) have reported soluble suppressive factors in murine serum following UV irradiation
which are potential candidates. Prostaglandins, induced by UV exposure, are other
possibilities as they have been shown to inhibit NK cell activity (42). In vitro epidermal
cells release an interleukin-l-like factor which augments NK cell activity. This is called
epidermal cell-derived NK cell activity-augmenting factor and may be relevant in vivo (43).
Finally there may be altered regulation of the function of other cells through modified
cytokine secretion by NK cells themselves.
One further factor which merits consideration is cis-UCA. formed in the epidermis from
trans-UCA on UV irradiation. We have shown in the present study that cis-UCA treatment
in vitro resulted in a dose-dependent suppression of NK cell activity while trans-UCA had
little effect. The concentration of cis-UCA required to modulate the activity was relatively
high (10"2 to 10"4M). However trans-UCA is present in considerable amounts in the human
epidermis (about 8 jzgcm'2; 44) and, on UV exposure, up to approximately 60% converts to
the cis-isomer in a dose dependent fashion. We have shown that cis-UCA is present in
suction blister fluid and it is retained in this compartment for at least four weeks after
irradiation (Gilmour JW, Vestey JP and Norval M: submitted for publication). Strenuous
efforts were made to ensure that the conditions were not toxic for the effector or target
cells in the NK assay. Trypan blue exclusion and propidium iodide staining indicated no
demonstrable cell death and PBMC were not suppressed in a lymphoproliferation test.
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While the second messenger system involved in NK cell lysis remains to be identified, an
increase in intracellular Ca++ is associated with NK cell activation and this is thought to be
regulated by cyclic adenosine monophosphate (45). Significantly cis-UCA has been shown
recently to down-regulate the induction of cyclic adenosine monophosphate by trans-UCA or
histamine (46) and therefore it is possible that cis-UCA may down-regulate the second
messenger system of the NK cell.
Finally, because NK cells are thought to play a major role in tumour surveillance, it is of
concern that currently employed phototherapies result in significant suppression of NK cell
function during treatment with some UV sources and for several weeks following treatment
with all UV sources.
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LEGEND FOR FIGURES
Figure 1. The effect of therapy on NK cell activity in patients with psoriasis and
normal subjects. Psoriasis patients receiving coal tar dressing had samples
taken on 2 occasions, before (O) and during ( A ) treatment (a). Assays
were performed before (□) during (A) and after (O) broad band UV6 (b),
narrow band TL01 (c) or PUVA (d) therapy of psoriasis patients. Normal
subjects, receiving no treatment, had samples taken on 2 occasions 4 weeks
apart (e, □ and A )■ Normal subjects were assayed before (□ ) during
(A ) and after (O) UV6 therapy (f). The figures represent the mean of 5
patients in (a), 6 in (b-d) and 4 in (e,f). The SEM shown for each group
prior to treatment was approximately the same on subsequent occasions.
Figure 2. The effect of cis-UCA (a) and trans-UCA (b) on NK cell activity in vitro.
Fig.2a represents the mean + SEM of 6-11 subjects at each UCA
concentration and Fig. 2b represents the mean + SEM of 4 subjects. * p <
0.05 and ** p < 0.01 compared with the mean of the same individuals with no
UCA added, paired sample t test.
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